data_2n95_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n95 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.438 -1.055 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -97.51 158.89 15.24 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 49.3 t -63.86 112.17 2.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.99 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.95 -0.29 55.23 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.812 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 mt -100.96 -37.35 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 120.692 0.282 . . . . 0.0 111.205 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.7 p -123.6 -14.74 7.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.311 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.21 30.83 19.05 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.518 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.63 -71.03 1.27 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.342 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 m -118.34 -169.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -62.64 145.99 53.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.489 0.661 . . . . 0.0 111.612 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.54 75.18 2.02 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.435 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -66.64 -27.59 67.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.673 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 17' ' ' LYS . 2.8 m-30 -102.62 154.78 18.81 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 11.9 tmtt? -136.93 145.73 44.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.741 0.305 . . . . 0.0 110.882 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.473 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 36.6 t -99.09 107.32 43.55 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.0 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.66 1.25 5.22 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.148 2.565 . . . . 0.0 112.878 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -92.19 -52.54 4.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.798 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.5 p -105.8 -37.03 6.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.081 0.467 . . . . 0.0 111.068 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.62 19.39 8.31 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.929 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.59 158.97 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.963 0.411 . . . . 0.0 110.224 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -118.21 119.45 34.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.073 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.576 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -118.79 156.12 29.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.697 0.76 . . . . 0.0 110.886 179.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -74.66 -20.9 59.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.556 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.8 t -177.19 -171.64 0.35 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.347 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 tp -66.36 -20.64 66.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.121 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -54.75 -52.96 60.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.704 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.3 m -86.26 -18.7 31.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.779 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.404 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -61.85 -63.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -83.81 54.54 2.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.721 0.772 . . . . 0.0 110.944 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -116.48 145.93 42.94 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.853 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.51 28.65 5.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.295 0.569 . . . . 0.0 110.572 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.069 178.893 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.439 -1.02 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -104.48 160.46 14.91 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.638 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.8 t -66.2 111.83 3.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.928 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.39 -1.36 57.29 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.943 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' A' ' 27' ' ' TYR . 11.4 mt -99.53 -40.4 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.799 0.333 . . . . 0.0 111.175 -176.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.7 p -120.74 -14.48 8.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.207 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 57.01 27.99 14.12 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.034 178.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.14 -69.66 1.31 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.246 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.22 -169.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.563 0.221 . . . . 0.0 110.7 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -62.89 143.01 58.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.434 0.635 . . . . 0.0 111.587 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.416 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -92.23 70.34 1.74 Allowed Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.408 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -65.1 -23.67 67.22 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -101.93 150.46 23.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 12.8 tmtt? -135.78 144.66 45.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.641 0.257 . . . . 0.0 110.545 -174.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.512 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 15.0 t -98.99 107.68 45.18 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.912 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.55 -13.0 36.25 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.102 2.535 . . . . 0.0 113.58 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -82.22 -63.26 1.42 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.022 0.439 . . . . 0.0 111.147 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -92.12 -33.08 14.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.917 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.82 18.96 13.99 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.671 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 p -84.2 158.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.129 0.49 . . . . 0.0 110.595 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.9 mmt180 -114.49 128.88 56.56 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.924 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.638 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.72 151.19 50.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.769 0.795 . . . . 0.0 111.173 176.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.3 p -71.34 -22.51 61.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.531 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.6 p -176.94 -169.44 0.26 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.58 0.229 . . . . 0.0 111.288 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 28.9 mt -65.82 -20.38 66.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.406 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -59.3 -43.38 92.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.118 0.485 . . . . 0.0 110.073 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.6 m -93.59 -23.53 18.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.881 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.473 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -59.49 -59.38 5.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.203 0.525 . . . . 0.0 109.922 177.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -89.65 45.82 1.31 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.529 0.681 . . . . 0.0 110.953 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -108.79 141.17 41.19 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.93 22.6 11.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.216 0.531 . . . . 0.0 110.936 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.741 0 CA-C-O 121.405 0.621 . . . . 0.0 110.045 179.084 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.43 -1.47 0 CA-C-O 120.965 0.412 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -101.23 157.92 16.42 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.948 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 45.8 t -60.4 114.32 2.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.39 3.74 52.45 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.822 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.0 mt -104.44 -39.66 5.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 122.676 -0.308 . . . . 0.0 110.98 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.6 p -118.85 -18.08 8.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.578 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 59.12 29.46 19.03 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.284 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.92 -70.14 1.31 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.03 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 m -120.83 -171.93 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -54.66 146.57 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.533 0.682 . . . . 0.0 112.031 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.24 71.77 1.61 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -60.23 -25.07 65.36 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -114.29 157.82 22.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.967 0.413 . . . . 0.0 110.942 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.57 146.02 51.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.134 -175.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 48.6 t -97.61 108.53 45.93 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.761 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.18 -14.27 44.25 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 122.715 2.276 . . . . 0.0 112.964 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -81.97 -59.97 2.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.293 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.81 -34.58 11.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.954 0.407 . . . . 0.0 110.545 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.7 6.91 26.35 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.237 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.18 157.04 6.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.146 0.498 . . . . 0.0 111.434 -173.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -111.8 127.96 55.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.242 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.65 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.1 155.06 46.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.833 0.825 . . . . 0.0 111.639 178.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' SER . 26.5 p -77.8 -17.4 57.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.507 -174.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 8.5 t 176.54 -171.42 0.08 Allowed 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.275 0.36 . . . . 0.0 110.052 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.456 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 23.2 tp -64.31 -19.78 65.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.168 0.508 . . . . 0.0 110.366 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -54.92 -48.39 73.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.12 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.1 m -93.59 -18.6 22.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.727 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.456 ' CB ' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -57.77 -62.36 1.86 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.125 177.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -85.45 53.78 2.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.289 0.566 . . . . 0.0 111.165 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -109.93 144.64 38.14 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.231 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.16 27.28 5.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.191 0.52 . . . . 0.0 110.478 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.951 178.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.435 -1.194 0 CA-C-O 120.804 0.335 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 28.4 mmmt -104.29 159.29 15.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.718 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.51 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 45.6 t -62.98 114.78 3.88 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.52 8.65 39.89 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.663 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.0 mt -109.3 -50.55 6.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.857 0.361 . . . . 0.0 110.657 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.8 p -108.61 -15.45 14.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.342 0.591 . . . . 0.0 110.327 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 92.7 mtt-85 55.95 32.26 19.47 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.001 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.12 -72.01 1.29 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.183 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 m -115.49 -171.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 122.763 -0.257 . . . . 0.0 110.41 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.5 p-10 -58.86 146.16 38.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.449 0.642 . . . . 0.0 111.739 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.571 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -89.13 67.17 2.93 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.297 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -57.68 -32.06 66.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -99.04 149.06 23.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.22 144.41 50.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.686 0.279 . . . . 0.0 110.758 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 33.7 t -95.12 104.79 16.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.598 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.29 -16.13 53.35 Favored 'Trans proline' 0 N--CA 1.471 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.853 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -73.66 -60.36 2.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.721 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.0 p -97.51 -35.62 10.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.639 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.55 15.59 13.4 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.943 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 p -80.34 157.71 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.132 0.491 . . . . 0.0 110.723 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.571 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.7 mmt180 -114.24 124.71 52.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.323 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.51 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -124.9 150.92 46.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.613 0.72 . . . . 0.0 110.738 176.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 29.2 p -67.15 -28.95 68.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.443 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.9 m -167.86 -177.32 3.38 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.421 0.153 . . . . 0.0 111.019 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.46 -27.38 69.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.166 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -56.94 -43.49 81.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.513 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.1 m -85.55 -23.69 27.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.754 0.311 . . . . 0.0 110.735 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.458 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -56.56 -56.26 23.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.34 0.591 . . . . 0.0 109.479 175.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -85.5 47.67 1.47 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.528 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -107.42 143.14 36.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.453 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.52 28.0 6.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.979 0.419 . . . . 0.0 110.837 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.559 0.695 . . . . 0.0 110.255 178.893 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.441 -0.924 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 32.9 mmtp -101.87 158.87 15.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.744 0.307 . . . . 0.0 110.863 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 34.8 t -64.54 124.65 22.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.305 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.38 1.4 88.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.617 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mt -105.34 -35.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.773 0.321 . . . . 0.0 111.152 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.3 p -120.88 -17.08 7.99 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.534 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 61.08 21.78 12.13 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.05 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.67 -70.2 1.33 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.429 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.4 m -117.24 -170.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.8 p-10 -61.07 145.76 49.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.518 0.675 . . . . 0.0 111.726 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.81 69.62 1.41 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -61.85 -31.04 71.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.355 -0.422 . . . . 0.0 111.961 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -100.6 150.47 22.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.102 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.42 146.63 46.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.742 0.306 . . . . 0.0 110.482 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 t -96.07 108.64 42.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.148 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.25 -3.76 11.43 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.707 2.271 . . . . 0.0 112.593 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -88.85 -61.75 1.64 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.4 p -97.7 -26.99 14.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.926 0.393 . . . . 0.0 110.776 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.62 18.25 21.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.988 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 p -84.73 155.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.062 0.458 . . . . 0.0 110.925 -177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.67 128.92 56.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.018 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.688 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -131.89 151.07 51.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 122.0 0.905 . . . . 0.0 111.517 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -72.98 -25.74 61.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.352 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.6 p -176.1 -170.31 0.37 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.964 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 35.1 mt -62.9 -21.88 66.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.312 176.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.49 -33.18 71.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.234 0.54 . . . . 0.0 110.615 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.8 m -106.5 -20.49 13.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.748 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.445 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -61.62 -58.04 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.18 0.514 . . . . 0.0 109.895 177.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HB2' ' HZ2' ' A' ' 34' ' ' LYS . 10.6 mtmp? -87.39 49.78 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.858 -176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -111.65 145.93 38.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.483 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.26 24.67 6.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.172 0.511 . . . . 0.0 111.146 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 121.32 0.581 . . . . 0.0 110.58 -179.465 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 46.2 mmtm -100.12 152.41 20.28 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.607 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 48.2 t -55.75 117.42 3.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.604 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.12 -1.77 75.55 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.927 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.1 mt -99.87 -37.33 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.761 0.315 . . . . 0.0 110.988 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.7 p -121.03 -18.3 7.55 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.44 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.502 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 29.1 mmm180 60.55 33.61 20.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.276 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.91 -78.31 1.3 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.23 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 m -112.91 -173.33 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.53 0.205 . . . . 0.0 110.72 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 32.6 m-20 -64.15 139.14 58.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.156 0.503 . . . . 0.0 110.925 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.54 81.45 1.65 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.714 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -66.4 -25.52 66.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.964 0.411 . . . . 0.0 111.505 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -105.54 153.45 21.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.139 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.5 tmtp? -134.75 146.46 49.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.349 -0.387 . . . . 0.0 109.994 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 19.9 t -101.29 103.54 27.18 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.29 -12.48 35.79 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.796 2.331 . . . . 0.0 112.693 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -76.52 -59.55 2.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.67 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.4 p -100.69 -31.85 11.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.227 0.537 . . . . 0.0 110.644 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.06 22.96 7.97 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.275 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.82 158.81 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.913 0.387 . . . . 0.0 110.953 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -114.93 126.89 55.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.368 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.607 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -126.87 154.1 44.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.684 0.754 . . . . 0.0 111.128 177.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.0 p -71.55 -23.11 61.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.253 -1.339 . . . . 0.0 111.616 -175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.8 p 178.25 -167.92 0.07 Allowed 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.493 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 19.9 mt -63.09 -21.57 66.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.442 175.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -51.35 -46.62 62.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.251 0.548 . . . . 0.0 111.104 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.8 m -100.67 -14.99 17.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.933 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.4 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -62.44 -60.84 2.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 110.312 178.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -85.18 45.89 1.23 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.381 0.61 . . . . 0.0 111.101 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -104.92 148.61 26.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.942 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.11 13.6 6.72 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.131 0.491 . . . . 0.0 110.983 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.766 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.437 -1.1 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -95.22 159.21 15.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.0 t -62.79 118.63 7.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.278 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.52 2.86 76.41 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.682 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.462 HD13 ' HB3' ' A' ' 27' ' ' TYR . 15.7 mt -102.33 -41.71 8.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 122.683 -0.304 . . . . 0.0 111.025 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.9 p -117.66 -16.36 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.242 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 62.34 21.96 12.89 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.515 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.97 -74.82 1.16 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.402 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.32 -169.35 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -57.64 142.77 43.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.483 0.659 . . . . 0.0 111.556 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.5 70.87 0.84 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -63.28 -31.4 72.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -95.45 149.77 21.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.5 tmtp? -132.74 148.05 52.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.527 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 38.6 t -99.71 108.14 49.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.208 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 2.33 3.44 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.893 2.395 . . . . 0.0 113.188 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -97.47 -58.57 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.698 0.285 . . . . 0.0 111.095 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.27 -30.95 13.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.138 0.494 . . . . 0.0 110.498 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.33 17.51 19.69 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.845 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 p -84.7 159.31 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.0 110.777 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -115.84 127.46 55.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.914 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.645 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.19 148.55 51.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.898 0.856 . . . . 0.0 111.538 178.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.6 p -69.94 -23.48 63.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.439 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.2 p -173.5 -167.62 0.4 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 111.633 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.4 tp -70.41 -20.14 62.95 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.257 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.6 -40.27 96.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.982 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -92.27 -22.47 19.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.645 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -58.85 -58.2 9.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.222 177.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -87.7 47.21 1.47 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.213 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -107.77 141.82 38.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.46 24.53 6.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.142 0.496 . . . . 0.0 110.792 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 121.414 0.626 . . . . 0.0 109.719 178.861 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 35.5 mmtp -99.81 157.12 16.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.3 t -62.18 113.69 3.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.073 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.51 5.01 47.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.771 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.464 HD13 ' HB3' ' A' ' 27' ' ' TYR . 12.2 mt -108.41 -33.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.7 -0.294 . . . . 0.0 111.433 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.65 -14.75 6.72 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.313 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.22 30.31 18.17 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.238 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.84 -73.82 1.27 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.247 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -112.35 -169.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 122.941 -0.153 . . . . 0.0 110.596 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 9.6 p-10 -64.39 144.63 57.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.361 0.6 . . . . 0.0 111.088 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.24 73.73 1.68 Allowed Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.309 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -60.1 -33.38 72.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -100.05 157.65 16.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.85 0.357 . . . . 0.0 110.275 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 13.8 tmtt? -142.23 145.05 33.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.505 -174.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.435 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 50.6 t -95.6 114.87 64.87 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.556 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.92 -6.15 16.3 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.753 2.302 . . . . 0.0 113.34 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.23 -56.77 2.61 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.709 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.9 p -97.75 -23.04 16.09 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.016 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.89 22.63 30.05 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.407 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 p -89.62 157.55 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.216 0.531 . . . . 0.0 110.552 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -114.27 127.97 56.13 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.821 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.658 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.29 153.82 48.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.873 0.844 . . . . 0.0 111.535 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.3 p -77.28 -22.07 52.62 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.055 -176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.4 p -176.05 -167.44 0.22 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.893 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 35.1 mt -65.93 -23.4 66.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.402 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -59.66 -35.7 74.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.141 0.495 . . . . 0.0 110.743 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.5 m -100.66 -23.72 14.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.539 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.493 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -59.47 -57.41 13.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.157 0.503 . . . . 0.0 109.685 176.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -88.61 41.89 1.04 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.359 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -108.79 141.92 40.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.11 29.98 5.3 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.235 0.54 . . . . 0.0 110.515 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 121.54 0.685 . . . . 0.0 109.443 177.402 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.032 0 CA-C-O 121.233 0.54 . . . . 0.0 110.924 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.41 136.94 55.0 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.377 167.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 40.2 t -47.42 113.03 0.62 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.416 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.55 12.12 22.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.883 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 27' ' ' TYR . 16.2 mt -109.98 -41.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 O-C-N 122.727 -0.278 . . . . 0.0 110.669 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.9 p -117.1 -18.78 9.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.267 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.462 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 25.6 mmm180 59.09 33.94 23.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.609 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.44 -69.8 1.18 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.975 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.9 m -122.84 -170.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.554 0.216 . . . . 0.0 110.526 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 12.7 m-20 -63.7 140.75 58.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.125 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.97 77.11 2.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.945 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -71.48 -16.86 62.37 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -109.64 157.15 19.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.427 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.8 tmtm? -140.1 146.47 38.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.838 0.351 . . . . 0.0 111.058 -173.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.408 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.5 t -103.45 111.51 65.14 Favored Pre-proline 0 CA--C 1.515 -0.402 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.039 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.76 -0.16 7.32 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 122.584 2.189 . . . . 0.0 112.838 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -98.19 -56.06 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.557 0.218 . . . . 0.0 111.515 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.4 p -100.72 -15.81 17.57 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.059 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.36 9.73 62.93 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.628 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.54 157.35 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 121.089 0.471 . . . . 0.0 110.919 -173.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -116.47 118.86 33.84 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.964 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.567 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -117.32 155.14 30.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.811 0.815 . . . . 0.0 111.248 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.5 p -70.33 -31.6 68.96 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.176 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.2 m -171.12 -169.41 0.74 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.3 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.2 -24.42 66.62 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.726 0.298 . . . . 0.0 111.03 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -51.94 -43.38 63.43 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.478 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.2 m -96.87 -20.59 18.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.775 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.51 -62.49 1.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.674 176.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -87.91 52.91 2.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.772 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -117.97 145.01 45.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.61 10.9 7.26 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.109 0.48 . . . . 0.0 110.655 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.897 -179.721 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.439 -1.025 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -101.24 158.11 16.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 42.7 t -62.28 116.53 5.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.599 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.92 17.25 22.9 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.566 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.412 HD12 ' HB3' ' A' ' 27' ' ' TYR . 10.2 mt -117.19 -37.5 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.617 -0.343 . . . . 0.0 110.864 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.3 p -120.6 -15.21 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.258 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 59.09 29.57 19.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.22 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.74 -76.08 1.31 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.9 m -112.88 -171.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 122.864 -0.198 . . . . 0.0 110.487 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -61.27 144.29 54.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.469 0.652 . . . . 0.0 111.339 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.487 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -88.23 68.17 3.0 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 175.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -29.9 68.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -104.07 153.77 20.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -133.03 146.71 51.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.305 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 38.4 t -94.43 106.29 22.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.99 -9.02 21.69 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.963 2.442 . . . . 0.0 112.563 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -81.8 -64.77 1.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.489 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.6 p -94.32 -38.38 11.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.195 0.521 . . . . 0.0 110.888 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.29 12.86 11.36 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.387 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 p -77.28 160.32 4.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.904 0.383 . . . . 0.0 110.727 -176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 24.4 mmt180 -117.15 125.84 51.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.576 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -128.13 156.2 43.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.904 0.859 . . . . 0.0 111.426 178.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.3 p -75.97 -21.2 57.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.677 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 t 179.08 -171.39 0.13 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 79.2 mt -65.94 -20.67 66.29 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.773 0.32 . . . . 0.0 110.357 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -55.62 -32.22 62.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.82 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.9 m -110.56 -20.49 12.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.094 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.79 -57.92 10.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.305 0.574 . . . . 0.0 109.548 176.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.75 50.82 2.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.631 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -114.33 147.71 38.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.118 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.07 14.0 7.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.042 0.449 . . . . 0.0 110.973 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 121.339 0.59 . . . . 0.0 110.137 -179.354 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -103.74 157.09 17.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.968 0.413 . . . . 0.0 110.807 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.6 t -62.35 115.77 4.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.553 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.89 12.85 40.31 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.644 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.417 HD11 ' HB3' ' A' ' 27' ' ' TYR . 7.7 mt -112.83 -38.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.737 0.303 . . . . 0.0 111.053 -177.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.1 p -119.9 -16.64 8.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.266 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 63.35 32.21 14.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.152 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.0 -81.73 1.41 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.304 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.27 -169.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.971 -0.135 . . . . 0.0 110.895 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -63.28 141.27 58.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.313 0.577 . . . . 0.0 111.03 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.58 75.52 2.35 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -60.6 -30.17 69.67 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.94 151.86 24.72 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -134.66 145.64 48.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.481 ' CB ' ' HH ' ' A' ' 27' ' ' TYR . 22.0 t -97.11 107.42 37.82 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.97 0.42 5.08 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.086 2.524 . . . . 0.0 113.454 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -94.14 -63.81 1.15 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.018 0.437 . . . . 0.0 110.927 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.5 p -92.85 -26.64 17.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.181 0.515 . . . . 0.0 110.492 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.2 21.33 18.01 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.672 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.24 155.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.158 0.504 . . . . 0.0 110.601 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -112.86 129.74 56.35 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.791 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.614 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.91 148.82 52.72 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.803 0.811 . . . . 0.0 111.516 177.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -71.77 -19.92 61.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.691 -175.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 8.2 t 176.93 -168.02 0.05 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.233 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 45.8 mt -64.24 -23.22 67.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.385 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -60.12 -31.7 70.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.044 0.45 . . . . 0.0 110.985 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.4 m -106.14 -21.5 13.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.729 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -59.5 -56.57 20.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.582 0.706 . . . . 0.0 109.489 176.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -91.47 39.81 1.01 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.111 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -103.15 140.57 37.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.68 19.66 13.77 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.231 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.226 0.536 . . . . 0.0 110.02 178.844 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.435 -1.223 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -101.2 154.43 18.76 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.619 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.2 t -58.28 116.1 3.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.525 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.74 6.08 49.09 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.791 -177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.456 HD11 ' HB3' ' A' ' 27' ' ' TYR . 8.6 mt -107.85 -38.73 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 120.654 0.264 . . . . 0.0 111.11 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.6 p -119.75 -15.42 8.9 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.605 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.514 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 29.3 mmm180 59.19 24.93 13.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.332 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.59 -73.53 1.27 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.268 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.8 m -114.84 -169.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.34 145.35 51.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.439 0.637 . . . . 0.0 111.421 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.401 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -93.65 72.99 1.23 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -65.93 -32.0 73.24 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -95.72 149.83 21.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.528 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.2 tmtp? -134.1 147.85 50.92 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.528 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.7 t -100.23 109.34 56.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.466 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.72 -5.39 14.19 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.988 2.458 . . . . 0.0 112.788 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -88.94 -60.71 1.88 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.907 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.4 p -96.51 -29.82 13.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.941 0.401 . . . . 0.0 111.067 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.2 21.5 11.67 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.896 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 p -89.31 158.83 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.075 0.464 . . . . 0.0 110.655 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 23.1 mmt180 -114.69 128.13 56.14 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.171 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.619 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -127.65 153.25 46.68 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.84 0.829 . . . . 0.0 110.817 176.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.0 p -70.49 -34.39 72.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.044 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.3 m -168.8 -172.43 1.6 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.018 -173.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 22.5 mt -62.19 -23.42 66.61 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.55 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -55.98 -51.63 67.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.703 0.763 . . . . 0.0 110.273 -179.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.5 m -85.39 -24.3 27.6 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.315 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.41 -60.64 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.052 178.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -87.48 44.23 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.064 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -110.77 139.69 45.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.661 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.02 23.77 9.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.115 0.483 . . . . 0.0 110.843 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 178.913 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.441 -0.884 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -103.96 157.67 16.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.865 0.364 . . . . 0.0 110.592 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.1 t -63.2 117.21 6.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.245 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.4 ' HA2' ' CZ ' ' A' ' 12' ' ' ARG . . . -80.67 5.38 65.08 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.666 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mt -105.25 -40.63 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 120.725 0.298 . . . . 0.0 110.975 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.3 p -117.99 -14.07 10.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.197 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.4 ' CZ ' ' HA2' ' A' ' 9' ' ' GLY . 38.6 mmt180 57.7 29.01 16.65 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.552 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.71 -77.91 1.27 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.359 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.0 m -113.42 -169.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.35 143.32 57.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.469 0.652 . . . . 0.0 111.422 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.445 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -88.69 76.9 1.84 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 175.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -64.08 -28.09 69.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -104.93 159.32 15.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.583 0.23 . . . . 0.0 110.547 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.494 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.2 tmtp? -135.7 145.76 47.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.732 0.301 . . . . 0.0 110.779 -174.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.501 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 33.8 t -100.63 102.92 20.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.3 -7.93 18.97 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 122.782 2.321 . . . . 0.0 113.269 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -79.31 -61.9 1.86 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.067 0.461 . . . . 0.0 110.967 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.2 p -97.58 -31.94 12.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.664 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.37 14.29 18.64 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.982 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 p -82.12 156.27 4.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.148 0.499 . . . . 0.0 110.913 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 24.3 mmt180 -113.34 121.5 44.56 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.014 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.579 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -119.47 148.33 43.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.859 0.838 . . . . 0.0 111.079 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.5 p -65.99 -26.14 67.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.518 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 p -176.11 -171.2 0.42 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.366 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.36 -20.88 66.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.671 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.54 -39.9 81.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.089 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.9 m -98.39 -17.82 18.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -65.02 0.73 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.912 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -85.06 48.16 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.217 0.532 . . . . 0.0 111.646 -174.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -106.73 150.0 26.73 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.511 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.09 29.03 4.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.166 0.508 . . . . 0.0 110.716 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.041 177.532 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 69.9 mmtt -98.35 159.87 14.66 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.634 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 44.0 t -63.43 114.24 3.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.057 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.01 7.85 41.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.578 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.401 HD11 ' HB3' ' A' ' 27' ' ' TYR . 7.7 mt -110.17 -38.69 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 122.672 -0.311 . . . . 0.0 111.078 -177.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 p -121.78 -15.09 7.99 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.445 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 61.89 22.89 13.37 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.91 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.25 -72.59 1.2 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.307 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.1 -169.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.9 p-10 -59.66 145.52 44.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.505 0.669 . . . . 0.0 111.806 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.88 69.39 2.43 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -63.11 -27.37 69.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.335 -0.433 . . . . 0.0 111.835 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -99.75 148.03 24.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.785 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER -137.13 145.52 43.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.805 0.335 . . . . 0.0 110.292 -174.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.546 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 43.3 t -98.2 108.29 46.24 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.183 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.11 0.03 5.01 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 122.811 2.34 . . . . 0.0 112.967 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -96.16 -60.32 1.65 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.62 0.248 . . . . 0.0 111.419 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.8 p -95.38 -27.15 15.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.038 0.447 . . . . 0.0 110.676 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.23 20.95 21.62 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.548 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 p -86.14 158.0 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.05 0.452 . . . . 0.0 110.187 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -115.65 128.15 55.71 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.912 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.634 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.74 147.53 52.41 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.985 0.898 . . . . 0.0 110.909 177.099 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.2 p -66.98 -31.71 72.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.347 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.4 ' HG ' ' C ' ' A' ' 28' ' ' CYS . 68.0 m -167.9 -176.25 2.99 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.647 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 47.8 mt -61.19 -26.3 67.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -56.26 -38.1 70.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.02 0.438 . . . . 0.0 111.127 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.2 m -95.11 -23.91 17.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.581 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.458 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -61.17 -57.8 10.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.807 176.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -85.27 43.56 1.02 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.331 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -111.35 149.17 31.53 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.82 3.23 6.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.014 0.435 . . . . 0.0 111.01 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.362 0.601 . . . . 0.0 110.103 179.395 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -104.15 154.74 19.38 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 44.9 t -59.46 112.21 1.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.322 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.85 0.62 43.8 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.776 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.417 HD12 ' HB3' ' A' ' 27' ' ' TYR . 11.3 mt -103.14 -40.51 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 122.755 -0.262 . . . . 0.0 111.206 -174.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.2 p -119.0 -18.44 8.78 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.323 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.32 36.51 27.62 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.026 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.54 -62.91 0.98 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.126 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -125.75 -176.2 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.722 0.296 . . . . 0.0 111.254 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.74 135.29 55.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.551 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -86.95 74.82 2.27 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -68.34 -31.13 70.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -95.47 152.32 18.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.677 0.275 . . . . 0.0 110.331 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -134.31 145.82 49.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.864 0.364 . . . . 0.0 111.045 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 35.5 t -100.48 108.49 53.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.789 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.94 -13.33 39.55 Favored 'Trans proline' 0 N--CA 1.471 0.174 0 C-N-CA 122.832 2.354 . . . . 0.0 112.744 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -82.82 -56.64 3.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.538 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.5 p -101.04 -29.47 12.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.969 0.414 . . . . 0.0 110.523 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.11 7.1 31.33 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.321 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 p -77.28 157.78 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.046 0.45 . . . . 0.0 111.447 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.1 mmt180 -115.0 124.33 51.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.22 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.579 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -123.89 153.93 40.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.616 0.722 . . . . 0.0 110.825 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -70.08 -33.07 71.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.981 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.401 ' HG ' ' C ' ' A' ' 28' ' ' CYS . 74.1 m -168.08 -173.53 2.08 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.589 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.65 -25.0 67.76 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.69 -41.07 73.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.923 0.392 . . . . 0.0 111.162 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.5 m -91.18 -23.0 20.37 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.803 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -60.91 2.93 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -86.95 52.79 2.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.226 0.536 . . . . 0.0 111.314 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -119.0 141.63 48.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.57 10.42 13.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.957 0.408 . . . . 0.0 111.16 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.326 -179.632 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.437 -1.121 0 CA-C-O 120.702 0.287 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -108.27 161.6 14.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.598 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 49.4 t -65.47 116.36 6.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.572 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.85 -4.87 78.09 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.785 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.6 mt -98.0 -40.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.795 0.331 . . . . 0.0 110.963 -174.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.5 p -117.65 -15.71 10.14 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.417 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 61.38 32.55 19.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.456 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.0 -82.88 1.47 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.292 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.03 -168.96 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.649 0.262 . . . . 0.0 110.814 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.22 139.16 58.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.28 0.562 . . . . 0.0 111.964 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.72 70.45 3.17 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -62.36 -27.46 69.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.503 -0.349 . . . . 0.0 111.753 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.7 153.88 20.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -138.17 143.79 40.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.729 0.299 . . . . 0.0 110.333 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.436 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 18.8 t -98.72 107.48 43.24 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.818 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.22 -9.97 27.01 Favored 'Trans proline' 0 C--N 1.335 -0.156 0 C-N-CA 122.776 2.317 . . . . 0.0 112.824 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.92 -62.5 1.55 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.209 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -93.66 -28.69 15.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.106 0.479 . . . . 0.0 110.496 -176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.3 10.73 35.55 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.802 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 p -79.11 157.99 4.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.153 0.501 . . . . 0.0 111.368 -174.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -113.0 126.54 55.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.199 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.598 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -127.47 148.28 50.31 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.861 0.838 . . . . 0.0 110.716 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -65.57 -32.28 73.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.294 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.5 m -168.62 -169.92 1.12 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.859 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.69 -27.62 68.48 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.426 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.46 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -55.47 -45.0 76.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.51 0.671 . . . . 0.0 111.22 -177.236 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.7 m -87.69 -23.15 24.28 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.71 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.28 -63.03 1.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.782 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -84.98 52.53 2.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.201 0.524 . . . . 0.0 110.842 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -112.42 148.99 33.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.68 15.84 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.077 0.465 . . . . 0.0 110.799 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.441 0.639 . . . . 0.0 109.759 179.644 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.443 -0.8 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.2 mmtt -110.08 158.11 18.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 0.0 110.734 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.655 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 33.9 t -66.16 113.95 4.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.123 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.23 3.06 59.57 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.861 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.465 HD12 ' HB3' ' A' ' 27' ' ' TYR . 16.5 mt -103.0 -40.55 6.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 122.715 -0.286 . . . . 0.0 110.955 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.7 p -118.09 -16.2 9.81 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.291 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 59.54 24.5 13.24 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.334 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.61 -69.76 1.36 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.408 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 m -120.79 -168.87 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.5 m-20 -66.77 142.8 57.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.133 0.492 . . . . 0.0 111.243 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.47 78.22 1.64 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -66.89 -33.44 75.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.883 0.373 . . . . 0.0 111.351 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.31 153.8 18.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 12.1 tmtt? -142.81 145.18 32.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.639 0.257 . . . . 0.0 110.694 -175.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.0 t -96.58 113.46 62.69 Favored Pre-proline 0 CA--C 1.516 -0.34 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.04 -13.77 41.38 Favored 'Trans proline' 0 C--N 1.334 -0.233 0 C-N-CA 122.575 2.184 . . . . 0.0 112.385 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -88.29 -56.02 3.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.819 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.0 p -98.35 -21.44 16.61 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.162 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.0 16.74 46.54 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.637 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.81 158.91 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 120.961 0.41 . . . . 0.0 110.4 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -116.62 129.07 55.94 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.014 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.655 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.96 152.94 48.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.795 0.807 . . . . 0.0 111.133 177.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.8 p -72.78 -20.5 61.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.442 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.4 p -178.28 -169.39 0.19 Allowed 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.291 0.369 . . . . 0.0 110.422 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 33.9 mt -65.34 -20.24 66.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.424 175.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -59.15 -39.47 82.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.162 0.506 . . . . 0.0 110.724 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.6 m -97.87 -22.31 16.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.453 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -57.96 -58.85 6.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.83 177.466 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -90.72 35.52 0.89 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.095 0.474 . . . . 0.0 111.07 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -101.13 122.32 43.39 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.36 17.11 24.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.904 0.383 . . . . 0.0 111.076 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.102 178.667 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.454 HG11 ' HG3' ' A' ' 26' ' ' ARG . 4.2 p . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.5 mmtt -99.54 156.82 16.85 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.5 t -62.59 111.93 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.424 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.7 24.7 3.13 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.664 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 mt -125.08 -39.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 122.666 -0.314 . . . . 0.0 110.857 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.4 p -119.78 -16.25 8.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.13 0.491 . . . . 0.0 110.745 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 56.75 27.69 13.14 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.518 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.19 -68.87 1.41 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.006 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.46 -168.91 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.514 0.197 . . . . 0.0 110.547 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.9 p-10 -61.31 146.52 47.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.418 0.628 . . . . 0.0 111.629 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.03 70.31 2.29 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.429 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -25.15 66.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.884 0.373 . . . . 0.0 111.805 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -98.68 149.49 22.77 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -131.73 145.66 51.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.822 0.344 . . . . 0.0 111.053 -174.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.53 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 43.4 t -102.51 107.28 53.24 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.109 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.33 -9.93 27.41 Favored 'Trans proline' 0 N--CA 1.472 0.236 0 C-N-CA 122.883 2.389 . . . . 0.0 112.97 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -82.7 -49.16 10.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.5 p -111.12 -33.18 6.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.844 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.45 16.2 13.74 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.152 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 p -81.19 158.9 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 110.675 -176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HD3' ' HG2' ' A' ' 19' ' ' LYS . 61.3 mmt-85 -114.58 121.35 43.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.296 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.533 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -122.24 155.88 34.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.548 0.689 . . . . 0.0 110.909 176.211 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.1 p -71.21 -34.08 70.5 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.807 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -167.58 -172.93 2.04 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.328 -174.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 tp -62.77 -31.59 72.58 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 122.65 0.38 . . . . 0.0 111.508 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -53.6 -43.34 68.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.544 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.6 m -87.99 -23.1 23.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.66 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.491 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -56.67 -58.73 6.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.141 177.092 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -87.04 50.8 2.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.409 0.623 . . . . 0.0 111.526 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -109.87 150.76 27.95 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.12 -0.6 5.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.246 0.546 . . . . 0.0 111.002 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.75 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.057 -179.869 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.432 -1.372 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.45 158.68 16.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.3 t -63.66 115.73 5.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.15 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.441 ' HA2' ' CZ ' ' A' ' 12' ' ' ARG . . . -81.3 17.86 12.07 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.494 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 mt -119.13 -46.03 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 120.853 0.359 . . . . 0.0 110.742 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.0 p -110.6 -13.87 14.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.485 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.441 ' CZ ' ' HA2' ' A' ' 9' ' ' GLY . 35.4 mmt180 55.45 30.63 15.41 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.833 178.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.24 -69.13 1.01 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.348 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.13 -170.18 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 121.276 -0.17 . . . . 0.0 110.765 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 5.7 p-10 -63.27 145.79 54.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.326 0.584 . . . . 0.0 111.619 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.496 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -92.1 65.74 2.21 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.365 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.446 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 6.7 ptpp? -56.89 -36.3 69.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.446 ' CD1' ' HG3' ' A' ' 17' ' ' LYS . 3.7 m-30 -94.65 149.63 21.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 13.1 tmtt? -134.43 144.29 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.789 0.328 . . . . 0.0 110.771 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.488 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 25.1 t -97.98 107.35 40.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.806 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.64 -10.07 26.69 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.04 2.493 . . . . 0.0 113.565 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -84.55 -63.11 1.39 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.908 0.385 . . . . 0.0 111.232 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.6 p -94.05 -32.34 13.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.201 0.524 . . . . 0.0 110.601 -173.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.41 21.47 9.3 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.168 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 p -88.04 158.74 3.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.969 0.414 . . . . 0.0 110.618 -177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 21.5 mmt180 -116.02 129.53 56.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.011 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.576 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -131.32 151.05 51.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.702 0.763 . . . . 0.0 110.949 177.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.0 p -71.24 -19.61 62.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.751 -174.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.3 t -175.94 -171.35 0.44 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.76 0.315 . . . . 0.0 110.547 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.41 ' HG ' ' HE2' ' A' ' 34' ' ' LYS . 37.2 tp -69.89 -19.82 63.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.529 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.56 -49.34 77.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.051 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.4 m -81.53 -20.88 39.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.67 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -59.32 -59.57 5.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.869 176.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HE2' ' HG ' ' A' ' 30' ' ' LEU . 55.0 mtmt -84.86 54.31 3.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.632 0.73 . . . . 0.0 110.999 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -111.64 149.79 31.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.564 174.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.57 13.05 7.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.731 0.3 . . . . 0.0 111.628 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 121.382 0.61 . . . . 0.0 110.092 -179.736 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 4.0 p . . . . . 0 N--CA 1.434 -1.254 0 CA-C-O 120.603 0.24 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -106.18 154.01 21.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.7 t -59.41 110.02 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.538 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.26 18.14 3.63 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.732 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.432 HD13 ' HB3' ' A' ' 27' ' ' TYR . 7.5 mt -119.98 -36.1 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.565 0.221 . . . . 0.0 111.15 -177.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.84 -14.7 6.64 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.439 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 5.7 mpt_? 58.77 28.9 17.98 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.835 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.4 -78.06 1.14 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.699 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.07 -171.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 6.2 p-10 -58.12 144.21 41.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.51 0.672 . . . . 0.0 111.425 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.585 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -86.92 68.54 3.22 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.175 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -58.86 -34.29 71.43 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -94.94 146.7 24.06 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.65 145.98 51.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.822 0.344 . . . . 0.0 110.772 -174.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 t -98.4 106.75 37.93 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.951 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.41 -6.41 16.36 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.615 2.21 . . . . 0.0 113.119 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.64 -63.48 1.31 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.866 0.365 . . . . 0.0 111.037 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.8 p -93.97 -30.29 14.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.049 0.452 . . . . 0.0 110.245 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.72 7.96 35.56 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.051 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 p -74.68 157.34 6.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.42 . . . . 0.0 111.002 -173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 22.2 mmt180 -114.73 125.75 54.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.518 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.593 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -128.02 153.22 47.01 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.724 0.773 . . . . 0.0 110.986 177.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.8 p -74.5 -20.24 60.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.434 -175.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.7 t -175.08 -177.03 1.01 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.683 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.0 tp -62.8 -24.98 68.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.081 0.467 . . . . 0.0 110.22 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -52.36 -54.05 36.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.261 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -84.1 -20.01 33.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.406 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -57.48 -56.14 25.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -89.55 47.34 1.46 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.693 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.55 133.26 53.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.11 25.38 11.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.064 0.459 . . . . 0.0 111.207 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.679 0 CA-C-O 121.445 0.641 . . . . 0.0 109.805 178.147 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.723 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.67 87.62 1.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.126 2.551 . . . . 0.0 112.406 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -112.63 -23.03 10.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.422 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -72.5 147.57 45.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.921 0.391 . . . . 0.0 110.33 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.5 19.6 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.7 t 61.23 68.88 0.7 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.866 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -79.8 51.61 1.34 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.919 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.97 166.71 29.82 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.774 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.8 p -135.3 154.46 35.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.815 -172.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -97.51 158.89 15.24 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 49.3 t -63.86 112.17 2.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.99 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.95 -0.29 55.23 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.812 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 mt -100.96 -37.35 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 120.692 0.282 . . . . 0.0 111.205 -175.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.7 p -123.6 -14.74 7.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.311 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.21 30.83 19.05 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.518 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.63 -71.03 1.27 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.342 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 m -118.34 -169.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -62.64 145.99 53.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.489 0.661 . . . . 0.0 111.612 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.54 75.18 2.02 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.435 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -66.64 -27.59 67.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.673 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 17' ' ' LYS . 2.8 m-30 -102.62 154.78 18.81 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 11.9 tmtt? -136.93 145.73 44.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.741 0.305 . . . . 0.0 110.882 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.473 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 36.6 t -99.09 107.32 43.55 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.0 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.66 1.25 5.22 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.148 2.565 . . . . 0.0 112.878 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.407 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 13.9 mmmm -92.19 -52.54 4.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.798 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.5 p -105.8 -37.03 6.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.081 0.467 . . . . 0.0 111.068 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.62 19.39 8.31 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.929 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.59 158.97 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.963 0.411 . . . . 0.0 110.224 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -118.21 119.45 34.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.073 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.576 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -118.79 156.12 29.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.697 0.76 . . . . 0.0 110.886 179.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -74.66 -20.9 59.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.556 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.8 t -177.19 -171.64 0.35 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.347 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 tp -66.36 -20.64 66.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.121 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -54.75 -52.96 60.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.704 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 89.3 m -86.26 -18.7 31.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.779 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.404 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -61.85 -63.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -83.81 54.54 2.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.721 0.772 . . . . 0.0 110.944 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.576 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 8.3 t70 -116.48 145.93 42.94 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.853 175.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.51 28.65 5.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.295 0.569 . . . . 0.0 110.572 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.82 -43.9 2.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.069 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -109.59 -32.82 6.98 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.561 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.576 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 10.0 t-160 -82.89 89.75 6.88 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -93.23 126.97 45.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.614 0.721 . . . . 0.0 112.187 -170.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.407 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 4.2 m170 -122.4 64.45 0.95 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.382 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 44' ' ' SER . 62.7 tttp -89.8 -46.21 8.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.623 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 67.0 -82.12 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.225 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 26.9 t -113.99 -175.94 2.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.83 -49.12 78.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.634 174.459 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.57 81.51 2.31 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.648 2.232 . . . . 0.0 112.494 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -111.68 8.37 20.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.969 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm -117.6 173.95 6.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.935 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.77 -43.44 98.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 m -103.2 -46.49 4.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.801 -0.182 . . . . 0.0 110.643 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.1 m 57.55 46.12 18.29 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.373 0.606 . . . . 0.0 110.092 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.49 147.08 30.82 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.564 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p -113.12 152.37 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.938 -173.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -104.48 160.46 14.91 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.638 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.8 t -66.2 111.83 3.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.928 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.39 -1.36 57.29 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.943 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.454 HD13 ' HB2' ' A' ' 39' ' ' HIS . 11.4 mt -99.53 -40.4 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.799 0.333 . . . . 0.0 111.175 -176.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.7 p -120.74 -14.48 8.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.207 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.403 ' HD3' ' N ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER 57.01 27.99 14.12 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.034 178.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.14 -69.66 1.31 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.246 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.22 -169.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.563 0.221 . . . . 0.0 110.7 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -62.89 143.01 58.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.434 0.635 . . . . 0.0 111.587 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.416 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -92.23 70.34 1.74 Allowed Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.408 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -65.1 -23.67 67.22 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -101.93 150.46 23.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 12.8 tmtt? -135.78 144.66 45.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.641 0.257 . . . . 0.0 110.545 -174.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.512 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 15.0 t -98.99 107.68 45.18 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.912 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.55 -13.0 36.25 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.102 2.535 . . . . 0.0 113.58 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 68.7 mmtt -82.22 -63.26 1.42 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.022 0.439 . . . . 0.0 111.147 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -92.12 -33.08 14.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.917 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.82 18.96 13.99 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.671 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 p -84.2 158.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.129 0.49 . . . . 0.0 110.595 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.9 mmt180 -114.49 128.88 56.56 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.924 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.638 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.72 151.19 50.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.769 0.795 . . . . 0.0 111.173 176.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.3 p -71.34 -22.51 61.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.531 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.6 p -176.94 -169.44 0.26 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.58 0.229 . . . . 0.0 111.288 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 28.9 mt -65.82 -20.38 66.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.406 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -59.3 -43.38 92.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.118 0.485 . . . . 0.0 110.073 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 91.6 m -93.59 -23.53 18.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.881 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.473 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -59.49 -59.38 5.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.203 0.525 . . . . 0.0 109.922 177.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -89.65 45.82 1.31 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.529 0.681 . . . . 0.0 110.953 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.557 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.8 t70 -108.79 141.17 41.19 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.93 22.6 11.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.216 0.531 . . . . 0.0 110.936 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.33 -44.47 3.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.405 0.621 . . . . 0.0 110.045 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -105.46 -33.45 8.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.818 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.557 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 11.0 t-80 -95.7 99.96 11.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.666 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.0 t -126.13 145.7 33.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.335 0.588 . . . . 0.0 111.046 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 5.0 m170 -113.58 164.06 14.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.606 -176.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -130.76 15.26 5.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.76 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -71.79 115.09 10.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.979 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.0 m -77.82 83.42 4.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.179 0.514 . . . . 0.0 111.433 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -72.6 -28.43 62.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.087 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.844 177.731 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.75 20.24 0.9 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.503 2.802 . . . . 0.0 113.039 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 42.4 m80 71.89 -71.97 0.12 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.388 0.675 . . . . 0.0 111.917 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttp -131.6 145.58 51.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.721 0.296 . . . . 0.0 110.475 -174.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.02 70.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.729 0.776 . . . . 0.0 110.361 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.9 t -145.14 105.35 4.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.3 m 63.12 55.62 1.89 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.518 0.675 . . . . 0.0 109.295 -169.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.64 -176.96 5.16 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.225 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 p -126.56 144.82 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.717 -172.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -101.23 157.92 16.42 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.948 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 45.8 t -60.4 114.32 2.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.39 3.74 52.45 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.822 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.0 mt -104.44 -39.66 5.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 122.676 -0.308 . . . . 0.0 110.98 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.6 p -118.85 -18.08 8.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.578 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 59.12 29.46 19.03 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.284 -178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.92 -70.14 1.31 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.03 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 m -120.83 -171.93 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -54.66 146.57 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.533 0.682 . . . . 0.0 112.031 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.24 71.77 1.61 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -60.23 -25.07 65.36 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -114.29 157.82 22.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.967 0.413 . . . . 0.0 110.942 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.57 146.02 51.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.134 -175.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.406 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 48.6 t -97.61 108.53 45.93 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.761 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.18 -14.27 44.25 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 122.715 2.276 . . . . 0.0 112.964 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -81.97 -59.97 2.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.293 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.81 -34.58 11.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.954 0.407 . . . . 0.0 110.545 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.7 6.91 26.35 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.237 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 p -75.18 157.04 6.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.146 0.498 . . . . 0.0 111.434 -173.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -111.8 127.96 55.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.242 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.65 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.1 155.06 46.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.833 0.825 . . . . 0.0 111.639 178.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' SER . 26.5 p -77.8 -17.4 57.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.507 -174.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 8.5 t 176.54 -171.42 0.08 Allowed 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.275 0.36 . . . . 0.0 110.052 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.456 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 23.2 tp -64.31 -19.78 65.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.168 0.508 . . . . 0.0 110.366 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -54.92 -48.39 73.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.12 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 93.1 m -93.59 -18.6 22.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.727 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.456 ' CB ' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -57.77 -62.36 1.86 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.125 177.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -85.45 53.78 2.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.289 0.566 . . . . 0.0 111.165 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.5 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 12.2 t70 -109.93 144.64 38.14 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.231 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.16 27.28 5.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.191 0.52 . . . . 0.0 110.478 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.97 -41.61 3.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.951 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -112.42 -35.59 5.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.262 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.5 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 18.6 t-160 -80.73 105.18 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.78 138.87 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.414 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -131.17 114.44 15.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.895 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -124.48 142.27 51.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.17 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 61.09 -168.19 0.18 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.682 0.614 . . . . 0.0 110.064 -175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.4 m 64.54 -72.85 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.16 0.584 . . . . 0.0 111.874 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -93.66 -20.06 20.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.036 0.446 . . . . 0.0 110.622 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.02 179.229 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.37 -33.9 68.32 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.937 2.425 . . . . 0.0 112.367 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -115.31 50.09 1.02 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.981 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp 67.27 168.54 0.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.213 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.439 ' C ' ' H ' ' A' ' 4' ' ' SER . 32.1 m -121.24 9.84 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 m 71.81 -31.21 0.22 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.606 0.763 . . . . 0.0 112.303 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 2' ' ' VAL . 19.9 m -67.92 -33.76 75.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.0 111.763 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.77 157.41 16.3 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 120.961 0.41 . . . . 0.0 109.975 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.4 p -128.59 145.66 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.523 -173.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 28.4 mmmt -104.29 159.29 15.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.718 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.51 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 45.6 t -62.98 114.78 3.88 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.52 8.65 39.89 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.663 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.451 HG21 ' HB2' ' A' ' 38' ' ' LYS . 17.0 mt -109.3 -50.55 6.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.857 0.361 . . . . 0.0 110.657 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.8 p -108.61 -15.45 14.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.342 0.591 . . . . 0.0 110.327 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 92.7 mtt-85 55.95 32.26 19.47 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.001 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.12 -72.01 1.29 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.183 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 m -115.49 -171.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 122.763 -0.257 . . . . 0.0 110.41 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.5 p-10 -58.86 146.16 38.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.449 0.642 . . . . 0.0 111.739 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.571 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -89.13 67.17 2.93 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.297 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 ptpp? -57.68 -32.06 66.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -99.04 149.06 23.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.22 144.41 50.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.686 0.279 . . . . 0.0 110.758 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 33.7 t -95.12 104.79 16.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.598 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.29 -16.13 53.35 Favored 'Trans proline' 0 N--CA 1.471 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.853 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -73.66 -60.36 2.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.721 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.0 p -97.51 -35.62 10.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.639 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.55 15.59 13.4 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.943 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 p -80.34 157.71 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.132 0.491 . . . . 0.0 110.723 -177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.571 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.7 mmt180 -114.24 124.71 52.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.323 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.51 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -124.9 150.92 46.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.613 0.72 . . . . 0.0 110.738 176.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 29.2 p -67.15 -28.95 68.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.443 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.9 m -167.86 -177.32 3.38 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.421 0.153 . . . . 0.0 111.019 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.46 -27.38 69.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.166 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -56.94 -43.49 81.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.513 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.1 m -85.55 -23.69 27.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.754 0.311 . . . . 0.0 110.735 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.458 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -56.56 -56.26 23.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.34 0.591 . . . . 0.0 109.479 175.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -85.5 47.67 1.47 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.528 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.573 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 10.1 t70 -107.42 143.14 36.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.453 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.52 28.0 6.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.979 0.419 . . . . 0.0 110.837 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.67 -43.74 2.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.559 0.695 . . . . 0.0 110.255 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 10' ' ' ILE . 99.4 mttt -110.88 -35.18 6.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.078 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.573 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 9.3 t-80 -78.45 93.91 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -104.13 132.91 49.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.419 0.628 . . . . 0.0 111.955 -170.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -130.04 28.38 5.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.702 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.0 tptt 70.55 -60.97 0.48 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.083 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -142.05 143.74 33.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.9 m -154.29 82.79 1.12 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.959 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.29 -37.03 15.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.059 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.146 177.879 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.54 77.42 2.57 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.65 2.233 . . . . 0.0 112.609 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -73.53 -33.54 64.79 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 tpp -119.82 120.89 37.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.658 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -121.74 20.05 5.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 122.011 0.91 . . . . 0.0 109.787 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.1 m 65.09 19.27 11.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.34 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -89.42 -14.11 36.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.268 0.556 . . . . 0.0 110.091 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.75 155.47 18.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.093 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.5 157.67 19.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.803 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 32.9 mmtp -101.87 158.87 15.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.744 0.307 . . . . 0.0 110.863 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.688 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 34.8 t -64.54 124.65 22.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.305 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.38 1.4 88.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.617 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mt -105.34 -35.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.773 0.321 . . . . 0.0 111.152 -176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.3 p -120.88 -17.08 7.99 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.534 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 61.08 21.78 12.13 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.05 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.67 -70.2 1.33 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.429 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.4 m -117.24 -170.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.8 p-10 -61.07 145.76 49.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.518 0.675 . . . . 0.0 111.726 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.81 69.62 1.41 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -61.85 -31.04 71.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.355 -0.422 . . . . 0.0 111.961 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -100.6 150.47 22.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.102 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.42 146.63 46.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.742 0.306 . . . . 0.0 110.482 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.8 t -96.07 108.64 42.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.148 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.25 -3.76 11.43 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.707 2.271 . . . . 0.0 112.593 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -88.85 -61.75 1.64 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.4 p -97.7 -26.99 14.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.926 0.393 . . . . 0.0 110.776 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.62 18.25 21.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.988 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.403 HG13 ' CD2' ' A' ' 39' ' ' HIS . 4.1 p -84.73 155.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.062 0.458 . . . . 0.0 110.925 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.67 128.92 56.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.018 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.688 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -131.89 151.07 51.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 122.0 0.905 . . . . 0.0 111.517 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -72.98 -25.74 61.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.352 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.6 p -176.1 -170.31 0.37 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.964 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 35.1 mt -62.9 -21.88 66.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.312 176.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.49 -33.18 71.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.234 0.54 . . . . 0.0 110.615 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.8 m -106.5 -20.49 13.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.748 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.445 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -61.62 -58.04 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.18 0.514 . . . . 0.0 109.895 177.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HB2' ' HZ2' ' A' ' 34' ' ' LYS . 10.6 mtmp? -87.39 49.78 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.858 -176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.555 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 8.3 t70 -111.65 145.93 38.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.483 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.26 24.67 6.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.172 0.511 . . . . 0.0 111.146 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.22 -42.72 2.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.32 0.581 . . . . 0.0 110.58 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -112.12 -28.57 7.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.004 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.555 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 18.2 t-160 -84.62 98.57 10.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.3 t -92.51 114.21 29.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.468 0.651 . . . . 0.0 112.191 -170.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -126.85 -56.07 1.37 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.844 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -96.34 86.73 4.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.177 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -154.0 143.98 21.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.995 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.6 t -149.06 80.42 1.42 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.47 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -61.17 105.05 0.44 Allowed 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.412 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 . . . . . 0 C--O 1.248 0.996 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.66 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -52.12 126.77 21.29 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.092 2.528 . . . . 0.0 112.441 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -102.51 62.04 0.84 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.161 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtm -110.1 -65.39 1.16 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.224 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 t 52.12 46.47 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.711 0.767 . . . . 0.0 110.38 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 m -94.98 -14.3 24.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.104 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.3 m -147.21 89.06 1.76 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.959 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.12 148.61 22.18 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.248 0.546 . . . . 0.0 109.578 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -131.39 143.16 41.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.073 -170.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 46.2 mmtm -100.12 152.41 20.28 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.607 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 48.2 t -55.75 117.42 3.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.604 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.12 -1.77 75.55 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.927 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.1 mt -99.87 -37.33 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.761 0.315 . . . . 0.0 110.988 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.7 p -121.03 -18.3 7.55 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.44 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.502 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 29.1 mmm180 60.55 33.61 20.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.276 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.91 -78.31 1.3 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.23 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 m -112.91 -173.33 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.53 0.205 . . . . 0.0 110.72 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 32.6 m-20 -64.15 139.14 58.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.156 0.503 . . . . 0.0 110.925 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.54 81.45 1.65 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.714 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -66.4 -25.52 66.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.964 0.411 . . . . 0.0 111.505 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -105.54 153.45 21.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.139 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.5 tmtp? -134.75 146.46 49.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.349 -0.387 . . . . 0.0 109.994 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 19.9 t -101.29 103.54 27.18 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.29 -12.48 35.79 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.796 2.331 . . . . 0.0 112.693 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -76.52 -59.55 2.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.67 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.4 p -100.69 -31.85 11.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.227 0.537 . . . . 0.0 110.644 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.06 22.96 7.97 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.275 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.82 158.81 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.913 0.387 . . . . 0.0 110.953 -177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -114.93 126.89 55.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.368 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.607 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -126.87 154.1 44.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.684 0.754 . . . . 0.0 111.128 177.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.0 p -71.55 -23.11 61.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.253 -1.339 . . . . 0.0 111.616 -175.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.8 p 178.25 -167.92 0.07 Allowed 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.493 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.4 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 19.9 mt -63.09 -21.57 66.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.442 175.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -51.35 -46.62 62.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.251 0.548 . . . . 0.0 111.104 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.8 m -100.67 -14.99 17.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.933 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.4 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -62.44 -60.84 2.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 110.312 178.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -85.18 45.89 1.23 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.381 0.61 . . . . 0.0 111.101 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.572 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 14.7 t70 -104.92 148.61 26.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.942 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.11 13.6 6.72 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.131 0.491 . . . . 0.0 110.983 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.28 -48.05 5.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.766 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -110.66 -34.24 6.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.047 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.572 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 7.6 t-160 -79.62 92.87 5.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.59 122.34 45.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.283 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -134.63 154.28 51.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.09 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -115.72 -71.6 0.73 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.843 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 63.44 141.07 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.009 0.818 . . . . 0.0 112.428 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.6 m 71.19 -60.29 0.52 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.172 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 57.77 62.88 1.96 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.474 0.654 . . . . 0.0 109.979 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.699 -179.338 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' -1' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.78 0 N-CA-C 111.949 -0.46 . . . . 0.0 111.949 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . 0.426 ' HD3' ' HA2' ' A' ' -2' ' ' GLY . 2.8 Cg_exo -75.39 100.59 1.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.551 2.167 . . . . 0.0 112.006 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 60.58 56.34 3.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.7 mtp -119.57 -63.42 1.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.944 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m 40.39 39.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.739 0.816 . . . . 0.0 112.092 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -142.22 140.74 32.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.741 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 m 61.85 20.86 11.81 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.193 0.521 . . . . 0.0 110.386 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.97 162.37 20.5 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.874 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -147.84 154.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.326 -171.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -95.22 159.21 15.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.0 t -62.79 118.63 7.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.278 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.52 2.86 76.41 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.682 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.519 HD12 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -102.33 -41.71 8.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 122.683 -0.304 . . . . 0.0 111.025 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.9 p -117.66 -16.36 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.242 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 62.34 21.96 12.89 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.515 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.97 -74.82 1.16 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.402 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.32 -169.35 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -57.64 142.77 43.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.483 0.659 . . . . 0.0 111.556 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.5 70.87 0.84 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -63.28 -31.4 72.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -95.45 149.77 21.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.527 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.5 tmtp? -132.74 148.05 52.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.527 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 38.6 t -99.71 108.14 49.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.208 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 2.33 3.44 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.893 2.395 . . . . 0.0 113.188 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 13.3 mmmm -97.47 -58.57 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.698 0.285 . . . . 0.0 111.095 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.27 -30.95 13.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.138 0.494 . . . . 0.0 110.498 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.33 17.51 19.69 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.845 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 p -84.7 159.31 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.0 110.777 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -115.84 127.46 55.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.914 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.645 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.19 148.55 51.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.898 0.856 . . . . 0.0 111.538 178.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.6 p -69.94 -23.48 63.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.439 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.2 p -173.5 -167.62 0.4 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 111.633 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.4 tp -70.41 -20.14 62.95 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.257 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.6 -40.27 96.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.982 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.7 m -92.27 -22.47 19.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.645 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -58.85 -58.2 9.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.222 177.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -87.7 47.21 1.47 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.213 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 12.5 t70 -107.77 141.82 38.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.46 24.53 6.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.142 0.496 . . . . 0.0 110.792 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.48 -44.45 3.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.414 0.626 . . . . 0.0 109.719 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -107.99 -36.7 6.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.537 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.519 ' HB2' HD12 ' A' ' 10' ' ' ILE . 13.8 t-160 -88.65 85.22 6.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.97 121.74 54.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.655 0.741 . . . . 0.0 112.148 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.402 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 4.5 m170 -100.25 167.91 10.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.975 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -94.31 15.3 17.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.451 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -94.25 7.22 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.919 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.1 m -74.3 89.54 2.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.825 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.24 77.21 2.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.759 -177.057 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -70.72 140.97 40.23 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.574 2.183 . . . . 0.0 112.058 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -106.01 -18.72 13.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.651 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp -126.49 134.24 50.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.626 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -92.07 -20.93 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.423 0.63 . . . . 0.0 109.567 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.7 t -89.86 169.01 11.61 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.765 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.9 t 58.94 44.24 16.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.363 0.601 . . . . 0.0 109.818 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.72 176.6 6.47 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.723 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.61 152.73 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.438 -169.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 35.5 mmtp -99.81 157.12 16.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.3 t -62.18 113.69 3.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.073 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.51 5.01 47.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.771 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.555 HD12 ' HB2' ' A' ' 39' ' ' HIS . 12.2 mt -108.41 -33.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.7 -0.294 . . . . 0.0 111.433 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.65 -14.75 6.72 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.313 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.22 30.31 18.17 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.238 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.84 -73.82 1.27 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.247 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -112.35 -169.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 122.941 -0.153 . . . . 0.0 110.596 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 9.6 p-10 -64.39 144.63 57.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.361 0.6 . . . . 0.0 111.088 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.24 73.73 1.68 Allowed Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.309 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -60.1 -33.38 72.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -100.05 157.65 16.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.85 0.357 . . . . 0.0 110.275 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 13.8 tmtt? -142.23 145.05 33.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.505 -174.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.435 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 50.6 t -95.6 114.87 64.87 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.556 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.92 -6.15 16.3 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.753 2.302 . . . . 0.0 113.34 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.23 -56.77 2.61 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.709 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.462 ' HB3' ' CD2' ' A' ' 41' ' ' HIS . 19.9 p -97.75 -23.04 16.09 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.016 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.89 22.63 30.05 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.407 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 p -89.62 157.55 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.216 0.531 . . . . 0.0 110.552 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -114.27 127.97 56.13 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.821 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.658 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.29 153.82 48.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.873 0.844 . . . . 0.0 111.535 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.3 p -77.28 -22.07 52.62 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.055 -176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.4 p -176.05 -167.44 0.22 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.893 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 35.1 mt -65.93 -23.4 66.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.402 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -59.66 -35.7 74.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.141 0.495 . . . . 0.0 110.743 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 78.5 m -100.66 -23.72 14.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.539 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.493 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -59.47 -57.41 13.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.157 0.503 . . . . 0.0 109.685 176.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -88.61 41.89 1.04 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.359 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 10.7 t70 -108.79 141.92 40.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.11 29.98 5.3 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.235 0.54 . . . . 0.0 110.515 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.07 -46.39 3.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.54 0.685 . . . . 0.0 109.443 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -102.55 -37.35 8.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.086 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.556 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 23.9 t-160 -88.58 89.76 8.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.535 176.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.57 121.99 64.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.398 0.618 . . . . 0.0 111.491 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.462 ' CD2' ' HB3' ' A' ' 23' ' ' CYS . 3.2 m170 -79.15 84.4 5.12 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.895 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -135.64 114.87 12.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.99 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.35 5.17 42.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.451 0.643 . . . . 0.0 109.369 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.9 t -142.14 155.64 45.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.122 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -83.04 5.84 20.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.124 0.487 . . . . 0.0 110.213 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 . . . . . 0 C--O 1.25 1.117 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.767 175.796 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.71 50.16 3.47 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.849 2.366 . . . . 0.0 112.423 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -141.3 28.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.235 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 ttp -166.35 115.23 0.92 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.505 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p -88.73 -21.8 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.954 0.407 . . . . 0.0 110.576 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 p -81.25 61.03 4.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.071 0.462 . . . . 0.0 111.391 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m -86.29 -17.98 33.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.131 0.491 . . . . 0.0 110.233 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.71 150.6 36.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.572 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -118.06 175.86 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 CA-C-O 121.233 0.54 . . . . 0.0 110.924 178.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.41 136.94 55.0 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.377 167.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.567 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 40.2 t -47.42 113.03 0.62 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.416 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.55 12.12 22.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.883 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 39' ' ' HIS . 16.2 mt -109.98 -41.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 O-C-N 122.727 -0.278 . . . . 0.0 110.669 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.9 p -117.1 -18.78 9.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.267 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.462 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 25.6 mmm180 59.09 33.94 23.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.609 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.44 -69.8 1.18 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.975 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.9 m -122.84 -170.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.554 0.216 . . . . 0.0 110.526 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 12.7 m-20 -63.7 140.75 58.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.125 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.97 77.11 2.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.945 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -71.48 -16.86 62.37 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -109.64 157.15 19.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.427 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.8 tmtm? -140.1 146.47 38.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.838 0.351 . . . . 0.0 111.058 -173.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.408 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.5 t -103.45 111.51 65.14 Favored Pre-proline 0 CA--C 1.515 -0.402 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.039 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.76 -0.16 7.32 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 122.584 2.189 . . . . 0.0 112.838 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -98.19 -56.06 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.557 0.218 . . . . 0.0 111.515 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.435 ' HB3' ' CD2' ' A' ' 41' ' ' HIS . 25.4 p -100.72 -15.81 17.57 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.059 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.36 9.73 62.93 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.628 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.54 157.35 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 121.089 0.471 . . . . 0.0 110.919 -173.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -116.47 118.86 33.84 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.964 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.567 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -117.32 155.14 30.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.811 0.815 . . . . 0.0 111.248 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.5 p -70.33 -31.6 68.96 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.176 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.2 m -171.12 -169.41 0.74 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.3 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.2 -24.42 66.62 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.726 0.298 . . . . 0.0 111.03 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -51.94 -43.38 63.43 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.478 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.2 m -96.87 -20.59 18.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.775 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.51 -62.49 1.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.674 176.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -87.91 52.91 2.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.772 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.522 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 19.5 t70 -117.97 145.01 45.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.61 10.9 7.26 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.109 0.48 . . . . 0.0 110.655 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.98 -41.95 8.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.897 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -109.63 -39.86 5.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.971 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.522 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 23.4 t-160 -84.78 109.31 17.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.07 131.76 72.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.09 0.471 . . . . 0.0 111.193 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.435 ' CD2' ' HB3' ' A' ' 23' ' ' CYS . 2.3 m170 -98.1 111.85 24.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.562 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -85.98 -152.7 0.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.025 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -63.99 96.15 0.13 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.763 0.316 . . . . 0.0 110.85 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -106.66 -26.94 11.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.858 0.361 . . . . 0.0 110.344 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -82.06 61.1 5.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.079 0.466 . . . . 0.0 110.584 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.977 179.179 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.29 -53.66 5.91 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.143 2.562 . . . . 0.0 112.924 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -121.81 11.98 10.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.926 0.393 . . . . 0.0 110.788 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp -116.02 118.64 33.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.71 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.4 t -88.98 -26.71 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.483 0.659 . . . . 0.0 109.255 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 m -83.28 164.69 19.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.839 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 m 60.48 43.82 12.64 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.361 0.6 . . . . 0.0 110.162 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.72 177.2 5.82 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.464 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p -135.13 149.38 28.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.753 -172.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -101.24 158.11 16.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 42.7 t -62.28 116.53 5.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.599 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.92 17.25 22.9 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.566 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.491 HD11 ' HB2' ' A' ' 39' ' ' HIS . 10.2 mt -117.19 -37.5 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.617 -0.343 . . . . 0.0 110.864 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.3 p -120.6 -15.21 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.258 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 59.09 29.57 19.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.22 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.74 -76.08 1.31 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.9 m -112.88 -171.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 122.864 -0.198 . . . . 0.0 110.487 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -61.27 144.29 54.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.469 0.652 . . . . 0.0 111.339 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.487 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -88.23 68.17 3.0 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 175.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -29.9 68.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -104.07 153.77 20.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -133.03 146.71 51.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.305 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.472 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 38.4 t -94.43 106.29 22.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.99 -9.02 21.69 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.963 2.442 . . . . 0.0 112.563 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -81.8 -64.77 1.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.489 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 26.6 p -94.32 -38.38 11.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.195 0.521 . . . . 0.0 110.888 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.29 12.86 11.36 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.387 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.412 HG11 ' CD2' ' A' ' 39' ' ' HIS . 3.7 p -77.28 160.32 4.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.904 0.383 . . . . 0.0 110.727 -176.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.487 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 24.4 mmt180 -117.15 125.84 51.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.576 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -128.13 156.2 43.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.904 0.859 . . . . 0.0 111.426 178.621 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.3 p -75.97 -21.2 57.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.677 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 t 179.08 -171.39 0.13 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 79.2 mt -65.94 -20.67 66.29 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.773 0.32 . . . . 0.0 110.357 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -55.62 -32.22 62.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.82 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.9 m -110.56 -20.49 12.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.094 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.79 -57.92 10.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.305 0.574 . . . . 0.0 109.548 176.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.75 50.82 2.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.631 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 13.0 t70 -114.33 147.71 38.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.118 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.07 14.0 7.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.042 0.449 . . . . 0.0 110.973 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.25 -44.64 5.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.339 0.59 . . . . 0.0 110.137 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.32 -30.14 6.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.309 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.491 ' HB2' HD11 ' A' ' 10' ' ' ILE . 10.4 t-80 -83.57 93.73 7.91 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.79 137.51 41.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.436 0.636 . . . . 0.0 111.413 -172.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -120.44 49.95 1.38 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.196 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.12 89.56 2.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.583 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 59.3 24.9 13.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.974 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 p -114.11 148.53 37.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.417 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 8.8 tp10 60.76 36.83 19.2 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.022 0.915 . . . . 0.0 109.6 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 . . . . . 0 C--O 1.249 1.052 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.78 179.582 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.95 -33.29 63.86 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.908 2.405 . . . . 0.0 112.835 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -71.9 -33.47 68.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.921 0.391 . . . . 0.0 110.539 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm -87.45 -72.04 0.54 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.678 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 p 37.8 47.78 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 122.367 1.079 . . . . 0.0 111.967 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.7 m -128.26 35.92 4.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.739 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.3 t -105.5 12.39 31.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.739 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.99 -172.07 0.19 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.692 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 p -157.11 151.85 8.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.179 -173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -103.74 157.09 17.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.968 0.413 . . . . 0.0 110.807 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.614 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.6 t -62.35 115.77 4.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.553 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.89 12.85 40.31 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.644 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.44 HG21 ' HB2' ' A' ' 38' ' ' LYS . 7.7 mt -112.83 -38.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.737 0.303 . . . . 0.0 111.053 -177.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.1 p -119.9 -16.64 8.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.266 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 63.35 32.21 14.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.152 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.0 -81.73 1.41 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.304 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.27 -169.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.971 -0.135 . . . . 0.0 110.895 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -63.28 141.27 58.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.313 0.577 . . . . 0.0 111.03 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.58 75.52 2.35 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -60.6 -30.17 69.67 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.94 151.86 24.72 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -134.66 145.64 48.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.481 ' CB ' ' HH ' ' A' ' 27' ' ' TYR . 22.0 t -97.11 107.42 37.82 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.97 0.42 5.08 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.086 2.524 . . . . 0.0 113.454 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -94.14 -63.81 1.15 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.018 0.437 . . . . 0.0 110.927 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.5 p -92.85 -26.64 17.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.181 0.515 . . . . 0.0 110.492 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.2 21.33 18.01 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.672 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.24 155.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.158 0.504 . . . . 0.0 110.601 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -112.86 129.74 56.35 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.791 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.614 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.91 148.82 52.72 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.803 0.811 . . . . 0.0 111.516 177.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -71.77 -19.92 61.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.691 -175.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 8.2 t 176.93 -168.02 0.05 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.233 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 45.8 mt -64.24 -23.22 67.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.385 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -60.12 -31.7 70.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.044 0.45 . . . . 0.0 110.985 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.4 m -106.14 -21.5 13.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.729 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -59.5 -56.57 20.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.582 0.706 . . . . 0.0 109.489 176.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -91.47 39.81 1.01 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.111 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 26.4 t70 -103.15 140.57 37.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.68 19.66 13.77 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.231 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.59 -45.07 4.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.226 0.536 . . . . 0.0 110.02 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.44 ' HB2' HG21 ' A' ' 10' ' ' ILE . 66.8 mmtt -103.12 -45.57 4.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.156 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.549 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 9.6 t-160 -80.7 105.29 11.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.792 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.86 135.31 59.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.09 0.471 . . . . 0.0 110.886 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -122.31 154.45 37.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.175 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -80.6 -1.6 42.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.512 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -81.81 -5.73 58.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.109 0.48 . . . . 0.0 109.782 174.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 m -109.55 25.24 12.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.607 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -80.42 59.46 3.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.205 0.526 . . . . 0.0 110.925 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.809 179.561 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.57 -56.01 2.84 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.076 2.517 . . . . 0.0 112.375 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -87.43 137.07 32.65 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mmm 60.11 58.09 2.78 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.615 0.572 . . . . 0.0 110.226 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.53 -21.28 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.201 0.524 . . . . 0.0 110.637 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 m -79.99 83.32 5.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.165 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.3 m -62.93 -34.12 76.78 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.229 0.538 . . . . 0.0 110.59 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.15 149.6 28.31 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.501 0.667 . . . . 0.0 109.942 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.85 157.97 42.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.244 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -101.2 154.43 18.76 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.619 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.2 t -58.28 116.1 3.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.525 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.74 6.08 49.09 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.791 -177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 39' ' ' HIS . 8.6 mt -107.85 -38.73 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 120.654 0.264 . . . . 0.0 111.11 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.6 p -119.75 -15.42 8.9 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.605 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.514 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 29.3 mmm180 59.19 24.93 13.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.332 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.59 -73.53 1.27 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.268 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.8 m -114.84 -169.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.34 145.35 51.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.439 0.637 . . . . 0.0 111.421 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.401 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -93.65 72.99 1.23 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -65.93 -32.0 73.24 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -95.72 149.83 21.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.528 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.2 tmtp? -134.1 147.85 50.92 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.528 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.7 t -100.23 109.34 56.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.466 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.72 -5.39 14.19 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.988 2.458 . . . . 0.0 112.788 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -88.94 -60.71 1.88 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.907 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.4 p -96.51 -29.82 13.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.941 0.401 . . . . 0.0 111.067 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.2 21.5 11.67 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.896 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 p -89.31 158.83 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.075 0.464 . . . . 0.0 110.655 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 23.1 mmt180 -114.69 128.13 56.14 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.171 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.619 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -127.65 153.25 46.68 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.84 0.829 . . . . 0.0 110.817 176.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.0 p -70.49 -34.39 72.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.044 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.3 m -168.8 -172.43 1.6 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.018 -173.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.497 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 22.5 mt -62.19 -23.42 66.61 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.55 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -55.98 -51.63 67.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.703 0.763 . . . . 0.0 110.273 -179.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.5 m -85.39 -24.3 27.6 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.315 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.41 -60.64 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.052 178.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -87.48 44.23 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.064 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.601 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 10.8 t70 -110.77 139.69 45.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.661 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.02 23.77 9.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.115 0.483 . . . . 0.0 110.843 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.65 -45.66 3.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -102.34 -43.43 5.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.214 177.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.601 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 20.2 t-160 -80.19 110.96 16.1 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.053 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.6 t -115.98 137.42 49.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.08 0.467 . . . . 0.0 111.455 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -117.63 -169.38 1.66 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.719 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -66.01 137.58 57.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.733 -172.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -153.74 -41.41 0.09 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.394 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.4 m -130.73 72.77 1.51 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.352 0.596 . . . . 0.0 111.61 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.22 17.94 18.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.994 174.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.915 179.077 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.56 109.93 2.59 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.504 2.136 . . . . 0.0 112.294 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -72.79 -32.99 65.96 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 mtm -123.5 144.29 49.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.118 174.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.46 -11.31 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.522 0.677 . . . . 0.0 109.669 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.3 m -103.61 155.27 18.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.602 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.0 m -97.8 38.66 1.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.052 0.453 . . . . 0.0 110.319 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.78 160.68 25.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.516 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.93 152.66 36.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.729 -172.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -103.96 157.67 16.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.865 0.364 . . . . 0.0 110.592 -177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.1 t -63.2 117.21 6.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.245 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.4 ' HA2' ' CZ ' ' A' ' 12' ' ' ARG . . . -80.67 5.38 65.08 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.666 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mt -105.25 -40.63 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 120.725 0.298 . . . . 0.0 110.975 -177.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.3 p -117.99 -14.07 10.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.197 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.4 ' CZ ' ' HA2' ' A' ' 9' ' ' GLY . 38.6 mmt180 57.7 29.01 16.65 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.552 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.71 -77.91 1.27 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.359 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.0 m -113.42 -169.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -64.35 143.32 57.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.469 0.652 . . . . 0.0 111.422 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.445 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -88.69 76.9 1.84 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 175.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -64.08 -28.09 69.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -104.93 159.32 15.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.583 0.23 . . . . 0.0 110.547 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.494 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.2 tmtp? -135.7 145.76 47.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.732 0.301 . . . . 0.0 110.779 -174.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.501 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 33.8 t -100.63 102.92 20.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.3 -7.93 18.97 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 122.782 2.321 . . . . 0.0 113.269 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -79.31 -61.9 1.86 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.067 0.461 . . . . 0.0 110.967 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.2 p -97.58 -31.94 12.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.664 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.37 14.29 18.64 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.982 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 p -82.12 156.27 4.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.148 0.499 . . . . 0.0 110.913 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 24.3 mmt180 -113.34 121.5 44.56 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.014 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.579 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -119.47 148.33 43.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.859 0.838 . . . . 0.0 111.079 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.5 p -65.99 -26.14 67.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.518 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 p -176.11 -171.2 0.42 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.366 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.36 -20.88 66.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.671 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.54 -39.9 81.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.089 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 98.9 m -98.39 -17.82 18.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -65.02 0.73 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.912 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -85.06 48.16 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.217 0.532 . . . . 0.0 111.646 -174.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.571 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.4 t70 -106.73 150.0 26.73 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.511 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.09 29.03 4.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.166 0.508 . . . . 0.0 110.716 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.19 -44.87 2.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.041 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -107.9 -33.51 7.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.447 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.571 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 8.8 t-160 -82.78 93.23 7.38 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.09 127.65 42.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.512 -170.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -141.92 137.22 31.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.438 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -136.27 17.53 3.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.818 170.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 51.83 50.11 19.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.433 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.3 m 56.5 68.62 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.834 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.35 71.22 3.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.387 0.613 . . . . 0.0 109.551 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 C--O 1.247 0.954 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.877 -178.524 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.14 -24.63 72.94 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.845 2.363 . . . . 0.0 112.774 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -87.56 69.4 9.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 110.842 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mtp -135.54 137.56 42.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.706 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.5 m -95.26 -17.54 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 0.0 111.117 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 m 61.67 32.74 18.35 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.797 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.4 m -86.52 9.43 18.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.65 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.94 170.86 9.24 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.078 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.13 152.45 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.178 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 69.9 mmtt -98.35 159.87 14.66 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.634 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 44.0 t -63.43 114.24 3.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.057 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.01 7.85 41.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.578 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 39' ' ' HIS . 7.7 mt -110.17 -38.69 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 122.672 -0.311 . . . . 0.0 111.078 -177.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 p -121.78 -15.09 7.99 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.445 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 61.89 22.89 13.37 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.91 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.25 -72.59 1.2 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.307 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.1 -169.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.9 p-10 -59.66 145.52 44.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.505 0.669 . . . . 0.0 111.806 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.88 69.39 2.43 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -63.11 -27.37 69.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.335 -0.433 . . . . 0.0 111.835 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -99.75 148.03 24.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.785 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER -137.13 145.52 43.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.805 0.335 . . . . 0.0 110.292 -174.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.546 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 43.3 t -98.2 108.29 46.24 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.183 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.11 0.03 5.01 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 122.811 2.34 . . . . 0.0 112.967 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -96.16 -60.32 1.65 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.62 0.248 . . . . 0.0 111.419 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.8 p -95.38 -27.15 15.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.038 0.447 . . . . 0.0 110.676 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.23 20.95 21.62 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.548 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 p -86.14 158.0 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.05 0.452 . . . . 0.0 110.187 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -115.65 128.15 55.71 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.912 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.634 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.74 147.53 52.41 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.985 0.898 . . . . 0.0 110.909 177.099 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.2 p -66.98 -31.71 72.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.347 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.4 ' HG ' ' C ' ' A' ' 28' ' ' CYS . 68.0 m -167.9 -176.25 2.99 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.647 -175.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.454 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 47.8 mt -61.19 -26.3 67.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -56.26 -38.1 70.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.02 0.438 . . . . 0.0 111.127 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.2 m -95.11 -23.91 17.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.581 177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.458 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -61.17 -57.8 10.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.807 176.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -85.27 43.56 1.02 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.331 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 20.0 t70 -111.35 149.17 31.53 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.82 3.23 6.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.014 0.435 . . . . 0.0 111.01 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -88.33 -45.54 9.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.362 0.601 . . . . 0.0 110.103 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -103.16 -42.01 5.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.435 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.535 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 14.5 t-160 -83.35 86.15 7.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.621 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.93 123.26 50.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.396 0.617 . . . . 0.0 111.83 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -100.76 117.22 34.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.829 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -137.76 22.93 2.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.807 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.75 -47.67 85.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.895 -172.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 t -87.41 132.1 34.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -72.93 93.26 1.71 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.34 0.59 . . . . 0.0 109.919 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 . . . . . 0 C--O 1.247 0.935 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.449 -179.007 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.87 -23.51 62.08 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.678 2.252 . . . . 0.0 112.807 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -108.15 105.03 14.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.902 0.382 . . . . 0.0 110.16 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 ttp -70.69 129.24 38.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.72 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.4 t -66.32 -42.65 91.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.731 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -88.01 61.33 6.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.046 0.451 . . . . 0.0 110.115 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 p -64.06 113.72 3.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.536 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.52 163.55 33.52 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.409 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.9 150.65 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.68 -174.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -104.15 154.74 19.38 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 44.9 t -59.46 112.21 1.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.322 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.85 0.62 43.8 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.776 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.458 HD11 ' HB2' ' A' ' 39' ' ' HIS . 11.3 mt -103.14 -40.51 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 122.755 -0.262 . . . . 0.0 111.206 -174.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.2 p -119.0 -18.44 8.78 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.323 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.32 36.51 27.62 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.026 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.54 -62.91 0.98 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.126 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -125.75 -176.2 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.722 0.296 . . . . 0.0 111.254 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.74 135.29 55.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.551 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -86.95 74.82 2.27 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -68.34 -31.13 70.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -95.47 152.32 18.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.677 0.275 . . . . 0.0 110.331 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -134.31 145.82 49.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.864 0.364 . . . . 0.0 111.045 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 35.5 t -100.48 108.49 53.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.789 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.94 -13.33 39.55 Favored 'Trans proline' 0 N--CA 1.471 0.174 0 C-N-CA 122.832 2.354 . . . . 0.0 112.744 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -82.82 -56.64 3.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.538 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.5 p -101.04 -29.47 12.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.969 0.414 . . . . 0.0 110.523 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.11 7.1 31.33 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.321 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 p -77.28 157.78 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.046 0.45 . . . . 0.0 111.447 -173.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.1 mmt180 -115.0 124.33 51.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.22 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.579 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -123.89 153.93 40.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.616 0.722 . . . . 0.0 110.825 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -70.08 -33.07 71.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.981 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.401 ' HG ' ' C ' ' A' ' 28' ' ' CYS . 74.1 m -168.08 -173.53 2.08 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.589 -175.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.65 -25.0 67.76 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.69 -41.07 73.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.923 0.392 . . . . 0.0 111.162 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.5 m -91.18 -23.0 20.37 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.803 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -60.91 2.93 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -86.95 52.79 2.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.226 0.536 . . . . 0.0 111.314 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.658 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 18.2 t70 -119.0 141.63 48.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 173.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.57 10.42 13.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.957 0.408 . . . . 0.0 111.16 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.67 -45.27 6.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.326 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -109.52 -27.92 9.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.658 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 18.4 t-160 -89.17 97.95 11.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.79 118.87 39.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.674 0.749 . . . . 0.0 112.259 -170.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -123.72 -74.75 0.61 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.984 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -162.69 21.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.976 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -127.23 129.39 47.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.138 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.2 t 60.4 33.29 20.72 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.584 0.553 . . . . 0.0 110.633 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.28 34.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.279 0.562 . . . . 0.0 111.273 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.505 -0.76 . . . . 0.0 109.757 176.61 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.63 122.33 11.11 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.797 2.331 . . . . 0.0 112.021 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -91.37 131.29 36.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.304 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 1.3 mmt -86.79 158.53 19.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.569 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t 60.04 60.68 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.92 0.867 . . . . 0.0 109.463 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -125.33 135.51 52.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.102 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -118.3 13.52 13.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.108 0.48 . . . . 0.0 110.72 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.25 144.57 43.0 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.375 0.607 . . . . 0.0 110.697 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.3 p -109.17 148.86 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.389 -173.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -108.27 161.6 14.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.598 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 49.4 t -65.47 116.36 6.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.572 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.85 -4.87 78.09 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.785 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.434 HD12 ' HB2' ' A' ' 39' ' ' HIS . 9.6 mt -98.0 -40.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.795 0.331 . . . . 0.0 110.963 -174.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.5 p -117.65 -15.71 10.14 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.417 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 61.38 32.55 19.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.456 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.0 -82.88 1.47 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.292 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.03 -168.96 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.649 0.262 . . . . 0.0 110.814 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.22 139.16 58.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.28 0.562 . . . . 0.0 111.964 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.72 70.45 3.17 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -62.36 -27.46 69.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.503 -0.349 . . . . 0.0 111.753 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.7 153.88 20.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -138.17 143.79 40.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.729 0.299 . . . . 0.0 110.333 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.436 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 18.8 t -98.72 107.48 43.24 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.818 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.22 -9.97 27.01 Favored 'Trans proline' 0 C--N 1.335 -0.156 0 C-N-CA 122.776 2.317 . . . . 0.0 112.824 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.92 -62.5 1.55 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.209 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -93.66 -28.69 15.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.106 0.479 . . . . 0.0 110.496 -176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.3 10.73 35.55 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.802 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 p -79.11 157.99 4.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.153 0.501 . . . . 0.0 111.368 -174.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -113.0 126.54 55.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.199 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.598 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -127.47 148.28 50.31 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.861 0.838 . . . . 0.0 110.716 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -65.57 -32.28 73.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.294 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.5 m -168.62 -169.92 1.12 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.859 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.69 -27.62 68.48 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.426 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.46 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -55.47 -45.0 76.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.51 0.671 . . . . 0.0 111.22 -177.236 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 73.7 m -87.69 -23.15 24.28 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.71 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.28 -63.03 1.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.782 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -84.98 52.53 2.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.201 0.524 . . . . 0.0 110.842 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -112.42 148.99 33.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.68 15.84 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.077 0.465 . . . . 0.0 110.799 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.31 -43.41 5.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.441 0.639 . . . . 0.0 109.759 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -108.56 -34.8 6.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.688 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.434 ' HB2' HD12 ' A' ' 10' ' ' ILE . 13.3 t-160 -91.67 94.0 9.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.935 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 t -115.92 126.61 73.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.61 0.719 . . . . 0.0 111.501 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -95.85 -47.38 6.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.072 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -99.85 76.84 1.99 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.326 0.584 . . . . 0.0 110.331 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -105.47 -59.15 1.8 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.934 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.3 t -151.42 115.61 5.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.255 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.02 8.64 18.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.881 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.977 -177.927 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.94 116.52 3.41 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.524 2.15 . . . . 0.0 111.522 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -79.55 51.09 1.2 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.175 0.512 . . . . 0.0 111.139 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mmm -114.48 -20.76 10.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.691 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.7 t 71.47 -54.77 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 123.151 0.58 . . . . 0.0 111.021 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.6 t -88.57 55.19 3.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.372 0.606 . . . . 0.0 109.678 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -77.8 -28.45 50.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.38 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.37 159.71 14.87 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.977 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.33 161.42 41.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.767 -173.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.2 mmtt -110.08 158.11 18.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 0.0 110.734 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.655 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 33.9 t -66.16 113.95 4.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.123 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.23 3.06 59.57 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.861 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 39' ' ' HIS . 16.5 mt -103.0 -40.55 6.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 122.715 -0.286 . . . . 0.0 110.955 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.7 p -118.09 -16.2 9.81 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.291 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 59.54 24.5 13.24 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.334 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.61 -69.76 1.36 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.408 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 m -120.79 -168.87 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.5 m-20 -66.77 142.8 57.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.133 0.492 . . . . 0.0 111.243 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.47 78.22 1.64 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -66.89 -33.44 75.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.883 0.373 . . . . 0.0 111.351 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.31 153.8 18.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 12.1 tmtt? -142.81 145.18 32.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.639 0.257 . . . . 0.0 110.694 -175.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.409 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.0 t -96.58 113.46 62.69 Favored Pre-proline 0 CA--C 1.516 -0.34 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.04 -13.77 41.38 Favored 'Trans proline' 0 C--N 1.334 -0.233 0 C-N-CA 122.575 2.184 . . . . 0.0 112.385 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.416 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 30.8 mmmt -88.29 -56.02 3.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.819 -175.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.0 p -98.35 -21.44 16.61 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.162 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.0 16.74 46.54 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.637 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.81 158.91 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 120.961 0.41 . . . . 0.0 110.4 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -116.62 129.07 55.94 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.014 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.655 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.96 152.94 48.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.795 0.807 . . . . 0.0 111.133 177.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.8 p -72.78 -20.5 61.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.442 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.4 p -178.28 -169.39 0.19 Allowed 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.291 0.369 . . . . 0.0 110.422 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.428 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 33.9 mt -65.34 -20.24 66.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.424 175.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -59.15 -39.47 82.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.162 0.506 . . . . 0.0 110.724 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 90.6 m -97.87 -22.31 16.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.453 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -57.96 -58.85 6.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.83 177.466 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -90.72 35.52 0.89 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.095 0.474 . . . . 0.0 111.07 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.541 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 10.5 t70 -101.13 122.32 43.39 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.36 17.11 24.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.904 0.383 . . . . 0.0 111.076 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.63 -47.15 5.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.102 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -103.66 -32.42 9.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.531 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.543 ' HB2' HD11 ' A' ' 10' ' ' ILE . 12.9 t-160 -100.54 88.92 3.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.583 0.706 . . . . 0.0 109.511 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.96 122.51 67.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.718 0.77 . . . . 0.0 111.838 -174.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.416 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 5.4 m170 -75.62 79.34 2.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.317 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.1 tptt -87.08 115.66 24.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.599 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 59.24 48.33 10.43 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.599 0.562 . . . . 0.0 110.636 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.5 p -81.66 58.51 3.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.262 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -93.52 88.63 5.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.067 -177.737 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.36 161.63 34.53 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.948 2.432 . . . . 0.0 111.608 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -86.56 46.33 1.34 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.166 0.507 . . . . 0.0 110.309 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.1 mmm 61.45 59.62 1.85 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.791 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.89 -9.81 11.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.935 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 m -63.55 127.74 32.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.346 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m -86.01 86.26 7.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.029 0.442 . . . . 0.0 110.683 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.94 154.03 25.25 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.538 0.685 . . . . 0.0 110.699 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.454 HG11 ' HG3' ' A' ' 26' ' ' ARG . 4.2 p -99.55 155.94 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.59 -176.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.5 mmtt -99.54 156.82 16.85 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.5 t -62.59 111.93 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.424 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.7 24.7 3.13 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.664 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 mt -125.08 -39.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 122.666 -0.314 . . . . 0.0 110.857 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.4 p -119.78 -16.25 8.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.13 0.491 . . . . 0.0 110.745 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 56.75 27.69 13.14 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.518 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.19 -68.87 1.41 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.006 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.46 -168.91 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.514 0.197 . . . . 0.0 110.547 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.9 p-10 -61.31 146.52 47.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.418 0.628 . . . . 0.0 111.629 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.03 70.31 2.29 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.429 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -25.15 66.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.884 0.373 . . . . 0.0 111.805 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -98.68 149.49 22.77 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.53 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -131.73 145.66 51.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.822 0.344 . . . . 0.0 111.053 -174.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.53 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 43.4 t -102.51 107.28 53.24 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.109 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.33 -9.93 27.41 Favored 'Trans proline' 0 N--CA 1.472 0.236 0 C-N-CA 122.883 2.389 . . . . 0.0 112.97 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.428 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 30.3 mmmt -82.7 -49.16 10.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 -176.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.5 p -111.12 -33.18 6.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.844 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.45 16.2 13.74 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.152 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 39' ' ' HIS . 4.3 p -81.19 158.9 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 110.675 -176.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HD3' ' HG2' ' A' ' 19' ' ' LYS . 61.3 mmt-85 -114.58 121.35 43.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.296 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.533 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -122.24 155.88 34.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.548 0.689 . . . . 0.0 110.909 176.211 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.1 p -71.21 -34.08 70.5 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.807 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -167.58 -172.93 2.04 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.328 -174.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 tp -62.77 -31.59 72.58 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 122.65 0.38 . . . . 0.0 111.508 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -53.6 -43.34 68.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.544 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.6 m -87.99 -23.1 23.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.66 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.491 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -56.67 -58.73 6.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.141 177.092 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -87.04 50.8 2.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.409 0.623 . . . . 0.0 111.526 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.652 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 9.4 t70 -109.87 150.76 27.95 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.12 -0.6 5.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.246 0.546 . . . . 0.0 111.002 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.88 -48.07 9.08 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.057 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -108.03 -33.9 7.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.518 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.652 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 10.4 t-160 -81.28 91.09 6.16 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.07 120.31 35.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.118 -169.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 5.4 m170 -138.54 172.43 12.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.228 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 22.3 pttp -143.9 -179.08 6.26 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 17.3 mm-40 72.59 -65.6 0.35 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.479 0.487 . . . . 0.0 111.018 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.6 m -80.77 54.59 2.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.238 0.542 . . . . 0.0 110.381 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.14 -32.46 24.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.353 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.598 -0.715 . . . . 0.0 110.029 179.101 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -60.91 136.0 63.08 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.673 2.249 . . . . 0.0 112.306 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.57 37.07 4.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.552 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.4 mtp 68.28 111.29 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.529 -175.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.9 t -55.45 -38.21 48.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.336 0.589 . . . . 0.0 109.723 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -91.28 70.35 6.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.704 173.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 m -69.6 -29.68 67.26 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.94 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.2 149.76 49.84 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.273 0.559 . . . . 0.0 110.225 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.54 148.98 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.253 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.45 158.68 16.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.3 t -63.66 115.73 5.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.15 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.441 ' HA2' ' CZ ' ' A' ' 12' ' ' ARG . . . -81.3 17.86 12.07 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.494 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.499 HG21 ' HB2' ' A' ' 38' ' ' LYS . 10.1 mt -119.13 -46.03 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 120.853 0.359 . . . . 0.0 110.742 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.0 p -110.6 -13.87 14.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.485 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.441 ' CZ ' ' HA2' ' A' ' 9' ' ' GLY . 35.4 mmt180 55.45 30.63 15.41 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.833 178.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.24 -69.13 1.01 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.348 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.13 -170.18 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 121.276 -0.17 . . . . 0.0 110.765 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 5.7 p-10 -63.27 145.79 54.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.326 0.584 . . . . 0.0 111.619 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.496 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -92.1 65.74 2.21 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.365 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.446 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 6.7 ptpp? -56.89 -36.3 69.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.446 ' CD1' ' HG3' ' A' ' 17' ' ' LYS . 3.7 m-30 -94.65 149.63 21.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 13.1 tmtt? -134.43 144.29 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.789 0.328 . . . . 0.0 110.771 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.488 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 25.1 t -97.98 107.35 40.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.806 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.64 -10.07 26.69 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.04 2.493 . . . . 0.0 113.565 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -84.55 -63.11 1.39 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.908 0.385 . . . . 0.0 111.232 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.6 p -94.05 -32.34 13.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.201 0.524 . . . . 0.0 110.601 -173.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.41 21.47 9.3 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.168 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.47 HG12 ' CD2' ' A' ' 39' ' ' HIS . 4.0 p -88.04 158.74 3.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.969 0.414 . . . . 0.0 110.618 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 21.5 mmt180 -116.02 129.53 56.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.011 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.576 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -131.32 151.05 51.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.702 0.763 . . . . 0.0 110.949 177.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.0 p -71.24 -19.61 62.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.751 -174.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.3 t -175.94 -171.35 0.44 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.76 0.315 . . . . 0.0 110.547 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' HG ' ' HE2' ' A' ' 34' ' ' LYS . 37.2 tp -69.89 -19.82 63.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.529 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.56 -49.34 77.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.051 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.4 m -81.53 -20.88 39.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.67 177.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -59.32 -59.57 5.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.869 176.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HE2' ' HG ' ' A' ' 30' ' ' LEU . 55.0 mtmt -84.86 54.31 3.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.632 0.73 . . . . 0.0 110.999 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 13.7 t70 -111.64 149.79 31.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.564 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.57 13.05 7.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.731 0.3 . . . . 0.0 111.628 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.73 -38.2 7.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.382 0.61 . . . . 0.0 110.092 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HB2' HG21 ' A' ' 10' ' ' ILE . 96.8 mttt -118.49 -32.97 4.45 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.296 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.565 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 7.8 t-160 -84.36 93.93 8.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.47 120.41 45.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.899 -172.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -134.36 57.99 1.79 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.541 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm 68.72 134.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.422 -176.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -88.17 -156.72 0.38 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.063 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.0 p -51.26 -43.88 61.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.106 0.479 . . . . 0.0 111.125 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -145.73 -51.4 0.25 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.422 173.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--O 1.251 1.133 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.592 -177.586 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.805 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.91 135.13 17.1 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.553 2.169 . . . . 0.0 111.91 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -80.46 128.54 33.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.919 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptm -145.96 136.42 24.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.646 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.6 m -89.21 72.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.452 0.644 . . . . 0.0 110.101 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 m -52.4 125.41 16.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.357 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.7 m 60.53 78.64 0.27 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.925 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.99 165.03 23.0 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.706 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 4.0 p -141.35 148.3 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.501 -170.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -106.18 154.01 21.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.7 t -59.41 110.02 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.538 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.26 18.14 3.63 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.732 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.52 HG21 ' HB2' ' A' ' 38' ' ' LYS . 7.5 mt -119.98 -36.1 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.565 0.221 . . . . 0.0 111.15 -177.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.84 -14.7 6.64 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.439 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 5.7 mpt_? 58.77 28.9 17.98 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.835 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.4 -78.06 1.14 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.699 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.07 -171.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 6.2 p-10 -58.12 144.21 41.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.51 0.672 . . . . 0.0 111.425 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.585 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -86.92 68.54 3.22 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.175 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -58.86 -34.29 71.43 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -94.94 146.7 24.06 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.65 145.98 51.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.822 0.344 . . . . 0.0 110.772 -174.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 38.3 t -98.4 106.75 37.93 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.951 178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.41 -6.41 16.36 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.615 2.21 . . . . 0.0 113.119 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.64 -63.48 1.31 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.866 0.365 . . . . 0.0 111.037 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.8 p -93.97 -30.29 14.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.049 0.452 . . . . 0.0 110.245 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.72 7.96 35.56 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.051 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.436 HG13 ' CD2' ' A' ' 39' ' ' HIS . 3.4 p -74.68 157.34 6.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.42 . . . . 0.0 111.002 -173.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 22.2 mmt180 -114.73 125.75 54.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.518 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.593 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -128.02 153.22 47.01 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.724 0.773 . . . . 0.0 110.986 177.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.8 p -74.5 -20.24 60.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.434 -175.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.7 t -175.08 -177.03 1.01 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.683 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.0 tp -62.8 -24.98 68.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.081 0.467 . . . . 0.0 110.22 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -52.36 -54.05 36.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.261 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -84.1 -20.01 33.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -57.48 -56.14 25.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.72 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -89.55 47.34 1.46 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.693 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.669 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 9.3 t70 -110.55 133.26 53.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.11 25.38 11.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.064 0.459 . . . . 0.0 111.207 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.98 -45.09 3.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.445 0.641 . . . . 0.0 109.805 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.52 ' HB2' HG21 ' A' ' 10' ' ' ILE . 48.9 mmtm -97.67 -47.57 5.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.679 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.669 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 12.3 t-160 -79.93 99.1 7.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.531 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.3 t -104.06 129.76 55.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.48 0.657 . . . . 0.0 111.966 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -123.05 97.44 5.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.652 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -87.1 145.12 26.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.676 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.78 144.49 51.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.02 0.438 . . . . 0.0 110.059 174.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 t -137.45 60.27 1.65 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.606 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.26 41.54 1.25 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.993 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.503 -177.731 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 26' ' ' ARG . 9.8 p . . . . . 0 N--CA 1.438 -1.055 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.8 mmtt -97.51 158.89 15.24 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.578 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 49.3 t -63.86 112.17 2.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.99 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.95 -0.29 55.23 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.812 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 32' ' ' CYS . 7.3 mt -100.96 -37.35 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 120.692 0.282 . . . . 0.0 111.205 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.7 p -123.6 -14.74 7.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.311 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.21 30.83 19.05 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.518 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.63 -71.03 1.27 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.342 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 m -118.34 -169.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.7 p-10 -62.64 145.99 53.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.489 0.661 . . . . 0.0 111.612 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.54 75.18 2.02 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -66.64 -27.59 67.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.673 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.431 ' CD1' ' HG3' ' A' ' 17' ' ' LYS . 2.8 m-30 -102.62 154.78 18.81 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 11.9 tmtt? -136.93 145.73 44.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.741 0.305 . . . . 0.0 110.882 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.515 ' HB3' HG12 ' A' ' 25' ' ' VAL . 36.6 t -99.09 107.32 43.55 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.0 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.66 1.25 5.22 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.148 2.565 . . . . 0.0 112.878 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -92.19 -52.54 4.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.798 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.5 p -105.8 -37.03 6.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.081 0.467 . . . . 0.0 111.068 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.62 19.39 8.31 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.929 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.1 p -85.59 158.97 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.963 0.411 . . . . 0.0 110.224 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HG3' HG11 ' A' ' 6' ' ' VAL . 24.8 mmt180 -118.21 119.45 34.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.073 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.578 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -118.79 156.12 29.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.697 0.76 . . . . 0.0 110.886 179.154 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -74.66 -20.9 59.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.556 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.8 t -177.19 -171.64 0.35 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.347 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 tp -66.36 -20.64 66.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.121 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -54.75 -52.96 60.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.704 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.402 ' HB3' HD12 ' A' ' 10' ' ' ILE . 89.3 m -86.26 -18.7 31.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.779 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -61.85 -63.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.595 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -83.81 54.54 2.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.721 0.772 . . . . 0.0 110.944 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -116.48 145.93 42.94 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.853 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.51 28.65 5.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.295 0.569 . . . . 0.0 110.572 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.069 178.893 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.439 -1.02 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 75.2 mmtt -104.48 160.46 14.91 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.633 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.8 t -66.2 111.83 3.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.928 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.39 -1.36 57.29 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.943 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 32' ' ' CYS . 11.4 mt -99.53 -40.4 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.799 0.333 . . . . 0.0 111.175 -176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.7 p -120.74 -14.48 8.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.207 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.01 27.99 14.12 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.034 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.14 -69.66 1.31 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.246 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.22 -169.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.563 0.221 . . . . 0.0 110.7 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 7.5 p-10 -62.89 143.01 58.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.434 0.635 . . . . 0.0 111.587 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.428 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -92.23 70.34 1.74 Allowed Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.408 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -65.1 -23.67 67.22 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -101.93 150.46 23.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 12.8 tmtt? -135.78 144.66 45.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.641 0.257 . . . . 0.0 110.545 -174.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 15.0 t -98.99 107.68 45.18 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.912 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 34.9 Cg_endo -64.55 -13.0 36.25 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.102 2.535 . . . . 0.0 113.58 -176.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -82.22 -63.26 1.42 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.022 0.439 . . . . 0.0 111.147 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -92.12 -33.08 14.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.917 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.82 18.96 13.99 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.671 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.475 HG12 ' CB ' ' A' ' 20' ' ' CYS . 3.5 p -84.2 158.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.129 0.49 . . . . 0.0 110.595 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.9 mmt180 -114.49 128.88 56.56 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.924 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.633 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.72 151.19 50.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.769 0.795 . . . . 0.0 111.173 176.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.3 p -71.34 -22.51 61.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.531 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.6 p -176.94 -169.44 0.26 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.58 0.229 . . . . 0.0 111.288 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 28.9 mt -65.82 -20.38 66.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.406 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -59.3 -43.38 92.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.118 0.485 . . . . 0.0 110.073 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.445 ' HB3' HD12 ' A' ' 10' ' ' ILE . 91.6 m -93.59 -23.53 18.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.881 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -59.49 -59.38 5.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.203 0.525 . . . . 0.0 109.922 177.345 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -89.65 45.82 1.31 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.529 0.681 . . . . 0.0 110.953 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -108.79 141.17 41.19 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.93 22.6 11.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.216 0.531 . . . . 0.0 110.936 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.741 0 CA-C-O 121.405 0.621 . . . . 0.0 110.045 179.084 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.43 -1.47 0 CA-C-O 120.965 0.412 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 34.9 mmtp -101.23 157.92 16.42 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.948 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 45.8 t -60.4 114.32 2.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.39 3.74 52.45 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.822 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 32' ' ' CYS . 12.0 mt -104.44 -39.66 5.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 122.676 -0.308 . . . . 0.0 110.98 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.6 p -118.85 -18.08 8.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.578 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 12' ' ' ARG . 34.7 mmt180 59.12 29.46 19.03 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.284 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.92 -70.14 1.31 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.03 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 m -120.83 -171.93 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.3 p30 -54.66 146.57 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.533 0.682 . . . . 0.0 112.031 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.24 71.77 1.61 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -60.23 -25.07 65.36 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -114.29 157.82 22.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.967 0.413 . . . . 0.0 110.942 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.57 146.02 51.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.134 -175.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.422 ' HB3' HG12 ' A' ' 25' ' ' VAL . 48.6 t -97.61 108.53 45.93 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.761 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 36.7 Cg_endo -65.18 -14.27 44.25 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 122.715 2.276 . . . . 0.0 112.964 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -81.97 -59.97 2.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.293 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.81 -34.58 11.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.954 0.407 . . . . 0.0 110.545 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.7 6.91 26.35 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.237 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.5 p -75.18 157.04 6.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.146 0.498 . . . . 0.0 111.434 -173.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -111.8 127.96 55.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.242 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.645 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.1 155.06 46.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.833 0.825 . . . . 0.0 111.639 178.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 29' ' ' SER . 26.5 p -77.8 -17.4 57.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.507 -174.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 8.5 t 176.54 -171.42 0.08 Allowed 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.275 0.36 . . . . 0.0 110.052 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.467 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 23.2 tp -64.31 -19.78 65.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.168 0.508 . . . . 0.0 110.366 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -54.92 -48.39 73.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.12 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HB3' HD12 ' A' ' 10' ' ' ILE . 93.1 m -93.59 -18.6 22.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.727 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.467 ' CB ' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -57.77 -62.36 1.86 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.125 177.12 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -85.45 53.78 2.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.289 0.566 . . . . 0.0 111.165 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -109.93 144.64 38.14 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.231 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.16 27.28 5.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.191 0.52 . . . . 0.0 110.478 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.951 178.971 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.476 HG21 ' HG3' ' A' ' 26' ' ' ARG . 4.4 p . . . . . 0 N--CA 1.435 -1.194 0 CA-C-O 120.804 0.335 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 28.4 mmmt -104.29 159.29 15.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.718 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 45.6 t -62.98 114.78 3.88 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.52 8.65 39.89 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.663 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.0 mt -109.3 -50.55 6.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.857 0.361 . . . . 0.0 110.657 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.8 p -108.61 -15.45 14.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.342 0.591 . . . . 0.0 110.327 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 92.7 mtt-85 55.95 32.26 19.47 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.001 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.12 -72.01 1.29 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.183 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 m -115.49 -171.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 122.763 -0.257 . . . . 0.0 110.41 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.5 p-10 -58.86 146.16 38.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.449 0.642 . . . . 0.0 111.739 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.586 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -89.13 67.17 2.93 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.297 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 17' ' ' LYS . 3.3 ptpp? -57.68 -32.06 66.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -99.04 149.06 23.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.22 144.41 50.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.686 0.279 . . . . 0.0 110.758 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.546 ' HB3' HG12 ' A' ' 25' ' ' VAL . 33.7 t -95.12 104.79 16.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.598 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.29 -16.13 53.35 Favored 'Trans proline' 0 N--CA 1.471 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.853 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -73.66 -60.36 2.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.721 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.0 p -97.51 -35.62 10.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.639 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.55 15.59 13.4 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.943 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.546 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.6 p -80.34 157.71 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.132 0.491 . . . . 0.0 110.723 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.586 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.7 mmt180 -114.24 124.71 52.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.323 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.507 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -124.9 150.92 46.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.613 0.72 . . . . 0.0 110.738 176.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 29.2 p -67.15 -28.95 68.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.443 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.9 m -167.86 -177.32 3.38 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.421 0.153 . . . . 0.0 111.019 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.46 -27.38 69.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.166 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -56.94 -43.49 81.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.513 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.1 m -85.55 -23.69 27.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.754 0.311 . . . . 0.0 110.735 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -56.56 -56.26 23.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.34 0.591 . . . . 0.0 109.479 175.073 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -85.5 47.67 1.47 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.528 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -107.42 143.14 36.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.453 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.52 28.0 6.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.979 0.419 . . . . 0.0 110.837 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.559 0.695 . . . . 0.0 110.255 178.893 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.441 -0.924 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 32.9 mmtp -101.87 158.87 15.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.744 0.307 . . . . 0.0 110.863 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.682 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 34.8 t -64.54 124.65 22.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.305 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.38 1.4 88.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.617 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 32' ' ' CYS . 8.6 mt -105.34 -35.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.773 0.321 . . . . 0.0 111.152 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.3 p -120.88 -17.08 7.99 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.534 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 61.08 21.78 12.13 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.05 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.67 -70.2 1.33 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.429 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.4 m -117.24 -170.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.8 p-10 -61.07 145.76 49.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.518 0.675 . . . . 0.0 111.726 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.81 69.62 1.41 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -61.85 -31.04 71.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.355 -0.422 . . . . 0.0 111.961 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -100.6 150.47 22.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.102 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.42 146.63 46.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.742 0.306 . . . . 0.0 110.482 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.455 ' HB3' HG12 ' A' ' 25' ' ' VAL . 47.8 t -96.07 108.64 42.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.148 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.25 -3.76 11.43 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.707 2.271 . . . . 0.0 112.593 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -88.85 -61.75 1.64 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.4 p -97.7 -26.99 14.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.926 0.393 . . . . 0.0 110.776 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.62 18.25 21.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.988 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.1 p -84.73 155.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.062 0.458 . . . . 0.0 110.925 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.67 128.92 56.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.018 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.682 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -131.89 151.07 51.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 122.0 0.905 . . . . 0.0 111.517 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.2 p -72.98 -25.74 61.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.352 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.6 p -176.1 -170.31 0.37 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.964 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 35.1 mt -62.9 -21.88 66.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.312 176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.49 -33.18 71.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.234 0.54 . . . . 0.0 110.615 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.498 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.8 m -106.5 -20.49 13.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.748 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -61.62 -58.04 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.18 0.514 . . . . 0.0 109.895 177.82 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -87.39 49.78 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.858 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -111.65 145.93 38.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.483 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.26 24.67 6.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.172 0.511 . . . . 0.0 111.146 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 121.32 0.581 . . . . 0.0 110.58 -179.465 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 46.2 mmtm -100.12 152.41 20.28 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 48.2 t -55.75 117.42 3.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.604 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.12 -1.77 75.55 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.927 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 32' ' ' CYS . 8.1 mt -99.87 -37.33 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.761 0.315 . . . . 0.0 110.988 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.7 p -121.03 -18.3 7.55 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.44 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 29.1 mmm180 60.55 33.61 20.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.276 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.91 -78.31 1.3 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.23 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 m -112.91 -173.33 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.53 0.205 . . . . 0.0 110.72 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 32.6 m-20 -64.15 139.14 58.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.156 0.503 . . . . 0.0 110.925 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.54 81.45 1.65 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.714 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -66.4 -25.52 66.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.964 0.411 . . . . 0.0 111.505 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -105.54 153.45 21.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.139 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.5 tmtp? -134.75 146.46 49.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.349 -0.387 . . . . 0.0 109.994 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 19.9 t -101.29 103.54 27.18 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.29 -12.48 35.79 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.796 2.331 . . . . 0.0 112.693 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -76.52 -59.55 2.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.67 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.4 p -100.69 -31.85 11.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.227 0.537 . . . . 0.0 110.644 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.06 22.96 7.97 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.275 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.2 p -91.82 158.81 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.913 0.387 . . . . 0.0 110.953 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -114.93 126.89 55.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.368 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.609 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -126.87 154.1 44.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.684 0.754 . . . . 0.0 111.128 177.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.0 p -71.55 -23.11 61.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.253 -1.339 . . . . 0.0 111.616 -175.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.8 p 178.25 -167.92 0.07 Allowed 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.493 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 19.9 mt -63.09 -21.57 66.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.442 175.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -51.35 -46.62 62.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.251 0.548 . . . . 0.0 111.104 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.474 ' HB3' HD12 ' A' ' 10' ' ' ILE . 73.8 m -100.67 -14.99 17.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.933 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -62.44 -60.84 2.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 110.312 178.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -85.18 45.89 1.23 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.381 0.61 . . . . 0.0 111.101 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -104.92 148.61 26.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.942 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.11 13.6 6.72 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.131 0.491 . . . . 0.0 110.983 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.766 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.437 -1.1 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 33.0 mmtp -95.22 159.21 15.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.0 t -62.79 118.63 7.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.278 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.52 2.86 76.41 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.682 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 32' ' ' CYS . 15.7 mt -102.33 -41.71 8.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 122.683 -0.304 . . . . 0.0 111.025 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.9 p -117.66 -16.36 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.242 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 62.34 21.96 12.89 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.515 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.97 -74.82 1.16 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.402 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.32 -169.35 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.9 p-10 -57.64 142.77 43.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.483 0.659 . . . . 0.0 111.556 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.402 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -96.5 70.87 0.84 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -63.28 -31.4 72.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -95.45 149.77 21.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.535 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.5 tmtp? -132.74 148.05 52.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 38.6 t -99.71 108.14 49.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.208 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 2.33 3.44 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.893 2.395 . . . . 0.0 113.188 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -97.47 -58.57 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.698 0.285 . . . . 0.0 111.095 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.27 -30.95 13.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.138 0.494 . . . . 0.0 110.498 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.33 17.51 19.69 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.845 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.409 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.3 p -84.7 159.31 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.0 110.777 -176.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 18.4 mmt180 -115.84 127.46 55.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.914 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.643 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.19 148.55 51.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.898 0.856 . . . . 0.0 111.538 178.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.6 p -69.94 -23.48 63.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.439 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.2 p -173.5 -167.62 0.4 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 111.633 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.4 tp -70.41 -20.14 62.95 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.257 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.6 -40.27 96.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.982 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.526 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.7 m -92.27 -22.47 19.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.645 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.412 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -58.85 -58.2 9.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.222 177.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -87.7 47.21 1.47 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.213 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -107.77 141.82 38.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.46 24.53 6.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.142 0.496 . . . . 0.0 110.792 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 121.414 0.626 . . . . 0.0 109.719 178.861 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 35.5 mmtp -99.81 157.12 16.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.655 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.3 t -62.18 113.69 3.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.073 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.51 5.01 47.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.771 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 32' ' ' CYS . 12.2 mt -108.41 -33.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.7 -0.294 . . . . 0.0 111.433 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.65 -14.75 6.72 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.313 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.22 30.31 18.17 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.238 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.84 -73.82 1.27 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.247 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -112.35 -169.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 122.941 -0.153 . . . . 0.0 110.596 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 9.6 p-10 -64.39 144.63 57.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.361 0.6 . . . . 0.0 111.088 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.24 73.73 1.68 Allowed Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.309 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -60.1 -33.38 72.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -100.05 157.65 16.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.85 0.357 . . . . 0.0 110.275 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 13.8 tmtt? -142.23 145.05 33.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.505 -174.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 50.6 t -95.6 114.87 64.87 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.556 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.92 -6.15 16.3 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.753 2.302 . . . . 0.0 113.34 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.23 -56.77 2.61 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.709 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.9 p -97.75 -23.04 16.09 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.016 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.89 22.63 30.05 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.407 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 p -89.62 157.55 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.216 0.531 . . . . 0.0 110.552 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -114.27 127.97 56.13 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.821 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.655 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.29 153.82 48.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.873 0.844 . . . . 0.0 111.535 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.3 p -77.28 -22.07 52.62 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.055 -176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.4 p -176.05 -167.44 0.22 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.893 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 35.1 mt -65.93 -23.4 66.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.402 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -59.66 -35.7 74.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.141 0.495 . . . . 0.0 110.743 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HB3' HD12 ' A' ' 10' ' ' ILE . 78.5 m -100.66 -23.72 14.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.539 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.527 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -59.47 -57.41 13.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.157 0.503 . . . . 0.0 109.685 176.606 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -88.61 41.89 1.04 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.359 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -108.79 141.92 40.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.11 29.98 5.3 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.235 0.54 . . . . 0.0 110.515 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 121.54 0.685 . . . . 0.0 109.443 177.402 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.032 0 CA-C-O 121.233 0.54 . . . . 0.0 110.924 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.41 136.94 55.0 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.377 167.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.563 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 40.2 t -47.42 113.03 0.62 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.416 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.55 12.12 22.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.883 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 32' ' ' CYS . 16.2 mt -109.98 -41.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 O-C-N 122.727 -0.278 . . . . 0.0 110.669 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.9 p -117.1 -18.78 9.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.267 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 25.6 mmm180 59.09 33.94 23.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.609 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.44 -69.8 1.18 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.975 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.9 m -122.84 -170.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.554 0.216 . . . . 0.0 110.526 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 12.7 m-20 -63.7 140.75 58.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.125 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.97 77.11 2.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.945 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -71.48 -16.86 62.37 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -109.64 157.15 19.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.427 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.8 tmtm? -140.1 146.47 38.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.838 0.351 . . . . 0.0 111.058 -173.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.5 t -103.45 111.51 65.14 Favored Pre-proline 0 CA--C 1.515 -0.402 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.039 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.76 -0.16 7.32 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 122.584 2.189 . . . . 0.0 112.838 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -98.19 -56.06 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.557 0.218 . . . . 0.0 111.515 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.4 p -100.72 -15.81 17.57 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.059 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.36 9.73 62.93 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.628 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.54 157.35 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 121.089 0.471 . . . . 0.0 110.919 -173.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -116.47 118.86 33.84 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.964 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.563 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -117.32 155.14 30.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.811 0.815 . . . . 0.0 111.248 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.5 p -70.33 -31.6 68.96 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.176 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.2 m -171.12 -169.41 0.74 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.3 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.2 -24.42 66.62 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.726 0.298 . . . . 0.0 111.03 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -51.94 -43.38 63.43 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.478 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB3' HD12 ' A' ' 10' ' ' ILE . 73.2 m -96.87 -20.59 18.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.775 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -59.51 -62.49 1.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.674 176.221 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -87.91 52.91 2.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.772 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -117.97 145.01 45.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.61 10.9 7.26 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.109 0.48 . . . . 0.0 110.655 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.897 -179.721 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.439 -1.025 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -101.24 158.11 16.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.574 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 42.7 t -62.28 116.53 5.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.599 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.92 17.25 22.9 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.566 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 32' ' ' CYS . 10.2 mt -117.19 -37.5 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.617 -0.343 . . . . 0.0 110.864 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.3 p -120.6 -15.21 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.258 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 59.09 29.57 19.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.22 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.74 -76.08 1.31 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.9 m -112.88 -171.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 122.864 -0.198 . . . . 0.0 110.487 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -61.27 144.29 54.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.469 0.652 . . . . 0.0 111.339 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -88.23 68.17 3.0 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 175.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -29.9 68.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -104.07 153.77 20.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -133.03 146.71 51.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.305 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.53 ' CB ' HG12 ' A' ' 25' ' ' VAL . 38.4 t -94.43 106.29 22.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.99 -9.02 21.69 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.963 2.442 . . . . 0.0 112.563 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -81.8 -64.77 1.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.489 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.6 p -94.32 -38.38 11.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.195 0.521 . . . . 0.0 110.888 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.29 12.86 11.36 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.387 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.53 HG12 ' CB ' ' A' ' 20' ' ' CYS . 3.7 p -77.28 160.32 4.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.904 0.383 . . . . 0.0 110.727 -176.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 24.4 mmt180 -117.15 125.84 51.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.574 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -128.13 156.2 43.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.904 0.859 . . . . 0.0 111.426 178.621 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.3 p -75.97 -21.2 57.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.677 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 t 179.08 -171.39 0.13 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 79.2 mt -65.94 -20.67 66.29 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.773 0.32 . . . . 0.0 110.357 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -55.62 -32.22 62.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.82 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' HB3' HD12 ' A' ' 10' ' ' ILE . 99.9 m -110.56 -20.49 12.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.094 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.79 -57.92 10.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.305 0.574 . . . . 0.0 109.548 176.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.75 50.82 2.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.631 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -114.33 147.71 38.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.118 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.07 14.0 7.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.042 0.449 . . . . 0.0 110.973 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 121.339 0.59 . . . . 0.0 110.137 -179.354 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.6 mmtt -103.74 157.09 17.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.968 0.413 . . . . 0.0 110.807 -177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.615 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.6 t -62.35 115.77 4.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.553 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.89 12.85 40.31 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.644 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 32' ' ' CYS . 7.7 mt -112.83 -38.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.737 0.303 . . . . 0.0 111.053 -177.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.1 p -119.9 -16.64 8.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.266 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 63.35 32.21 14.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.152 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.0 -81.73 1.41 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.304 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.27 -169.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.971 -0.135 . . . . 0.0 110.895 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 53.2 m-20 -63.28 141.27 58.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.313 0.577 . . . . 0.0 111.03 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.58 75.52 2.35 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -60.6 -30.17 69.67 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.94 151.86 24.72 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -134.66 145.64 48.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.419 ' HB3' HG12 ' A' ' 25' ' ' VAL . 22.0 t -97.11 107.42 37.82 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.97 0.42 5.08 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.086 2.524 . . . . 0.0 113.454 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -94.14 -63.81 1.15 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.018 0.437 . . . . 0.0 110.927 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.5 p -92.85 -26.64 17.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.181 0.515 . . . . 0.0 110.492 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.2 21.33 18.01 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.672 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.419 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.7 p -89.24 155.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.158 0.504 . . . . 0.0 110.601 -176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -112.86 129.74 56.35 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.791 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.615 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.91 148.82 52.72 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.803 0.811 . . . . 0.0 111.516 177.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -71.77 -19.92 61.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.691 -175.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 8.2 t 176.93 -168.02 0.05 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.233 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 45.8 mt -64.24 -23.22 67.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.385 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -60.12 -31.7 70.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.044 0.45 . . . . 0.0 110.985 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HB3' HD12 ' A' ' 10' ' ' ILE . 99.4 m -106.14 -21.5 13.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.729 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -59.5 -56.57 20.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.582 0.706 . . . . 0.0 109.489 176.524 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -91.47 39.81 1.01 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.111 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -103.15 140.57 37.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.68 19.66 13.77 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.231 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.226 0.536 . . . . 0.0 110.02 178.844 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.435 -1.223 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -101.2 154.43 18.76 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.2 t -58.28 116.1 3.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.525 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.414 ' HA2' HH11 ' A' ' 12' ' ' ARG . . . -77.74 6.08 49.09 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.791 -177.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 32' ' ' CYS . 8.6 mt -107.85 -38.73 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 120.654 0.264 . . . . 0.0 111.11 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.6 p -119.75 -15.42 8.9 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.605 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 29.3 mmm180 59.19 24.93 13.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.332 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.59 -73.53 1.27 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.268 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.8 m -114.84 -169.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.34 145.35 51.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.439 0.637 . . . . 0.0 111.421 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -93.65 72.99 1.23 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -65.93 -32.0 73.24 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -95.72 149.83 21.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.534 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.2 tmtp? -134.1 147.85 50.92 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.534 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.7 t -100.23 109.34 56.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.466 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 40.9 Cg_endo -67.72 -5.39 14.19 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.988 2.458 . . . . 0.0 112.788 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -88.94 -60.71 1.88 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.907 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.4 p -96.51 -29.82 13.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.941 0.401 . . . . 0.0 111.067 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.2 21.5 11.67 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.896 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.5 p -89.31 158.83 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.075 0.464 . . . . 0.0 110.655 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 23.1 mmt180 -114.69 128.13 56.14 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.171 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.61 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -127.65 153.25 46.68 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.84 0.829 . . . . 0.0 110.817 176.925 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.0 p -70.49 -34.39 72.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.044 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.3 m -168.8 -172.43 1.6 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.018 -173.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 22.5 mt -62.19 -23.42 66.61 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.634 ' HD2' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -55.98 -51.63 67.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.703 0.763 . . . . 0.0 110.273 -179.713 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.492 ' HB3' HD12 ' A' ' 10' ' ' ILE . 72.5 m -85.39 -24.3 27.6 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.315 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.534 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.41 -60.64 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.052 178.001 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -87.48 44.23 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.064 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -110.77 139.69 45.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.661 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.02 23.77 9.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.115 0.483 . . . . 0.0 110.843 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 178.913 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.441 -0.884 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 13.7 mmmm -103.96 157.67 16.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.865 0.364 . . . . 0.0 110.592 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.575 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.1 t -63.2 117.21 6.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.245 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 12' ' ' ARG . . . -80.67 5.38 65.08 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.666 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 32' ' ' CYS . 10.4 mt -105.25 -40.63 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 120.725 0.298 . . . . 0.0 110.975 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.3 p -117.99 -14.07 10.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.197 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.42 ' CZ ' ' HA2' ' A' ' 9' ' ' GLY . 38.6 mmt180 57.7 29.01 16.65 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.552 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.71 -77.91 1.27 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.359 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.0 m -113.42 -169.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 6.7 p-10 -64.35 143.32 57.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.469 0.652 . . . . 0.0 111.422 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -88.69 76.9 1.84 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 175.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -64.08 -28.09 69.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -104.93 159.32 15.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.583 0.23 . . . . 0.0 110.547 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.2 tmtp? -135.7 145.76 47.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.732 0.301 . . . . 0.0 110.779 -174.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.559 ' HB3' HG12 ' A' ' 25' ' ' VAL . 33.8 t -100.63 102.92 20.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.3 -7.93 18.97 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 122.782 2.321 . . . . 0.0 113.269 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -79.31 -61.9 1.86 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.067 0.461 . . . . 0.0 110.967 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.2 p -97.58 -31.94 12.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.664 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.37 14.29 18.64 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.982 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.5 p -82.12 156.27 4.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.148 0.499 . . . . 0.0 110.913 -175.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 24.3 mmt180 -113.34 121.5 44.56 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.014 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.575 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -119.47 148.33 43.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.859 0.838 . . . . 0.0 111.079 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.5 p -65.99 -26.14 67.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.518 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 p -176.11 -171.2 0.42 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.366 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.36 -20.88 66.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.671 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.54 -39.9 81.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.089 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' HB3' HD12 ' A' ' 10' ' ' ILE . 98.9 m -98.39 -17.82 18.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -65.02 0.73 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.912 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -85.06 48.16 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.217 0.532 . . . . 0.0 111.646 -174.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -106.73 150.0 26.73 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.511 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.09 29.03 4.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.166 0.508 . . . . 0.0 110.716 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.041 177.532 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 69.9 mmtt -98.35 159.87 14.66 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 44.0 t -63.43 114.24 3.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.057 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.01 7.85 41.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.578 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.401 HD12 ' HB3' ' A' ' 32' ' ' CYS . 7.7 mt -110.17 -38.69 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 122.672 -0.311 . . . . 0.0 111.078 -177.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 p -121.78 -15.09 7.99 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.445 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 61.89 22.89 13.37 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.91 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.25 -72.59 1.2 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.307 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.1 -169.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.9 p-10 -59.66 145.52 44.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.505 0.669 . . . . 0.0 111.806 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.88 69.39 2.43 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -63.11 -27.37 69.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.335 -0.433 . . . . 0.0 111.835 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -99.75 148.03 24.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.785 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER -137.13 145.52 43.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.805 0.335 . . . . 0.0 110.292 -174.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.553 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 43.3 t -98.2 108.29 46.24 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.183 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.11 0.03 5.01 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 122.811 2.34 . . . . 0.0 112.967 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -96.16 -60.32 1.65 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.62 0.248 . . . . 0.0 111.419 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.8 p -95.38 -27.15 15.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.038 0.447 . . . . 0.0 110.676 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.23 20.95 21.62 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.548 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 p -86.14 158.0 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.05 0.452 . . . . 0.0 110.187 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -115.65 128.15 55.71 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.912 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.629 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.74 147.53 52.41 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.985 0.898 . . . . 0.0 110.909 177.099 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.2 p -66.98 -31.71 72.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.347 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.0 m -167.9 -176.25 2.99 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.647 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 47.8 mt -61.19 -26.3 67.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -56.26 -38.1 70.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.02 0.438 . . . . 0.0 111.127 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.401 ' HB3' HD12 ' A' ' 10' ' ' ILE . 81.2 m -95.11 -23.91 17.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.581 177.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -61.17 -57.8 10.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.807 176.826 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -85.27 43.56 1.02 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.331 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -111.35 149.17 31.53 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.82 3.23 6.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.014 0.435 . . . . 0.0 111.01 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.362 0.601 . . . . 0.0 110.103 179.395 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -104.15 154.74 19.38 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 44.9 t -59.46 112.21 1.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.322 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.85 0.62 43.8 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.776 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 32' ' ' CYS . 11.3 mt -103.14 -40.51 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 122.755 -0.262 . . . . 0.0 111.206 -174.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.2 p -119.0 -18.44 8.78 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.323 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.32 36.51 27.62 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.026 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.54 -62.91 0.98 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.126 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -125.75 -176.2 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.722 0.296 . . . . 0.0 111.254 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.74 135.29 55.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.551 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -86.95 74.82 2.27 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -68.34 -31.13 70.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -95.47 152.32 18.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.677 0.275 . . . . 0.0 110.331 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -134.31 145.82 49.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.864 0.364 . . . . 0.0 111.045 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.436 ' CB ' HG12 ' A' ' 25' ' ' VAL . 35.5 t -100.48 108.49 53.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.789 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 39.4 Cg_endo -66.94 -13.33 39.55 Favored 'Trans proline' 0 N--CA 1.471 0.174 0 C-N-CA 122.832 2.354 . . . . 0.0 112.744 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -82.82 -56.64 3.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.538 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.5 p -101.04 -29.47 12.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.969 0.414 . . . . 0.0 110.523 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.11 7.1 31.33 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.321 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.436 HG12 ' CB ' ' A' ' 20' ' ' CYS . 3.2 p -77.28 157.78 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.046 0.45 . . . . 0.0 111.447 -173.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.482 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.1 mmt180 -115.0 124.33 51.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.22 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.576 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -123.89 153.93 40.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.616 0.722 . . . . 0.0 110.825 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -70.08 -33.07 71.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.981 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.1 m -168.08 -173.53 2.08 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.589 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.65 -25.0 67.76 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.69 -41.07 73.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.923 0.392 . . . . 0.0 111.162 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.51 ' HB3' HD12 ' A' ' 10' ' ' ILE . 99.5 m -91.18 -23.0 20.37 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.803 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -60.91 2.93 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -86.95 52.79 2.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.226 0.536 . . . . 0.0 111.314 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -119.0 141.63 48.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.57 10.42 13.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.957 0.408 . . . . 0.0 111.16 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.326 -179.632 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.437 -1.121 0 CA-C-O 120.702 0.287 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -108.27 161.6 14.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 49.4 t -65.47 116.36 6.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.572 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.85 -4.87 78.09 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.785 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 32' ' ' CYS . 9.6 mt -98.0 -40.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.795 0.331 . . . . 0.0 110.963 -174.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.5 p -117.65 -15.71 10.14 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.417 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 61.38 32.55 19.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.456 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.0 -82.88 1.47 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.292 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.03 -168.96 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.649 0.262 . . . . 0.0 110.814 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.22 139.16 58.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.28 0.562 . . . . 0.0 111.964 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.72 70.45 3.17 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -62.36 -27.46 69.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.503 -0.349 . . . . 0.0 111.753 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.7 153.88 20.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -138.17 143.79 40.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.729 0.299 . . . . 0.0 110.333 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.439 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 18.8 t -98.72 107.48 43.24 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.818 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.22 -9.97 27.01 Favored 'Trans proline' 0 C--N 1.335 -0.156 0 C-N-CA 122.776 2.317 . . . . 0.0 112.824 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.92 -62.5 1.55 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.209 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -93.66 -28.69 15.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.106 0.479 . . . . 0.0 110.496 -176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.3 10.73 35.55 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.802 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.6 p -79.11 157.99 4.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.153 0.501 . . . . 0.0 111.368 -174.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -113.0 126.54 55.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.199 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.595 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -127.47 148.28 50.31 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.861 0.838 . . . . 0.0 110.716 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -65.57 -32.28 73.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.294 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.5 m -168.62 -169.92 1.12 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.859 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.69 -27.62 68.48 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.426 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.538 ' HD2' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -55.47 -45.0 76.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.51 0.671 . . . . 0.0 111.22 -177.236 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.442 ' HB3' HD12 ' A' ' 10' ' ' ILE . 73.7 m -87.69 -23.15 24.28 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.71 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -61.28 -63.03 1.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.782 176.55 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -84.98 52.53 2.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.201 0.524 . . . . 0.0 110.842 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -112.42 148.99 33.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.68 15.84 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.077 0.465 . . . . 0.0 110.799 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.441 0.639 . . . . 0.0 109.759 179.644 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.443 -0.8 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.2 mmtt -110.08 158.11 18.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 0.0 110.734 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 33.9 t -66.16 113.95 4.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.123 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.23 3.06 59.57 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.861 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.494 HD12 ' HB3' ' A' ' 32' ' ' CYS . 16.5 mt -103.0 -40.55 6.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 122.715 -0.286 . . . . 0.0 110.955 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.7 p -118.09 -16.2 9.81 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.291 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 59.54 24.5 13.24 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.334 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.61 -69.76 1.36 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.408 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 m -120.79 -168.87 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.5 m-20 -66.77 142.8 57.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.133 0.492 . . . . 0.0 111.243 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.47 78.22 1.64 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -66.89 -33.44 75.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.883 0.373 . . . . 0.0 111.351 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.31 153.8 18.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 12.1 tmtt? -142.81 145.18 32.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.639 0.257 . . . . 0.0 110.694 -175.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.413 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.0 t -96.58 113.46 62.69 Favored Pre-proline 0 CA--C 1.516 -0.34 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.04 -13.77 41.38 Favored 'Trans proline' 0 C--N 1.334 -0.233 0 C-N-CA 122.575 2.184 . . . . 0.0 112.385 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -88.29 -56.02 3.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.819 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.0 p -98.35 -21.44 16.61 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.162 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.0 16.74 46.54 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.637 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.81 158.91 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 120.961 0.41 . . . . 0.0 110.4 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -116.62 129.07 55.94 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.014 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.651 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.96 152.94 48.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.795 0.807 . . . . 0.0 111.133 177.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.8 p -72.78 -20.5 61.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.442 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.4 p -178.28 -169.39 0.19 Allowed 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.291 0.369 . . . . 0.0 110.422 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 33.9 mt -65.34 -20.24 66.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.424 175.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -59.15 -39.47 82.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.162 0.506 . . . . 0.0 110.724 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.494 ' HB3' HD12 ' A' ' 10' ' ' ILE . 90.6 m -97.87 -22.31 16.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.453 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -57.96 -58.85 6.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.83 177.466 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -90.72 35.52 0.89 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.095 0.474 . . . . 0.0 111.07 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -101.13 122.32 43.39 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.36 17.11 24.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.904 0.383 . . . . 0.0 111.076 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.102 178.667 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.551 HG11 ' HG3' ' A' ' 26' ' ' ARG . 4.2 p . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.5 mmtt -99.54 156.82 16.85 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.5 t -62.59 111.93 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.424 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.7 24.7 3.13 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.664 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 32' ' ' CYS . 10.1 mt -125.08 -39.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 122.666 -0.314 . . . . 0.0 110.857 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.4 p -119.78 -16.25 8.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.13 0.491 . . . . 0.0 110.745 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 56.75 27.69 13.14 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.518 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.19 -68.87 1.41 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.006 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.46 -168.91 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.514 0.197 . . . . 0.0 110.547 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.9 p-10 -61.31 146.52 47.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.418 0.628 . . . . 0.0 111.629 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.03 70.31 2.29 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.429 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -25.15 66.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.884 0.373 . . . . 0.0 111.805 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -98.68 149.49 22.77 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.545 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -131.73 145.66 51.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.822 0.344 . . . . 0.0 111.053 -174.35 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.569 ' HB3' HG12 ' A' ' 25' ' ' VAL . 43.4 t -102.51 107.28 53.24 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.109 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.33 -9.93 27.41 Favored 'Trans proline' 0 N--CA 1.472 0.236 0 C-N-CA 122.883 2.389 . . . . 0.0 112.97 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -82.7 -49.16 10.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.5 p -111.12 -33.18 6.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.844 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.45 16.2 13.74 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.152 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.3 p -81.19 158.9 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 110.675 -176.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HG3' HG11 ' A' ' 6' ' ' VAL . 61.3 mmt-85 -114.58 121.35 43.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.296 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.527 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -122.24 155.88 34.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.548 0.689 . . . . 0.0 110.909 176.211 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.1 p -71.21 -34.08 70.5 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.807 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -167.58 -172.93 2.04 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.328 -174.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 tp -62.77 -31.59 72.58 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 122.65 0.38 . . . . 0.0 111.508 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -53.6 -43.34 68.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.544 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.416 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.6 m -87.99 -23.1 23.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.66 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.494 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -56.67 -58.73 6.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.141 177.092 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -87.04 50.8 2.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.409 0.623 . . . . 0.0 111.526 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -109.87 150.76 27.95 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.12 -0.6 5.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.246 0.546 . . . . 0.0 111.002 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.75 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.057 -179.869 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.432 -1.372 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.45 158.68 16.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.3 t -63.66 115.73 5.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.15 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 12' ' ' ARG . . . -81.3 17.86 12.07 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.494 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 32' ' ' CYS . 10.1 mt -119.13 -46.03 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 120.853 0.359 . . . . 0.0 110.742 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.0 p -110.6 -13.87 14.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.485 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.457 ' CZ ' ' HA2' ' A' ' 9' ' ' GLY . 35.4 mmt180 55.45 30.63 15.41 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.833 178.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.24 -69.13 1.01 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.348 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.13 -170.18 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 121.276 -0.17 . . . . 0.0 110.765 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 5.7 p-10 -63.27 145.79 54.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.326 0.584 . . . . 0.0 111.619 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -92.1 65.74 2.21 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.365 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 6.7 ptpp? -56.89 -36.3 69.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.438 ' CD1' ' HG3' ' A' ' 17' ' ' LYS . 3.7 m-30 -94.65 149.63 21.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 13.1 tmtt? -134.43 144.29 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.789 0.328 . . . . 0.0 110.771 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.492 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 25.1 t -97.98 107.35 40.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.806 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 39.8 Cg_endo -66.64 -10.07 26.69 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.04 2.493 . . . . 0.0 113.565 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -84.55 -63.11 1.39 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.908 0.385 . . . . 0.0 111.232 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.6 p -94.05 -32.34 13.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.201 0.524 . . . . 0.0 110.601 -173.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.41 21.47 9.3 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.168 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.0 p -88.04 158.74 3.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.969 0.414 . . . . 0.0 110.618 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 21.5 mmt180 -116.02 129.53 56.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.011 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.581 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -131.32 151.05 51.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.702 0.763 . . . . 0.0 110.949 177.645 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.0 p -71.24 -19.61 62.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.751 -174.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.3 t -175.94 -171.35 0.44 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.76 0.315 . . . . 0.0 110.547 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.418 ' HG ' ' HE2' ' A' ' 34' ' ' LYS . 37.2 tp -69.89 -19.82 63.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.529 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.56 -49.34 77.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.051 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.4 m -81.53 -20.88 39.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.67 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -59.32 -59.57 5.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.869 176.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HE2' ' HG ' ' A' ' 30' ' ' LEU . 55.0 mtmt -84.86 54.31 3.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.632 0.73 . . . . 0.0 110.999 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -111.64 149.79 31.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.564 174.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.57 13.05 7.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.731 0.3 . . . . 0.0 111.628 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 121.382 0.61 . . . . 0.0 110.092 -179.736 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 4.0 p . . . . . 0 N--CA 1.434 -1.254 0 CA-C-O 120.603 0.24 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -106.18 154.01 21.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.7 t -59.41 110.02 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.538 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.26 18.14 3.63 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.732 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.5 mt -119.98 -36.1 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.565 0.221 . . . . 0.0 111.15 -177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.84 -14.7 6.64 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.439 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 5.7 mpt_? 58.77 28.9 17.98 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.835 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.4 -78.06 1.14 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.699 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.07 -171.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 6.2 p-10 -58.12 144.21 41.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.51 0.672 . . . . 0.0 111.425 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.602 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -86.92 68.54 3.22 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.175 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 17' ' ' LYS . 4.3 ptpp? -58.86 -34.29 71.43 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -94.94 146.7 24.06 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.65 145.98 51.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.822 0.344 . . . . 0.0 110.772 -174.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.431 ' CB ' HG12 ' A' ' 25' ' ' VAL . 38.3 t -98.4 106.75 37.93 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.951 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.41 -6.41 16.36 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.615 2.21 . . . . 0.0 113.119 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.64 -63.48 1.31 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.866 0.365 . . . . 0.0 111.037 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.8 p -93.97 -30.29 14.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.049 0.452 . . . . 0.0 110.245 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.72 7.96 35.56 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.051 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.431 HG12 ' CB ' ' A' ' 20' ' ' CYS . 3.4 p -74.68 157.34 6.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.42 . . . . 0.0 111.002 -173.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.602 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 22.2 mmt180 -114.73 125.75 54.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.518 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.593 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -128.02 153.22 47.01 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.724 0.773 . . . . 0.0 110.986 177.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.8 p -74.5 -20.24 60.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.434 -175.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.7 t -175.08 -177.03 1.01 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.683 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.0 tp -62.8 -24.98 68.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.081 0.467 . . . . 0.0 110.22 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -52.36 -54.05 36.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.261 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -84.1 -20.01 33.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.406 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -57.48 -56.14 25.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.72 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -89.55 47.34 1.46 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.693 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.55 133.26 53.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.11 25.38 11.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.064 0.459 . . . . 0.0 111.207 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.679 0 CA-C-O 121.445 0.641 . . . . 0.0 109.805 178.147 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.723 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.67 87.62 1.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.126 2.551 . . . . 0.0 112.406 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -112.63 -23.03 10.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.422 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -72.5 147.57 45.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.921 0.391 . . . . 0.0 110.33 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.5 19.6 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.7 t 61.23 68.88 0.7 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.866 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -79.8 51.61 1.34 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.919 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.97 166.71 29.82 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.774 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 26' ' ' ARG . 9.8 p -135.3 154.46 35.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.815 -172.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.8 mmtt -97.51 158.89 15.24 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.578 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 49.3 t -63.86 112.17 2.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.99 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.95 -0.29 55.23 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.812 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 32' ' ' CYS . 7.3 mt -100.96 -37.35 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 120.692 0.282 . . . . 0.0 111.205 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.7 p -123.6 -14.74 7.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.311 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.21 30.83 19.05 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.518 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.63 -71.03 1.27 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.342 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 m -118.34 -169.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.7 p-10 -62.64 145.99 53.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.489 0.661 . . . . 0.0 111.612 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.54 75.18 2.02 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -66.64 -27.59 67.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.673 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.431 ' CD1' ' HG3' ' A' ' 17' ' ' LYS . 2.8 m-30 -102.62 154.78 18.81 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 11.9 tmtt? -136.93 145.73 44.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.741 0.305 . . . . 0.0 110.882 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.515 ' HB3' HG12 ' A' ' 25' ' ' VAL . 36.6 t -99.09 107.32 43.55 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.0 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.66 1.25 5.22 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.148 2.565 . . . . 0.0 112.878 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 13.9 mmmm -92.19 -52.54 4.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.798 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.5 p -105.8 -37.03 6.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.081 0.467 . . . . 0.0 111.068 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.62 19.39 8.31 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.929 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.519 HG11 ' CD2' ' A' ' 39' ' ' HIS . 4.1 p -85.59 158.97 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.963 0.411 . . . . 0.0 110.224 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HG3' HG11 ' A' ' 6' ' ' VAL . 24.8 mmt180 -118.21 119.45 34.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.073 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.578 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -118.79 156.12 29.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.697 0.76 . . . . 0.0 110.886 179.154 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -74.66 -20.9 59.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.556 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.8 t -177.19 -171.64 0.35 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.347 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 tp -66.36 -20.64 66.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.121 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -54.75 -52.96 60.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.704 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.402 ' HB3' HD12 ' A' ' 10' ' ' ILE . 89.3 m -86.26 -18.7 31.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.779 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -61.85 -63.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -83.81 54.54 2.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.721 0.772 . . . . 0.0 110.944 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 8.3 t70 -116.48 145.93 42.94 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.853 175.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.51 28.65 5.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.295 0.569 . . . . 0.0 110.572 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.82 -43.9 2.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.069 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -109.59 -32.82 6.98 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.561 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.583 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 10.0 t-160 -82.89 89.75 6.88 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -93.23 126.97 45.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.614 0.721 . . . . 0.0 112.187 -170.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 4.2 m170 -122.4 64.45 0.95 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.382 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 44' ' ' SER . 62.7 tttp -89.8 -46.21 8.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.623 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 67.0 -82.12 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.225 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 26.9 t -113.99 -175.94 2.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.83 -49.12 78.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.634 174.459 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.57 81.51 2.31 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.648 2.232 . . . . 0.0 112.494 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -111.68 8.37 20.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.969 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm -117.6 173.95 6.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.935 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.77 -43.44 98.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 m -103.2 -46.49 4.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.801 -0.182 . . . . 0.0 110.643 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.1 m 57.55 46.12 18.29 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.373 0.606 . . . . 0.0 110.092 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.49 147.08 30.82 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.564 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p -113.12 152.37 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.938 -173.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 75.2 mmtt -104.48 160.46 14.91 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.633 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.8 t -66.2 111.83 3.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.928 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.39 -1.36 57.29 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.943 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 39' ' ' HIS . 11.4 mt -99.53 -40.4 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.799 0.333 . . . . 0.0 111.175 -176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.7 p -120.74 -14.48 8.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.207 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.01 27.99 14.12 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.034 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.14 -69.66 1.31 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.246 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.22 -169.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.563 0.221 . . . . 0.0 110.7 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 7.5 p-10 -62.89 143.01 58.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.434 0.635 . . . . 0.0 111.587 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.428 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -92.23 70.34 1.74 Allowed Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.408 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -65.1 -23.67 67.22 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -101.93 150.46 23.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 12.8 tmtt? -135.78 144.66 45.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.641 0.257 . . . . 0.0 110.545 -174.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 15.0 t -98.99 107.68 45.18 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.912 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 34.9 Cg_endo -64.55 -13.0 36.25 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.102 2.535 . . . . 0.0 113.58 -176.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 68.7 mmtt -82.22 -63.26 1.42 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.022 0.439 . . . . 0.0 111.147 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -92.12 -33.08 14.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.917 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.82 18.96 13.99 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.671 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 39' ' ' HIS . 3.5 p -84.2 158.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.129 0.49 . . . . 0.0 110.595 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.9 mmt180 -114.49 128.88 56.56 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.924 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.633 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.72 151.19 50.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.769 0.795 . . . . 0.0 111.173 176.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.3 p -71.34 -22.51 61.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.531 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.6 p -176.94 -169.44 0.26 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.58 0.229 . . . . 0.0 111.288 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 28.9 mt -65.82 -20.38 66.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.406 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -59.3 -43.38 92.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.118 0.485 . . . . 0.0 110.073 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.445 ' HB3' HD12 ' A' ' 10' ' ' ILE . 91.6 m -93.59 -23.53 18.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.881 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -59.49 -59.38 5.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.203 0.525 . . . . 0.0 109.922 177.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -89.65 45.82 1.31 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.529 0.681 . . . . 0.0 110.953 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.568 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.8 t70 -108.79 141.17 41.19 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.93 22.6 11.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.216 0.531 . . . . 0.0 110.936 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.33 -44.47 3.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.405 0.621 . . . . 0.0 110.045 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -105.46 -33.45 8.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.818 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.568 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 11.0 t-80 -95.7 99.96 11.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.666 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.0 t -126.13 145.7 33.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.335 0.588 . . . . 0.0 111.046 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.443 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 5.0 m170 -113.58 164.06 14.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.606 -176.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -130.76 15.26 5.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.76 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -71.79 115.09 10.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.979 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.0 m -77.82 83.42 4.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.179 0.514 . . . . 0.0 111.433 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -72.6 -28.43 62.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.087 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.844 177.731 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.75 20.24 0.9 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.503 2.802 . . . . 0.0 113.039 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 42.4 m80 71.89 -71.97 0.12 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.388 0.675 . . . . 0.0 111.917 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttp -131.6 145.58 51.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.721 0.296 . . . . 0.0 110.475 -174.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.02 70.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.729 0.776 . . . . 0.0 110.361 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.9 t -145.14 105.35 4.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.3 m 63.12 55.62 1.89 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.518 0.675 . . . . 0.0 109.295 -169.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.64 -176.96 5.16 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.225 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 p -126.56 144.82 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.717 -172.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 34.9 mmtp -101.23 157.92 16.42 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.948 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 45.8 t -60.4 114.32 2.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.39 3.74 52.45 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.822 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 32' ' ' CYS . 12.0 mt -104.44 -39.66 5.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 122.676 -0.308 . . . . 0.0 110.98 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.6 p -118.85 -18.08 8.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.578 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 12' ' ' ARG . 34.7 mmt180 59.12 29.46 19.03 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.284 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.92 -70.14 1.31 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.03 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 m -120.83 -171.93 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.3 p30 -54.66 146.57 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.533 0.682 . . . . 0.0 112.031 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.24 71.77 1.61 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -60.23 -25.07 65.36 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -114.29 157.82 22.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.967 0.413 . . . . 0.0 110.942 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.57 146.02 51.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.134 -175.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.422 ' HB3' HG12 ' A' ' 25' ' ' VAL . 48.6 t -97.61 108.53 45.93 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.761 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 36.7 Cg_endo -65.18 -14.27 44.25 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 122.715 2.276 . . . . 0.0 112.964 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -81.97 -59.97 2.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.293 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.81 -34.58 11.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.954 0.407 . . . . 0.0 110.545 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.7 6.91 26.35 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.237 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.5 p -75.18 157.04 6.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.146 0.498 . . . . 0.0 111.434 -173.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -111.8 127.96 55.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.242 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.645 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.1 155.06 46.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.833 0.825 . . . . 0.0 111.639 178.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 29' ' ' SER . 26.5 p -77.8 -17.4 57.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.507 -174.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 8.5 t 176.54 -171.42 0.08 Allowed 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.275 0.36 . . . . 0.0 110.052 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.467 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 23.2 tp -64.31 -19.78 65.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.168 0.508 . . . . 0.0 110.366 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -54.92 -48.39 73.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.12 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HB3' HD12 ' A' ' 10' ' ' ILE . 93.1 m -93.59 -18.6 22.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.727 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.467 ' CB ' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -57.77 -62.36 1.86 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.125 177.12 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -85.45 53.78 2.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.289 0.566 . . . . 0.0 111.165 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 12.2 t70 -109.93 144.64 38.14 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.231 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.16 27.28 5.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.191 0.52 . . . . 0.0 110.478 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.97 -41.61 3.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.951 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -112.42 -35.59 5.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.262 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.505 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 18.6 t-160 -80.73 105.18 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.78 138.87 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.414 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -131.17 114.44 15.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.895 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -124.48 142.27 51.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.17 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 61.09 -168.19 0.18 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.682 0.614 . . . . 0.0 110.064 -175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.4 m 64.54 -72.85 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.16 0.584 . . . . 0.0 111.874 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -93.66 -20.06 20.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.036 0.446 . . . . 0.0 110.622 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.02 179.229 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.37 -33.9 68.32 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.937 2.425 . . . . 0.0 112.367 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -115.31 50.09 1.02 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.981 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp 67.27 168.54 0.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.213 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 4' ' ' SER . 32.1 m -121.24 9.84 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 m 71.81 -31.21 0.22 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.606 0.763 . . . . 0.0 112.303 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 2' ' ' VAL . 19.9 m -67.92 -33.76 75.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.0 111.763 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.77 157.41 16.3 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 120.961 0.41 . . . . 0.0 109.975 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.476 HG21 ' HG3' ' A' ' 26' ' ' ARG . 4.4 p -128.59 145.66 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.523 -173.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 28.4 mmmt -104.29 159.29 15.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.718 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 45.6 t -62.98 114.78 3.88 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.52 8.65 39.89 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.663 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.5 HG23 ' HB2' ' A' ' 38' ' ' LYS . 17.0 mt -109.3 -50.55 6.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.857 0.361 . . . . 0.0 110.657 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.8 p -108.61 -15.45 14.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.342 0.591 . . . . 0.0 110.327 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 92.7 mtt-85 55.95 32.26 19.47 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.001 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.12 -72.01 1.29 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.183 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 m -115.49 -171.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 122.763 -0.257 . . . . 0.0 110.41 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.5 p-10 -58.86 146.16 38.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.449 0.642 . . . . 0.0 111.739 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.586 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -89.13 67.17 2.93 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.297 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 17' ' ' LYS . 3.3 ptpp? -57.68 -32.06 66.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -99.04 149.06 23.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.22 144.41 50.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.686 0.279 . . . . 0.0 110.758 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.546 ' HB3' HG12 ' A' ' 25' ' ' VAL . 33.7 t -95.12 104.79 16.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.598 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.29 -16.13 53.35 Favored 'Trans proline' 0 N--CA 1.471 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.853 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -73.66 -60.36 2.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.721 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.0 p -97.51 -35.62 10.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.639 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.55 15.59 13.4 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.943 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.546 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.6 p -80.34 157.71 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.132 0.491 . . . . 0.0 110.723 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.586 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.7 mmt180 -114.24 124.71 52.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.323 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.507 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -124.9 150.92 46.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.613 0.72 . . . . 0.0 110.738 176.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 29.2 p -67.15 -28.95 68.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.443 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.9 m -167.86 -177.32 3.38 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.421 0.153 . . . . 0.0 111.019 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.46 -27.38 69.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.166 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -56.94 -43.49 81.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.513 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.1 m -85.55 -23.69 27.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.754 0.311 . . . . 0.0 110.735 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -56.56 -56.26 23.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.34 0.591 . . . . 0.0 109.479 175.073 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -85.5 47.67 1.47 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.528 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.587 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 10.1 t70 -107.42 143.14 36.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.453 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.52 28.0 6.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.979 0.419 . . . . 0.0 110.837 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.67 -43.74 2.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.559 0.695 . . . . 0.0 110.255 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HB2' HG23 ' A' ' 10' ' ' ILE . 99.4 mttt -110.88 -35.18 6.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.078 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.587 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 9.3 t-80 -78.45 93.91 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 42' ' ' LYS . 60.8 t -104.13 132.91 49.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.419 0.628 . . . . 0.0 111.955 -170.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -130.04 28.38 5.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.702 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' H ' HG12 ' A' ' 40' ' ' VAL . 57.0 tptt 70.55 -60.97 0.48 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.083 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -142.05 143.74 33.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.9 m -154.29 82.79 1.12 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.959 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -89.29 -37.03 15.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.059 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.146 177.879 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.54 77.42 2.57 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.65 2.233 . . . . 0.0 112.609 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -73.53 -33.54 64.79 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 tpp -119.82 120.89 37.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.658 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -121.74 20.05 5.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 122.011 0.91 . . . . 0.0 109.787 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.1 m 65.09 19.27 11.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.34 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -89.42 -14.11 36.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.268 0.556 . . . . 0.0 110.091 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.75 155.47 18.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.093 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.5 157.67 19.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.803 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 32.9 mmtp -101.87 158.87 15.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.744 0.307 . . . . 0.0 110.863 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.682 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 34.8 t -64.54 124.65 22.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.305 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.38 1.4 88.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.617 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 32' ' ' CYS . 8.6 mt -105.34 -35.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.773 0.321 . . . . 0.0 111.152 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.3 p -120.88 -17.08 7.99 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.534 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 61.08 21.78 12.13 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.05 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.67 -70.2 1.33 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.429 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.4 m -117.24 -170.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.8 p-10 -61.07 145.76 49.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.518 0.675 . . . . 0.0 111.726 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.81 69.62 1.41 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -61.85 -31.04 71.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.355 -0.422 . . . . 0.0 111.961 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -100.6 150.47 22.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.102 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.42 146.63 46.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.742 0.306 . . . . 0.0 110.482 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' HB3' HG12 ' A' ' 25' ' ' VAL . 47.8 t -96.07 108.64 42.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.148 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.25 -3.76 11.43 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.707 2.271 . . . . 0.0 112.593 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -88.85 -61.75 1.64 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.4 p -97.7 -26.99 14.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.926 0.393 . . . . 0.0 110.776 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.62 18.25 21.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.988 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.481 HG11 ' CD2' ' A' ' 39' ' ' HIS . 4.1 p -84.73 155.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.062 0.458 . . . . 0.0 110.925 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.67 128.92 56.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.018 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.682 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -131.89 151.07 51.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 122.0 0.905 . . . . 0.0 111.517 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.2 p -72.98 -25.74 61.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.352 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.6 p -176.1 -170.31 0.37 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.964 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 35.1 mt -62.9 -21.88 66.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.312 176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.49 -33.18 71.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.234 0.54 . . . . 0.0 110.615 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.498 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.8 m -106.5 -20.49 13.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.748 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -61.62 -58.04 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.18 0.514 . . . . 0.0 109.895 177.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -87.39 49.78 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.858 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.564 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 8.3 t70 -111.65 145.93 38.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.483 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.26 24.67 6.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.172 0.511 . . . . 0.0 111.146 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.22 -42.72 2.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.32 0.581 . . . . 0.0 110.58 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -112.12 -28.57 7.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.004 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.564 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 18.2 t-160 -84.62 98.57 10.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.3 t -92.51 114.21 29.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.468 0.651 . . . . 0.0 112.191 -170.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -126.85 -56.07 1.37 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.844 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -96.34 86.73 4.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.177 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -154.0 143.98 21.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.995 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.6 t -149.06 80.42 1.42 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.47 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -61.17 105.05 0.44 Allowed 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.412 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 . . . . . 0 C--O 1.248 0.996 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.66 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -52.12 126.77 21.29 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.092 2.528 . . . . 0.0 112.441 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -102.51 62.04 0.84 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.161 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtm -110.1 -65.39 1.16 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.224 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 t 52.12 46.47 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.711 0.767 . . . . 0.0 110.38 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 m -94.98 -14.3 24.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.104 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.3 m -147.21 89.06 1.76 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.959 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.12 148.61 22.18 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.248 0.546 . . . . 0.0 109.578 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -131.39 143.16 41.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.073 -170.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 46.2 mmtm -100.12 152.41 20.28 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 48.2 t -55.75 117.42 3.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.604 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.12 -1.77 75.55 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.927 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 32' ' ' CYS . 8.1 mt -99.87 -37.33 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.761 0.315 . . . . 0.0 110.988 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.7 p -121.03 -18.3 7.55 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.44 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 29.1 mmm180 60.55 33.61 20.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.276 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.91 -78.31 1.3 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.23 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 m -112.91 -173.33 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.53 0.205 . . . . 0.0 110.72 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 32.6 m-20 -64.15 139.14 58.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.156 0.503 . . . . 0.0 110.925 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.54 81.45 1.65 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.714 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -66.4 -25.52 66.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.964 0.411 . . . . 0.0 111.505 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -105.54 153.45 21.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.139 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.5 tmtp? -134.75 146.46 49.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.349 -0.387 . . . . 0.0 109.994 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 19.9 t -101.29 103.54 27.18 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.29 -12.48 35.79 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.796 2.331 . . . . 0.0 112.693 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -76.52 -59.55 2.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.67 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.4 p -100.69 -31.85 11.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.227 0.537 . . . . 0.0 110.644 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.06 22.96 7.97 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.275 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.2 p -91.82 158.81 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.913 0.387 . . . . 0.0 110.953 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -114.93 126.89 55.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.368 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.609 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -126.87 154.1 44.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.684 0.754 . . . . 0.0 111.128 177.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.0 p -71.55 -23.11 61.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.253 -1.339 . . . . 0.0 111.616 -175.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.8 p 178.25 -167.92 0.07 Allowed 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.493 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 19.9 mt -63.09 -21.57 66.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.442 175.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -51.35 -46.62 62.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.251 0.548 . . . . 0.0 111.104 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.474 ' HB3' HD12 ' A' ' 10' ' ' ILE . 73.8 m -100.67 -14.99 17.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.933 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -62.44 -60.84 2.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 110.312 178.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -85.18 45.89 1.23 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.381 0.61 . . . . 0.0 111.101 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 14.7 t70 -104.92 148.61 26.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.942 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.11 13.6 6.72 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.131 0.491 . . . . 0.0 110.983 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.28 -48.05 5.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.766 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -110.66 -34.24 6.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.047 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.58 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 7.6 t-160 -79.62 92.87 5.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.59 122.34 45.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.283 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -134.63 154.28 51.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.09 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -115.72 -71.6 0.73 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.843 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 63.44 141.07 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.009 0.818 . . . . 0.0 112.428 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.6 m 71.19 -60.29 0.52 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.172 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 57.77 62.88 1.96 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.474 0.654 . . . . 0.0 109.979 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.699 -179.338 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . 0.446 ' HA2' ' HD3' ' A' ' -1' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.78 0 N-CA-C 111.949 -0.46 . . . . 0.0 111.949 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' PRO . . . . . 0.446 ' HD3' ' HA2' ' A' ' -2' ' ' GLY . 2.8 Cg_exo -75.39 100.59 1.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.551 2.167 . . . . 0.0 112.006 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 60.58 56.34 3.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.7 mtp -119.57 -63.42 1.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.944 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m 40.39 39.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.739 0.816 . . . . 0.0 112.092 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -142.22 140.74 32.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.741 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 m 61.85 20.86 11.81 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.193 0.521 . . . . 0.0 110.386 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.97 162.37 20.5 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.874 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -147.84 154.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.326 -171.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 33.0 mmtp -95.22 159.21 15.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.0 t -62.79 118.63 7.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.278 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.52 2.86 76.41 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.682 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.717 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -102.33 -41.71 8.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 122.683 -0.304 . . . . 0.0 111.025 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.9 p -117.66 -16.36 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.242 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 62.34 21.96 12.89 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.515 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.97 -74.82 1.16 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.402 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.32 -169.35 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.9 p-10 -57.64 142.77 43.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.483 0.659 . . . . 0.0 111.556 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.402 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -96.5 70.87 0.84 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -63.28 -31.4 72.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -95.45 149.77 21.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.535 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.5 tmtp? -132.74 148.05 52.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 38.6 t -99.71 108.14 49.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.208 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 2.33 3.44 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.893 2.395 . . . . 0.0 113.188 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 13.3 mmmm -97.47 -58.57 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.698 0.285 . . . . 0.0 111.095 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.27 -30.95 13.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.138 0.494 . . . . 0.0 110.498 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.33 17.51 19.69 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.845 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.409 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.3 p -84.7 159.31 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.0 110.777 -176.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 18.4 mmt180 -115.84 127.46 55.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.914 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.643 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.19 148.55 51.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.898 0.856 . . . . 0.0 111.538 178.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.6 p -69.94 -23.48 63.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.439 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.2 p -173.5 -167.62 0.4 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 111.633 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.4 tp -70.41 -20.14 62.95 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.257 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.6 -40.27 96.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.982 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.526 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.7 m -92.27 -22.47 19.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.645 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.412 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -58.85 -58.2 9.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.222 177.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -87.7 47.21 1.47 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.213 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 12.5 t70 -107.77 141.82 38.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.46 24.53 6.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.142 0.496 . . . . 0.0 110.792 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.48 -44.45 3.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.414 0.626 . . . . 0.0 109.719 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -107.99 -36.7 6.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.537 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.717 ' HB2' HD13 ' A' ' 10' ' ' ILE . 13.8 t-160 -88.65 85.22 6.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.97 121.74 54.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.655 0.741 . . . . 0.0 112.148 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 4.5 m170 -100.25 167.91 10.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.975 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -94.31 15.3 17.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.451 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -94.25 7.22 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.919 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.1 m -74.3 89.54 2.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.825 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.24 77.21 2.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.759 -177.057 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -70.72 140.97 40.23 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.574 2.183 . . . . 0.0 112.058 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -106.01 -18.72 13.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.651 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp -126.49 134.24 50.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.626 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -92.07 -20.93 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.423 0.63 . . . . 0.0 109.567 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.7 t -89.86 169.01 11.61 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.765 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.9 t 58.94 44.24 16.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.363 0.601 . . . . 0.0 109.818 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.72 176.6 6.47 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.723 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.61 152.73 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.438 -169.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 35.5 mmtp -99.81 157.12 16.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.655 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.3 t -62.18 113.69 3.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.073 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.51 5.01 47.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.771 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.687 HD13 ' HB2' ' A' ' 39' ' ' HIS . 12.2 mt -108.41 -33.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.7 -0.294 . . . . 0.0 111.433 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.65 -14.75 6.72 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.313 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.22 30.31 18.17 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.238 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.84 -73.82 1.27 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.247 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -112.35 -169.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 122.941 -0.153 . . . . 0.0 110.596 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 9.6 p-10 -64.39 144.63 57.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.361 0.6 . . . . 0.0 111.088 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.24 73.73 1.68 Allowed Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.309 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -60.1 -33.38 72.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -100.05 157.65 16.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.85 0.357 . . . . 0.0 110.275 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 13.8 tmtt? -142.23 145.05 33.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.505 -174.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 50.6 t -95.6 114.87 64.87 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.556 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.92 -6.15 16.3 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.753 2.302 . . . . 0.0 113.34 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.23 -56.77 2.61 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.709 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.462 ' HB3' ' CD2' ' A' ' 41' ' ' HIS . 19.9 p -97.75 -23.04 16.09 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.016 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.89 22.63 30.05 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.407 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 p -89.62 157.55 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.216 0.531 . . . . 0.0 110.552 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -114.27 127.97 56.13 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.821 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.655 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.29 153.82 48.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.873 0.844 . . . . 0.0 111.535 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.3 p -77.28 -22.07 52.62 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.055 -176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.4 p -176.05 -167.44 0.22 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.893 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 35.1 mt -65.93 -23.4 66.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.402 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -59.66 -35.7 74.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.141 0.495 . . . . 0.0 110.743 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HB3' HD12 ' A' ' 10' ' ' ILE . 78.5 m -100.66 -23.72 14.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.539 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.527 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -59.47 -57.41 13.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.157 0.503 . . . . 0.0 109.685 176.606 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -88.61 41.89 1.04 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.359 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 10.7 t70 -108.79 141.92 40.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.11 29.98 5.3 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.235 0.54 . . . . 0.0 110.515 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.07 -46.39 3.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.54 0.685 . . . . 0.0 109.443 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -102.55 -37.35 8.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.086 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.687 ' HB2' HD13 ' A' ' 10' ' ' ILE . 23.9 t-160 -88.58 89.76 8.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.535 176.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.57 121.99 64.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.398 0.618 . . . . 0.0 111.491 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.462 ' CD2' ' HB3' ' A' ' 23' ' ' CYS . 3.2 m170 -79.15 84.4 5.12 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.895 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -135.64 114.87 12.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.99 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.35 5.17 42.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.451 0.643 . . . . 0.0 109.369 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.9 t -142.14 155.64 45.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.122 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -83.04 5.84 20.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.124 0.487 . . . . 0.0 110.213 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 . . . . . 0 C--O 1.25 1.117 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.767 175.796 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.71 50.16 3.47 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.849 2.366 . . . . 0.0 112.423 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -141.3 28.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.235 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 ttp -166.35 115.23 0.92 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.505 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p -88.73 -21.8 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.954 0.407 . . . . 0.0 110.576 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 p -81.25 61.03 4.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.071 0.462 . . . . 0.0 111.391 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m -86.29 -17.98 33.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.131 0.491 . . . . 0.0 110.233 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.71 150.6 36.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.572 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -118.06 175.86 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 CA-C-O 121.233 0.54 . . . . 0.0 110.924 178.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.41 136.94 55.0 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.377 167.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.563 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 40.2 t -47.42 113.03 0.62 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.416 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.55 12.12 22.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.883 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.605 HD13 ' HB2' ' A' ' 39' ' ' HIS . 16.2 mt -109.98 -41.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 O-C-N 122.727 -0.278 . . . . 0.0 110.669 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.9 p -117.1 -18.78 9.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.267 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 25.6 mmm180 59.09 33.94 23.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.609 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.44 -69.8 1.18 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.975 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.9 m -122.84 -170.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.554 0.216 . . . . 0.0 110.526 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 12.7 m-20 -63.7 140.75 58.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.125 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.97 77.11 2.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.945 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -71.48 -16.86 62.37 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -109.64 157.15 19.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.427 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.8 tmtm? -140.1 146.47 38.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.838 0.351 . . . . 0.0 111.058 -173.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.5 t -103.45 111.51 65.14 Favored Pre-proline 0 CA--C 1.515 -0.402 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.039 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.76 -0.16 7.32 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 122.584 2.189 . . . . 0.0 112.838 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -98.19 -56.06 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.557 0.218 . . . . 0.0 111.515 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.437 ' HB3' ' CD2' ' A' ' 41' ' ' HIS . 25.4 p -100.72 -15.81 17.57 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.059 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.36 9.73 62.93 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.628 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.54 157.35 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 121.089 0.471 . . . . 0.0 110.919 -173.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -116.47 118.86 33.84 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.964 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.563 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -117.32 155.14 30.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.811 0.815 . . . . 0.0 111.248 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.5 p -70.33 -31.6 68.96 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.176 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.2 m -171.12 -169.41 0.74 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.3 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.2 -24.42 66.62 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.726 0.298 . . . . 0.0 111.03 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -51.94 -43.38 63.43 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.478 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB3' HD12 ' A' ' 10' ' ' ILE . 73.2 m -96.87 -20.59 18.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.775 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -59.51 -62.49 1.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.674 176.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -87.91 52.91 2.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.772 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 19.5 t70 -117.97 145.01 45.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.61 10.9 7.26 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.109 0.48 . . . . 0.0 110.655 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.98 -41.95 8.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.897 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -109.63 -39.86 5.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.971 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.605 ' HB2' HD13 ' A' ' 10' ' ' ILE . 23.4 t-160 -84.78 109.31 17.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.07 131.76 72.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.09 0.471 . . . . 0.0 111.193 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.437 ' CD2' ' HB3' ' A' ' 23' ' ' CYS . 2.3 m170 -98.1 111.85 24.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.562 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -85.98 -152.7 0.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.025 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -63.99 96.15 0.13 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.763 0.316 . . . . 0.0 110.85 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -106.66 -26.94 11.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.858 0.361 . . . . 0.0 110.344 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -82.06 61.1 5.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.079 0.466 . . . . 0.0 110.584 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.977 179.179 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.29 -53.66 5.91 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.143 2.562 . . . . 0.0 112.924 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -121.81 11.98 10.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.926 0.393 . . . . 0.0 110.788 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp -116.02 118.64 33.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.71 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.4 t -88.98 -26.71 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.483 0.659 . . . . 0.0 109.255 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 m -83.28 164.69 19.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.839 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 m 60.48 43.82 12.64 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.361 0.6 . . . . 0.0 110.162 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.72 177.2 5.82 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.464 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p -135.13 149.38 28.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.753 -172.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -101.24 158.11 16.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.574 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 42.7 t -62.28 116.53 5.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.599 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.92 17.25 22.9 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.566 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 39' ' ' HIS . 10.2 mt -117.19 -37.5 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.617 -0.343 . . . . 0.0 110.864 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.3 p -120.6 -15.21 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.258 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 59.09 29.57 19.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.22 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.74 -76.08 1.31 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.9 m -112.88 -171.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 122.864 -0.198 . . . . 0.0 110.487 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -61.27 144.29 54.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.469 0.652 . . . . 0.0 111.339 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -88.23 68.17 3.0 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 175.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -29.9 68.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -104.07 153.77 20.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -133.03 146.71 51.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.305 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.53 ' CB ' HG12 ' A' ' 25' ' ' VAL . 38.4 t -94.43 106.29 22.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.99 -9.02 21.69 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.963 2.442 . . . . 0.0 112.563 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -81.8 -64.77 1.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.489 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 26.6 p -94.32 -38.38 11.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.195 0.521 . . . . 0.0 110.888 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.29 12.86 11.36 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.387 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' A' ' 39' ' ' HIS . 3.7 p -77.28 160.32 4.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.904 0.383 . . . . 0.0 110.727 -176.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 24.4 mmt180 -117.15 125.84 51.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.574 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -128.13 156.2 43.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.904 0.859 . . . . 0.0 111.426 178.621 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.3 p -75.97 -21.2 57.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.677 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 t 179.08 -171.39 0.13 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 79.2 mt -65.94 -20.67 66.29 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.773 0.32 . . . . 0.0 110.357 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -55.62 -32.22 62.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.82 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' HB3' HD12 ' A' ' 10' ' ' ILE . 99.9 m -110.56 -20.49 12.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.094 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.79 -57.92 10.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.305 0.574 . . . . 0.0 109.548 176.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.75 50.82 2.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.631 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 13.0 t70 -114.33 147.71 38.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.118 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.07 14.0 7.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.042 0.449 . . . . 0.0 110.973 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.25 -44.64 5.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.339 0.59 . . . . 0.0 110.137 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.32 -30.14 6.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.309 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.586 ' CD2' HG11 ' A' ' 25' ' ' VAL . 10.4 t-80 -83.57 93.73 7.91 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.79 137.51 41.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.436 0.636 . . . . 0.0 111.413 -172.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -120.44 49.95 1.38 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.196 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.12 89.56 2.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.583 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 59.3 24.9 13.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.974 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 p -114.11 148.53 37.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.417 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 8.8 tp10 60.76 36.83 19.2 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.022 0.915 . . . . 0.0 109.6 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 . . . . . 0 C--O 1.249 1.052 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.78 179.582 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.95 -33.29 63.86 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.908 2.405 . . . . 0.0 112.835 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -71.9 -33.47 68.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.921 0.391 . . . . 0.0 110.539 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm -87.45 -72.04 0.54 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.678 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 p 37.8 47.78 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 122.367 1.079 . . . . 0.0 111.967 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.7 m -128.26 35.92 4.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.739 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.3 t -105.5 12.39 31.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.739 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.99 -172.07 0.19 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.692 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 p -157.11 151.85 8.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.179 -173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.6 mmtt -103.74 157.09 17.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.968 0.413 . . . . 0.0 110.807 -177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.615 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.6 t -62.35 115.77 4.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.553 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.89 12.85 40.31 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.644 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.494 HG23 ' HB2' ' A' ' 38' ' ' LYS . 7.7 mt -112.83 -38.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.737 0.303 . . . . 0.0 111.053 -177.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.1 p -119.9 -16.64 8.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.266 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 63.35 32.21 14.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.152 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.0 -81.73 1.41 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.304 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.27 -169.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.971 -0.135 . . . . 0.0 110.895 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 53.2 m-20 -63.28 141.27 58.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.313 0.577 . . . . 0.0 111.03 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.58 75.52 2.35 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -60.6 -30.17 69.67 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.94 151.86 24.72 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -134.66 145.64 48.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.419 ' HB3' HG12 ' A' ' 25' ' ' VAL . 22.0 t -97.11 107.42 37.82 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.97 0.42 5.08 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.086 2.524 . . . . 0.0 113.454 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -94.14 -63.81 1.15 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.018 0.437 . . . . 0.0 110.927 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.5 p -92.85 -26.64 17.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.181 0.515 . . . . 0.0 110.492 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.2 21.33 18.01 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.672 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.419 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.7 p -89.24 155.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.158 0.504 . . . . 0.0 110.601 -176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -112.86 129.74 56.35 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.791 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.615 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.91 148.82 52.72 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.803 0.811 . . . . 0.0 111.516 177.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -71.77 -19.92 61.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.691 -175.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 8.2 t 176.93 -168.02 0.05 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.233 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 45.8 mt -64.24 -23.22 67.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.385 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -60.12 -31.7 70.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.044 0.45 . . . . 0.0 110.985 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HB3' HD12 ' A' ' 10' ' ' ILE . 99.4 m -106.14 -21.5 13.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.729 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -59.5 -56.57 20.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.582 0.706 . . . . 0.0 109.489 176.524 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -91.47 39.81 1.01 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.111 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 26.4 t70 -103.15 140.57 37.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.68 19.66 13.77 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.231 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.59 -45.07 4.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.226 0.536 . . . . 0.0 110.02 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.494 ' HB2' HG23 ' A' ' 10' ' ' ILE . 66.8 mmtt -103.12 -45.57 4.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.156 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.559 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 9.6 t-160 -80.7 105.29 11.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.792 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.86 135.31 59.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.09 0.471 . . . . 0.0 110.886 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -122.31 154.45 37.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.175 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -80.6 -1.6 42.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.512 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -81.81 -5.73 58.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.109 0.48 . . . . 0.0 109.782 174.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 m -109.55 25.24 12.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.607 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -80.42 59.46 3.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.205 0.526 . . . . 0.0 110.925 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.809 179.561 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.57 -56.01 2.84 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.076 2.517 . . . . 0.0 112.375 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -87.43 137.07 32.65 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mmm 60.11 58.09 2.78 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.615 0.572 . . . . 0.0 110.226 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.53 -21.28 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.201 0.524 . . . . 0.0 110.637 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 m -79.99 83.32 5.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.165 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.3 m -62.93 -34.12 76.78 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.229 0.538 . . . . 0.0 110.59 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.15 149.6 28.31 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.501 0.667 . . . . 0.0 109.942 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.85 157.97 42.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.244 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -101.2 154.43 18.76 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.2 t -58.28 116.1 3.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.525 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.414 ' HA2' HH11 ' A' ' 12' ' ' ARG . . . -77.74 6.08 49.09 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.791 -177.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' ' 39' ' ' HIS . 8.6 mt -107.85 -38.73 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 120.654 0.264 . . . . 0.0 111.11 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.6 p -119.75 -15.42 8.9 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.605 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 29.3 mmm180 59.19 24.93 13.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.332 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.59 -73.53 1.27 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.268 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.8 m -114.84 -169.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.34 145.35 51.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.439 0.637 . . . . 0.0 111.421 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -93.65 72.99 1.23 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -65.93 -32.0 73.24 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -95.72 149.83 21.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.534 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.2 tmtp? -134.1 147.85 50.92 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.534 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.7 t -100.23 109.34 56.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.466 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 40.9 Cg_endo -67.72 -5.39 14.19 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.988 2.458 . . . . 0.0 112.788 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -88.94 -60.71 1.88 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.907 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.4 p -96.51 -29.82 13.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.941 0.401 . . . . 0.0 111.067 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.2 21.5 11.67 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.896 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.5 p -89.31 158.83 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.075 0.464 . . . . 0.0 110.655 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 23.1 mmt180 -114.69 128.13 56.14 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.171 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.61 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -127.65 153.25 46.68 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.84 0.829 . . . . 0.0 110.817 176.925 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.0 p -70.49 -34.39 72.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.044 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.3 m -168.8 -172.43 1.6 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.018 -173.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 22.5 mt -62.19 -23.42 66.61 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.634 ' HD2' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -55.98 -51.63 67.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.703 0.763 . . . . 0.0 110.273 -179.713 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.492 ' HB3' HD12 ' A' ' 10' ' ' ILE . 72.5 m -85.39 -24.3 27.6 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.315 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.534 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.41 -60.64 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.052 178.001 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -87.48 44.23 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.064 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.608 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 10.8 t70 -110.77 139.69 45.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.661 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.02 23.77 9.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.115 0.483 . . . . 0.0 110.843 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.65 -45.66 3.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -102.34 -43.43 5.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.214 177.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.608 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 20.2 t-160 -80.19 110.96 16.1 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.053 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.6 t -115.98 137.42 49.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.08 0.467 . . . . 0.0 111.455 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -117.63 -169.38 1.66 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.719 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -66.01 137.58 57.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.733 -172.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -153.74 -41.41 0.09 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.394 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.4 m -130.73 72.77 1.51 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.352 0.596 . . . . 0.0 111.61 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.22 17.94 18.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.994 174.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.915 179.077 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.56 109.93 2.59 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.504 2.136 . . . . 0.0 112.294 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -72.79 -32.99 65.96 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 mtm -123.5 144.29 49.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.118 174.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.46 -11.31 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.522 0.677 . . . . 0.0 109.669 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.3 m -103.61 155.27 18.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.602 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.0 m -97.8 38.66 1.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.052 0.453 . . . . 0.0 110.319 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.78 160.68 25.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.516 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.93 152.66 36.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.729 -172.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 13.7 mmmm -103.96 157.67 16.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.865 0.364 . . . . 0.0 110.592 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.575 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.1 t -63.2 117.21 6.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.245 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 12' ' ' ARG . . . -80.67 5.38 65.08 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.666 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 32' ' ' CYS . 10.4 mt -105.25 -40.63 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 120.725 0.298 . . . . 0.0 110.975 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.3 p -117.99 -14.07 10.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.197 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.42 ' CZ ' ' HA2' ' A' ' 9' ' ' GLY . 38.6 mmt180 57.7 29.01 16.65 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.552 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.71 -77.91 1.27 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.359 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.0 m -113.42 -169.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 6.7 p-10 -64.35 143.32 57.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.469 0.652 . . . . 0.0 111.422 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -88.69 76.9 1.84 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 175.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -64.08 -28.09 69.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -104.93 159.32 15.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.583 0.23 . . . . 0.0 110.547 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.2 tmtp? -135.7 145.76 47.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.732 0.301 . . . . 0.0 110.779 -174.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.559 ' HB3' HG12 ' A' ' 25' ' ' VAL . 33.8 t -100.63 102.92 20.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.3 -7.93 18.97 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 122.782 2.321 . . . . 0.0 113.269 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -79.31 -61.9 1.86 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.067 0.461 . . . . 0.0 110.967 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.2 p -97.58 -31.94 12.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.664 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.37 14.29 18.64 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.982 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.5 p -82.12 156.27 4.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.148 0.499 . . . . 0.0 110.913 -175.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 24.3 mmt180 -113.34 121.5 44.56 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.014 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.575 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -119.47 148.33 43.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.859 0.838 . . . . 0.0 111.079 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.5 p -65.99 -26.14 67.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.518 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 p -176.11 -171.2 0.42 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.366 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.36 -20.88 66.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.671 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.54 -39.9 81.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.089 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' HB3' HD12 ' A' ' 10' ' ' ILE . 98.9 m -98.39 -17.82 18.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -65.02 0.73 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.912 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -85.06 48.16 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.217 0.532 . . . . 0.0 111.646 -174.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.4 t70 -106.73 150.0 26.73 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.511 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.09 29.03 4.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.166 0.508 . . . . 0.0 110.716 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.19 -44.87 2.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.041 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -107.9 -33.51 7.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.447 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.583 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 8.8 t-160 -82.78 93.23 7.38 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.09 127.65 42.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.512 -170.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -141.92 137.22 31.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.438 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -136.27 17.53 3.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.818 170.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 51.83 50.11 19.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.433 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.3 m 56.5 68.62 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.834 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.35 71.22 3.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.387 0.613 . . . . 0.0 109.551 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 C--O 1.247 0.954 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.877 -178.524 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.14 -24.63 72.94 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.845 2.363 . . . . 0.0 112.774 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -87.56 69.4 9.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 110.842 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mtp -135.54 137.56 42.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.706 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.5 m -95.26 -17.54 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 0.0 111.117 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 m 61.67 32.74 18.35 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.797 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.4 m -86.52 9.43 18.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.65 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.94 170.86 9.24 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.078 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.13 152.45 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.178 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 69.9 mmtt -98.35 159.87 14.66 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 44.0 t -63.43 114.24 3.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.057 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.01 7.85 41.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.578 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 39' ' ' HIS . 7.7 mt -110.17 -38.69 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 122.672 -0.311 . . . . 0.0 111.078 -177.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 p -121.78 -15.09 7.99 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.445 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 61.89 22.89 13.37 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.91 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.25 -72.59 1.2 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.307 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.1 -169.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.9 p-10 -59.66 145.52 44.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.505 0.669 . . . . 0.0 111.806 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.88 69.39 2.43 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -63.11 -27.37 69.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.335 -0.433 . . . . 0.0 111.835 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -99.75 148.03 24.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.785 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER -137.13 145.52 43.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.805 0.335 . . . . 0.0 110.292 -174.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.553 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 43.3 t -98.2 108.29 46.24 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.183 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.11 0.03 5.01 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 122.811 2.34 . . . . 0.0 112.967 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -96.16 -60.32 1.65 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.62 0.248 . . . . 0.0 111.419 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.8 p -95.38 -27.15 15.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.038 0.447 . . . . 0.0 110.676 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.23 20.95 21.62 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.548 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 p -86.14 158.0 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.05 0.452 . . . . 0.0 110.187 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -115.65 128.15 55.71 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.912 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.629 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.74 147.53 52.41 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.985 0.898 . . . . 0.0 110.909 177.099 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.2 p -66.98 -31.71 72.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.347 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.0 m -167.9 -176.25 2.99 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.647 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 47.8 mt -61.19 -26.3 67.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -56.26 -38.1 70.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.02 0.438 . . . . 0.0 111.127 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.401 ' HB3' HD12 ' A' ' 10' ' ' ILE . 81.2 m -95.11 -23.91 17.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.581 177.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -61.17 -57.8 10.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.807 176.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -85.27 43.56 1.02 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.331 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 20.0 t70 -111.35 149.17 31.53 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.82 3.23 6.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.014 0.435 . . . . 0.0 111.01 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -88.33 -45.54 9.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.362 0.601 . . . . 0.0 110.103 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -103.16 -42.01 5.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.435 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.539 ' HB2' HD13 ' A' ' 10' ' ' ILE . 14.5 t-160 -83.35 86.15 7.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.621 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.93 123.26 50.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.396 0.617 . . . . 0.0 111.83 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -100.76 117.22 34.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.829 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -137.76 22.93 2.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.807 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.75 -47.67 85.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.895 -172.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 t -87.41 132.1 34.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -72.93 93.26 1.71 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.34 0.59 . . . . 0.0 109.919 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 . . . . . 0 C--O 1.247 0.935 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.449 -179.007 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.87 -23.51 62.08 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.678 2.252 . . . . 0.0 112.807 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -108.15 105.03 14.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.902 0.382 . . . . 0.0 110.16 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 ttp -70.69 129.24 38.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.72 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.4 t -66.32 -42.65 91.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.731 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -88.01 61.33 6.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.046 0.451 . . . . 0.0 110.115 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 p -64.06 113.72 3.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.536 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.52 163.55 33.52 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.409 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.9 150.65 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.68 -174.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -104.15 154.74 19.38 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 44.9 t -59.46 112.21 1.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.322 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.85 0.62 43.8 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.776 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.542 HD13 ' HB2' ' A' ' 39' ' ' HIS . 11.3 mt -103.14 -40.51 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 122.755 -0.262 . . . . 0.0 111.206 -174.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.2 p -119.0 -18.44 8.78 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.323 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.32 36.51 27.62 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.026 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.54 -62.91 0.98 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.126 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -125.75 -176.2 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.722 0.296 . . . . 0.0 111.254 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.74 135.29 55.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.551 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -86.95 74.82 2.27 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -68.34 -31.13 70.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -95.47 152.32 18.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.677 0.275 . . . . 0.0 110.331 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -134.31 145.82 49.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.864 0.364 . . . . 0.0 111.045 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.436 ' CB ' HG12 ' A' ' 25' ' ' VAL . 35.5 t -100.48 108.49 53.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.789 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 39.4 Cg_endo -66.94 -13.33 39.55 Favored 'Trans proline' 0 N--CA 1.471 0.174 0 C-N-CA 122.832 2.354 . . . . 0.0 112.744 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -82.82 -56.64 3.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.538 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.5 p -101.04 -29.47 12.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.969 0.414 . . . . 0.0 110.523 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.11 7.1 31.33 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.321 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.436 HG12 ' CB ' ' A' ' 20' ' ' CYS . 3.2 p -77.28 157.78 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.046 0.45 . . . . 0.0 111.447 -173.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.482 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.1 mmt180 -115.0 124.33 51.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.22 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.576 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -123.89 153.93 40.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.616 0.722 . . . . 0.0 110.825 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -70.08 -33.07 71.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.981 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.1 m -168.08 -173.53 2.08 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.589 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.65 -25.0 67.76 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.69 -41.07 73.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.923 0.392 . . . . 0.0 111.162 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.51 ' HB3' HD12 ' A' ' 10' ' ' ILE . 99.5 m -91.18 -23.0 20.37 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.803 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -60.91 2.93 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -86.95 52.79 2.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.226 0.536 . . . . 0.0 111.314 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.669 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 18.2 t70 -119.0 141.63 48.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 173.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.57 10.42 13.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.957 0.408 . . . . 0.0 111.16 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.67 -45.27 6.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.326 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -109.52 -27.92 9.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.669 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 18.4 t-160 -89.17 97.95 11.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.79 118.87 39.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.674 0.749 . . . . 0.0 112.259 -170.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -123.72 -74.75 0.61 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.984 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -162.69 21.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.976 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -127.23 129.39 47.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.138 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.2 t 60.4 33.29 20.72 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.584 0.553 . . . . 0.0 110.633 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.28 34.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.279 0.562 . . . . 0.0 111.273 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.505 -0.76 . . . . 0.0 109.757 176.61 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.63 122.33 11.11 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.797 2.331 . . . . 0.0 112.021 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -91.37 131.29 36.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.304 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 1.3 mmt -86.79 158.53 19.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.569 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t 60.04 60.68 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.92 0.867 . . . . 0.0 109.463 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -125.33 135.51 52.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.102 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -118.3 13.52 13.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.108 0.48 . . . . 0.0 110.72 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.25 144.57 43.0 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.375 0.607 . . . . 0.0 110.697 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.3 p -109.17 148.86 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.389 -173.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -108.27 161.6 14.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 49.4 t -65.47 116.36 6.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.572 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.85 -4.87 78.09 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.785 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 39' ' ' HIS . 9.6 mt -98.0 -40.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.795 0.331 . . . . 0.0 110.963 -174.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.5 p -117.65 -15.71 10.14 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.417 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 61.38 32.55 19.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.456 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.0 -82.88 1.47 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.292 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.03 -168.96 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.649 0.262 . . . . 0.0 110.814 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.22 139.16 58.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.28 0.562 . . . . 0.0 111.964 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.72 70.45 3.17 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -62.36 -27.46 69.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.503 -0.349 . . . . 0.0 111.753 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.7 153.88 20.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -138.17 143.79 40.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.729 0.299 . . . . 0.0 110.333 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.439 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 18.8 t -98.72 107.48 43.24 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.818 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.22 -9.97 27.01 Favored 'Trans proline' 0 C--N 1.335 -0.156 0 C-N-CA 122.776 2.317 . . . . 0.0 112.824 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.41 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 31.1 mmmt -83.92 -62.5 1.55 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.209 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -93.66 -28.69 15.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.106 0.479 . . . . 0.0 110.496 -176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.3 10.73 35.55 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.802 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.6 p -79.11 157.99 4.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.153 0.501 . . . . 0.0 111.368 -174.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -113.0 126.54 55.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.199 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.595 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -127.47 148.28 50.31 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.861 0.838 . . . . 0.0 110.716 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -65.57 -32.28 73.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.294 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.5 m -168.62 -169.92 1.12 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.859 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.69 -27.62 68.48 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.426 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.538 ' HD2' ' H ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -55.47 -45.0 76.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.51 0.671 . . . . 0.0 111.22 -177.236 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.442 ' HB3' HD12 ' A' ' 10' ' ' ILE . 73.7 m -87.69 -23.15 24.28 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.71 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -61.28 -63.03 1.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.782 176.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -84.98 52.53 2.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.201 0.524 . . . . 0.0 110.842 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -112.42 148.99 33.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.68 15.84 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.077 0.465 . . . . 0.0 110.799 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.31 -43.41 5.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.441 0.639 . . . . 0.0 109.759 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -108.56 -34.8 6.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.688 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.501 ' HB2' HD13 ' A' ' 10' ' ' ILE . 13.3 t-160 -91.67 94.0 9.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.935 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 t -115.92 126.61 73.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.61 0.719 . . . . 0.0 111.501 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.41 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 3.5 m170 -95.85 -47.38 6.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.072 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -99.85 76.84 1.99 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.326 0.584 . . . . 0.0 110.331 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -105.47 -59.15 1.8 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.934 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.3 t -151.42 115.61 5.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.255 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.02 8.64 18.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.881 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.977 -177.927 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.94 116.52 3.41 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.524 2.15 . . . . 0.0 111.522 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -79.55 51.09 1.2 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.175 0.512 . . . . 0.0 111.139 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mmm -114.48 -20.76 10.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.691 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.7 t 71.47 -54.77 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 123.151 0.58 . . . . 0.0 111.021 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.6 t -88.57 55.19 3.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.372 0.606 . . . . 0.0 109.678 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -77.8 -28.45 50.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.38 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.37 159.71 14.87 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.977 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.33 161.42 41.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.767 -173.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.2 mmtt -110.08 158.11 18.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 0.0 110.734 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 33.9 t -66.16 113.95 4.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.123 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.23 3.06 59.57 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.861 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.794 HD13 ' HB2' ' A' ' 39' ' ' HIS . 16.5 mt -103.0 -40.55 6.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 122.715 -0.286 . . . . 0.0 110.955 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.7 p -118.09 -16.2 9.81 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.291 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 59.54 24.5 13.24 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.334 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.61 -69.76 1.36 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.408 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 m -120.79 -168.87 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.5 m-20 -66.77 142.8 57.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.133 0.492 . . . . 0.0 111.243 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.47 78.22 1.64 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -66.89 -33.44 75.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.883 0.373 . . . . 0.0 111.351 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.31 153.8 18.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 12.1 tmtt? -142.81 145.18 32.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.639 0.257 . . . . 0.0 110.694 -175.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.413 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.0 t -96.58 113.46 62.69 Favored Pre-proline 0 CA--C 1.516 -0.34 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.04 -13.77 41.38 Favored 'Trans proline' 0 C--N 1.334 -0.233 0 C-N-CA 122.575 2.184 . . . . 0.0 112.385 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.436 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 30.8 mmmt -88.29 -56.02 3.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.819 -175.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.0 p -98.35 -21.44 16.61 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.162 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.0 16.74 46.54 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.637 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.81 158.91 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 120.961 0.41 . . . . 0.0 110.4 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -116.62 129.07 55.94 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.014 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.651 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.96 152.94 48.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.795 0.807 . . . . 0.0 111.133 177.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.8 p -72.78 -20.5 61.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.442 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.4 p -178.28 -169.39 0.19 Allowed 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.291 0.369 . . . . 0.0 110.422 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 33.9 mt -65.34 -20.24 66.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.424 175.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -59.15 -39.47 82.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.162 0.506 . . . . 0.0 110.724 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.494 ' HB3' HD12 ' A' ' 10' ' ' ILE . 90.6 m -97.87 -22.31 16.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.453 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -57.96 -58.85 6.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.83 177.466 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -90.72 35.52 0.89 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.095 0.474 . . . . 0.0 111.07 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 10.5 t70 -101.13 122.32 43.39 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.36 17.11 24.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.904 0.383 . . . . 0.0 111.076 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.63 -47.15 5.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.102 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -103.66 -32.42 9.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.531 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.794 ' HB2' HD13 ' A' ' 10' ' ' ILE . 12.9 t-160 -100.54 88.92 3.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.583 0.706 . . . . 0.0 109.511 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.96 122.51 67.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.718 0.77 . . . . 0.0 111.838 -174.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.436 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 5.4 m170 -75.62 79.34 2.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.317 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.1 tptt -87.08 115.66 24.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.599 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 59.24 48.33 10.43 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.599 0.562 . . . . 0.0 110.636 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.5 p -81.66 58.51 3.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.262 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -93.52 88.63 5.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.067 -177.737 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.36 161.63 34.53 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.948 2.432 . . . . 0.0 111.608 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -86.56 46.33 1.34 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.166 0.507 . . . . 0.0 110.309 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.1 mmm 61.45 59.62 1.85 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.791 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.89 -9.81 11.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.935 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 m -63.55 127.74 32.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.346 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m -86.01 86.26 7.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.029 0.442 . . . . 0.0 110.683 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.94 154.03 25.25 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.538 0.685 . . . . 0.0 110.699 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.551 HG11 ' HG3' ' A' ' 26' ' ' ARG . 4.2 p -99.55 155.94 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.59 -176.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.5 mmtt -99.54 156.82 16.85 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.5 t -62.59 111.93 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.424 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.7 24.7 3.13 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.664 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.446 HD13 ' HB2' ' A' ' 39' ' ' HIS . 10.1 mt -125.08 -39.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 122.666 -0.314 . . . . 0.0 110.857 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.4 p -119.78 -16.25 8.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.13 0.491 . . . . 0.0 110.745 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 56.75 27.69 13.14 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.518 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.19 -68.87 1.41 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.006 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.46 -168.91 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.514 0.197 . . . . 0.0 110.547 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.9 p-10 -61.31 146.52 47.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.418 0.628 . . . . 0.0 111.629 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.03 70.31 2.29 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.429 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -25.15 66.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.884 0.373 . . . . 0.0 111.805 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -98.68 149.49 22.77 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.545 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -131.73 145.66 51.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.822 0.344 . . . . 0.0 111.053 -174.35 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.569 ' HB3' HG12 ' A' ' 25' ' ' VAL . 43.4 t -102.51 107.28 53.24 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.109 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.33 -9.93 27.41 Favored 'Trans proline' 0 N--CA 1.472 0.236 0 C-N-CA 122.883 2.389 . . . . 0.0 112.97 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 30.3 mmmt -82.7 -49.16 10.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 -176.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.5 p -111.12 -33.18 6.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.844 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.45 16.2 13.74 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.152 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.616 HG11 ' CD2' ' A' ' 39' ' ' HIS . 4.3 p -81.19 158.9 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 110.675 -176.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HG3' HG11 ' A' ' 6' ' ' VAL . 61.3 mmt-85 -114.58 121.35 43.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.296 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.527 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -122.24 155.88 34.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.548 0.689 . . . . 0.0 110.909 176.211 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.1 p -71.21 -34.08 70.5 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.807 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -167.58 -172.93 2.04 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.328 -174.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 tp -62.77 -31.59 72.58 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 122.65 0.38 . . . . 0.0 111.508 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -53.6 -43.34 68.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.544 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.416 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.6 m -87.99 -23.1 23.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.66 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.494 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -56.67 -58.73 6.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.141 177.092 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -87.04 50.8 2.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.409 0.623 . . . . 0.0 111.526 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.66 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 9.4 t70 -109.87 150.76 27.95 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.12 -0.6 5.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.246 0.546 . . . . 0.0 111.002 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.88 -48.07 9.08 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.057 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -108.03 -33.9 7.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.518 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.66 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 10.4 t-160 -81.28 91.09 6.16 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.07 120.31 35.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.118 -169.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.441 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 5.4 m170 -138.54 172.43 12.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.228 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 22.3 pttp -143.9 -179.08 6.26 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 17.3 mm-40 72.59 -65.6 0.35 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.479 0.487 . . . . 0.0 111.018 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.6 m -80.77 54.59 2.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.238 0.542 . . . . 0.0 110.381 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.14 -32.46 24.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.353 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.598 -0.715 . . . . 0.0 110.029 179.101 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -60.91 136.0 63.08 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.673 2.249 . . . . 0.0 112.306 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.57 37.07 4.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.552 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.4 mtp 68.28 111.29 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.529 -175.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.9 t -55.45 -38.21 48.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.336 0.589 . . . . 0.0 109.723 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -91.28 70.35 6.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.704 173.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 m -69.6 -29.68 67.26 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.94 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.2 149.76 49.84 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.273 0.559 . . . . 0.0 110.225 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.54 148.98 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.253 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.45 158.68 16.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.3 t -63.66 115.73 5.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.15 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 12' ' ' ARG . . . -81.3 17.86 12.07 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.494 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.537 HG23 ' HB2' ' A' ' 38' ' ' LYS . 10.1 mt -119.13 -46.03 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 120.853 0.359 . . . . 0.0 110.742 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.0 p -110.6 -13.87 14.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.485 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.457 ' CZ ' ' HA2' ' A' ' 9' ' ' GLY . 35.4 mmt180 55.45 30.63 15.41 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.833 178.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.24 -69.13 1.01 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.348 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.13 -170.18 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 121.276 -0.17 . . . . 0.0 110.765 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 5.7 p-10 -63.27 145.79 54.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.326 0.584 . . . . 0.0 111.619 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -92.1 65.74 2.21 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.365 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 6.7 ptpp? -56.89 -36.3 69.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.438 ' CD1' ' HG3' ' A' ' 17' ' ' LYS . 3.7 m-30 -94.65 149.63 21.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 13.1 tmtt? -134.43 144.29 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.789 0.328 . . . . 0.0 110.771 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.492 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 25.1 t -97.98 107.35 40.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.806 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 39.8 Cg_endo -66.64 -10.07 26.69 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.04 2.493 . . . . 0.0 113.565 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -84.55 -63.11 1.39 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.908 0.385 . . . . 0.0 111.232 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.6 p -94.05 -32.34 13.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.201 0.524 . . . . 0.0 110.601 -173.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.41 21.47 9.3 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.168 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.621 HG11 ' CD2' ' A' ' 39' ' ' HIS . 4.0 p -88.04 158.74 3.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.969 0.414 . . . . 0.0 110.618 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 21.5 mmt180 -116.02 129.53 56.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.011 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.581 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -131.32 151.05 51.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.702 0.763 . . . . 0.0 110.949 177.645 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.0 p -71.24 -19.61 62.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.751 -174.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.3 t -175.94 -171.35 0.44 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.76 0.315 . . . . 0.0 110.547 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.418 ' HG ' ' HE2' ' A' ' 34' ' ' LYS . 37.2 tp -69.89 -19.82 63.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.529 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.56 -49.34 77.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.051 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.4 m -81.53 -20.88 39.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.67 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -59.32 -59.57 5.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.869 176.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HE2' ' HG ' ' A' ' 30' ' ' LEU . 55.0 mtmt -84.86 54.31 3.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.632 0.73 . . . . 0.0 110.999 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.576 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 13.7 t70 -111.64 149.79 31.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.564 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.57 13.05 7.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.731 0.3 . . . . 0.0 111.628 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.73 -38.2 7.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.382 0.61 . . . . 0.0 110.092 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.537 ' HB2' HG23 ' A' ' 10' ' ' ILE . 96.8 mttt -118.49 -32.97 4.45 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.296 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.621 ' CD2' HG11 ' A' ' 25' ' ' VAL . 7.8 t-160 -84.36 93.93 8.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.47 120.41 45.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.899 -172.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -134.36 57.99 1.79 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.541 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm 68.72 134.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.422 -176.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -88.17 -156.72 0.38 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.063 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.0 p -51.26 -43.88 61.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.106 0.479 . . . . 0.0 111.125 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -145.73 -51.4 0.25 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.422 173.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--O 1.251 1.133 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.592 -177.586 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.805 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.91 135.13 17.1 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.553 2.169 . . . . 0.0 111.91 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -80.46 128.54 33.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.919 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptm -145.96 136.42 24.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.646 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.6 m -89.21 72.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.452 0.644 . . . . 0.0 110.101 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 m -52.4 125.41 16.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.357 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.7 m 60.53 78.64 0.27 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.925 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.99 165.03 23.0 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.706 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 4.0 p -141.35 148.3 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.501 -170.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -106.18 154.01 21.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.7 t -59.41 110.02 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.538 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.26 18.14 3.63 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.732 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.652 HG23 ' HB2' ' A' ' 38' ' ' LYS . 7.5 mt -119.98 -36.1 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.565 0.221 . . . . 0.0 111.15 -177.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.84 -14.7 6.64 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.439 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 5.7 mpt_? 58.77 28.9 17.98 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.835 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.4 -78.06 1.14 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.699 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.07 -171.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 6.2 p-10 -58.12 144.21 41.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.51 0.672 . . . . 0.0 111.425 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.602 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -86.92 68.54 3.22 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.175 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 17' ' ' LYS . 4.3 ptpp? -58.86 -34.29 71.43 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -94.94 146.7 24.06 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.65 145.98 51.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.822 0.344 . . . . 0.0 110.772 -174.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.431 ' CB ' HG12 ' A' ' 25' ' ' VAL . 38.3 t -98.4 106.75 37.93 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.951 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.41 -6.41 16.36 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.615 2.21 . . . . 0.0 113.119 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.64 -63.48 1.31 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.866 0.365 . . . . 0.0 111.037 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.8 p -93.97 -30.29 14.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.049 0.452 . . . . 0.0 110.245 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.72 7.96 35.56 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.051 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.499 HG11 ' CD2' ' A' ' 39' ' ' HIS . 3.4 p -74.68 157.34 6.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.42 . . . . 0.0 111.002 -173.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.602 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 22.2 mmt180 -114.73 125.75 54.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.518 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.593 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -128.02 153.22 47.01 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.724 0.773 . . . . 0.0 110.986 177.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.8 p -74.5 -20.24 60.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.434 -175.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.7 t -175.08 -177.03 1.01 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.683 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.0 tp -62.8 -24.98 68.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.081 0.467 . . . . 0.0 110.22 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -52.36 -54.05 36.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.261 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -84.1 -20.01 33.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -57.48 -56.14 25.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -89.55 47.34 1.46 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.693 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.681 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 9.3 t70 -110.55 133.26 53.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.11 25.38 11.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.064 0.459 . . . . 0.0 111.207 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.98 -45.09 3.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.445 0.641 . . . . 0.0 109.805 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.652 ' HB2' HG23 ' A' ' 10' ' ' ILE . 48.9 mmtm -97.67 -47.57 5.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.679 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.681 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 12.3 t-160 -79.93 99.1 7.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.531 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.3 t -104.06 129.76 55.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.48 0.657 . . . . 0.0 111.966 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -123.05 97.44 5.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.652 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -87.1 145.12 26.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.676 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.78 144.49 51.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.02 0.438 . . . . 0.0 110.059 174.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 t -137.45 60.27 1.65 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.606 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.26 41.54 1.25 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.993 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.503 -177.731 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 26' ' ' ARG . 9.8 p . . . . . 0 N--CA 1.438 -1.055 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.8 mmtt -97.51 158.89 15.24 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.578 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 49.3 t -63.86 112.17 2.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.99 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.95 -0.29 55.23 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.812 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 32' ' ' CYS . 7.3 mt -100.96 -37.35 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 120.692 0.282 . . . . 0.0 111.205 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.7 p -123.6 -14.74 7.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.311 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.21 30.83 19.05 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.518 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.63 -71.03 1.27 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.342 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 m -118.34 -169.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.7 p-10 -62.64 145.99 53.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.489 0.661 . . . . 0.0 111.612 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.54 75.18 2.02 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -66.64 -27.59 67.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.673 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.431 ' CD1' ' HG3' ' A' ' 17' ' ' LYS . 2.8 m-30 -102.62 154.78 18.81 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 11.9 tmtt? -136.93 145.73 44.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.741 0.305 . . . . 0.0 110.882 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.515 ' HB3' HG12 ' A' ' 25' ' ' VAL . 36.6 t -99.09 107.32 43.55 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.0 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.66 1.25 5.22 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.148 2.565 . . . . 0.0 112.878 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -92.19 -52.54 4.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.798 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.5 p -105.8 -37.03 6.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.081 0.467 . . . . 0.0 111.068 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.62 19.39 8.31 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.929 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.1 p -85.59 158.97 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.963 0.411 . . . . 0.0 110.224 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HG3' HG11 ' A' ' 6' ' ' VAL . 24.8 mmt180 -118.21 119.45 34.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.073 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.578 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -118.79 156.12 29.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.697 0.76 . . . . 0.0 110.886 179.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -74.66 -20.9 59.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.556 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.8 t -177.19 -171.64 0.35 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.347 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 tp -66.36 -20.64 66.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.121 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -54.75 -52.96 60.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.704 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.402 ' HB3' HD12 ' A' ' 10' ' ' ILE . 89.3 m -86.26 -18.7 31.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.779 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -61.85 -63.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -83.81 54.54 2.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.721 0.772 . . . . 0.0 110.944 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -116.48 145.93 42.94 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.853 175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.51 28.65 5.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.295 0.569 . . . . 0.0 110.572 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.069 178.893 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.439 -1.02 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 75.2 mmtt -104.48 160.46 14.91 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.633 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.8 t -66.2 111.83 3.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.928 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.39 -1.36 57.29 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.943 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 32' ' ' CYS . 11.4 mt -99.53 -40.4 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.799 0.333 . . . . 0.0 111.175 -176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.7 p -120.74 -14.48 8.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.207 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.01 27.99 14.12 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.034 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.14 -69.66 1.31 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.246 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.22 -169.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.563 0.221 . . . . 0.0 110.7 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 7.5 p-10 -62.89 143.01 58.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.434 0.635 . . . . 0.0 111.587 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.428 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -92.23 70.34 1.74 Allowed Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.408 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -65.1 -23.67 67.22 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -101.93 150.46 23.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 12.8 tmtt? -135.78 144.66 45.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.641 0.257 . . . . 0.0 110.545 -174.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 15.0 t -98.99 107.68 45.18 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.912 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 34.9 Cg_endo -64.55 -13.0 36.25 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.102 2.535 . . . . 0.0 113.58 -176.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -82.22 -63.26 1.42 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.022 0.439 . . . . 0.0 111.147 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -92.12 -33.08 14.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.917 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.82 18.96 13.99 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.671 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.475 HG12 ' CB ' ' A' ' 20' ' ' CYS . 3.5 p -84.2 158.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.129 0.49 . . . . 0.0 110.595 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.9 mmt180 -114.49 128.88 56.56 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.924 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.633 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.72 151.19 50.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.769 0.795 . . . . 0.0 111.173 176.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.3 p -71.34 -22.51 61.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.531 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.6 p -176.94 -169.44 0.26 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.58 0.229 . . . . 0.0 111.288 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 28.9 mt -65.82 -20.38 66.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.406 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -59.3 -43.38 92.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.118 0.485 . . . . 0.0 110.073 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.445 ' HB3' HD12 ' A' ' 10' ' ' ILE . 91.6 m -93.59 -23.53 18.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.881 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -59.49 -59.38 5.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.203 0.525 . . . . 0.0 109.922 177.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -89.65 45.82 1.31 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.529 0.681 . . . . 0.0 110.953 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -108.79 141.17 41.19 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.93 22.6 11.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.216 0.531 . . . . 0.0 110.936 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.741 0 CA-C-O 121.405 0.621 . . . . 0.0 110.045 179.084 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.43 -1.47 0 CA-C-O 120.965 0.412 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 34.9 mmtp -101.23 157.92 16.42 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.948 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 45.8 t -60.4 114.32 2.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.39 3.74 52.45 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.822 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 32' ' ' CYS . 12.0 mt -104.44 -39.66 5.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 122.676 -0.308 . . . . 0.0 110.98 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.6 p -118.85 -18.08 8.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.578 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 12' ' ' ARG . 34.7 mmt180 59.12 29.46 19.03 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.284 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.92 -70.14 1.31 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.03 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 m -120.83 -171.93 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.3 p30 -54.66 146.57 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.533 0.682 . . . . 0.0 112.031 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.24 71.77 1.61 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -60.23 -25.07 65.36 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -114.29 157.82 22.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.967 0.413 . . . . 0.0 110.942 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.57 146.02 51.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.134 -175.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.422 ' HB3' HG12 ' A' ' 25' ' ' VAL . 48.6 t -97.61 108.53 45.93 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.761 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 36.7 Cg_endo -65.18 -14.27 44.25 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 122.715 2.276 . . . . 0.0 112.964 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -81.97 -59.97 2.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.293 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.81 -34.58 11.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.954 0.407 . . . . 0.0 110.545 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.7 6.91 26.35 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.237 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.5 p -75.18 157.04 6.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.146 0.498 . . . . 0.0 111.434 -173.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -111.8 127.96 55.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.242 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.645 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.1 155.06 46.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.833 0.825 . . . . 0.0 111.639 178.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 29' ' ' SER . 26.5 p -77.8 -17.4 57.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.507 -174.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 8.5 t 176.54 -171.42 0.08 Allowed 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.275 0.36 . . . . 0.0 110.052 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.467 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 23.2 tp -64.31 -19.78 65.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.168 0.508 . . . . 0.0 110.366 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -54.92 -48.39 73.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.12 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HB3' HD12 ' A' ' 10' ' ' ILE . 93.1 m -93.59 -18.6 22.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.727 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.467 ' CB ' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -57.77 -62.36 1.86 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.125 177.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -85.45 53.78 2.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.289 0.566 . . . . 0.0 111.165 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -109.93 144.64 38.14 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.231 174.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.16 27.28 5.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.191 0.52 . . . . 0.0 110.478 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.951 178.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.476 HG21 ' HG3' ' A' ' 26' ' ' ARG . 4.4 p . . . . . 0 N--CA 1.435 -1.194 0 CA-C-O 120.804 0.335 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 28.4 mmmt -104.29 159.29 15.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.718 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 45.6 t -62.98 114.78 3.88 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.52 8.65 39.89 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.663 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.0 mt -109.3 -50.55 6.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.857 0.361 . . . . 0.0 110.657 -176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.8 p -108.61 -15.45 14.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.342 0.591 . . . . 0.0 110.327 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 92.7 mtt-85 55.95 32.26 19.47 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.001 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.12 -72.01 1.29 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.183 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 m -115.49 -171.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 122.763 -0.257 . . . . 0.0 110.41 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.5 p-10 -58.86 146.16 38.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.449 0.642 . . . . 0.0 111.739 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.586 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -89.13 67.17 2.93 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.297 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 17' ' ' LYS . 3.3 ptpp? -57.68 -32.06 66.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -99.04 149.06 23.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.22 144.41 50.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.686 0.279 . . . . 0.0 110.758 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.546 ' HB3' HG12 ' A' ' 25' ' ' VAL . 33.7 t -95.12 104.79 16.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.598 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.29 -16.13 53.35 Favored 'Trans proline' 0 N--CA 1.471 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.853 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -73.66 -60.36 2.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.721 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.0 p -97.51 -35.62 10.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.639 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.55 15.59 13.4 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.943 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.546 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.6 p -80.34 157.71 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.132 0.491 . . . . 0.0 110.723 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.586 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.7 mmt180 -114.24 124.71 52.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.323 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.507 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -124.9 150.92 46.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.613 0.72 . . . . 0.0 110.738 176.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 29.2 p -67.15 -28.95 68.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.443 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.9 m -167.86 -177.32 3.38 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.421 0.153 . . . . 0.0 111.019 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.46 -27.38 69.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.166 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -56.94 -43.49 81.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.513 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.1 m -85.55 -23.69 27.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.754 0.311 . . . . 0.0 110.735 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -56.56 -56.26 23.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.34 0.591 . . . . 0.0 109.479 175.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -85.5 47.67 1.47 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.528 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -107.42 143.14 36.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.453 176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.52 28.0 6.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.979 0.419 . . . . 0.0 110.837 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 121.559 0.695 . . . . 0.0 110.255 178.893 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.441 -0.924 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 32.9 mmtp -101.87 158.87 15.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.744 0.307 . . . . 0.0 110.863 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.682 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 34.8 t -64.54 124.65 22.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.305 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.38 1.4 88.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.617 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 32' ' ' CYS . 8.6 mt -105.34 -35.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.773 0.321 . . . . 0.0 111.152 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.3 p -120.88 -17.08 7.99 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.534 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 61.08 21.78 12.13 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.05 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.67 -70.2 1.33 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.429 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.4 m -117.24 -170.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.8 p-10 -61.07 145.76 49.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.518 0.675 . . . . 0.0 111.726 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.81 69.62 1.41 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -61.85 -31.04 71.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.355 -0.422 . . . . 0.0 111.961 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -100.6 150.47 22.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.102 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.42 146.63 46.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.742 0.306 . . . . 0.0 110.482 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.455 ' HB3' HG12 ' A' ' 25' ' ' VAL . 47.8 t -96.07 108.64 42.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.148 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.25 -3.76 11.43 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.707 2.271 . . . . 0.0 112.593 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -88.85 -61.75 1.64 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.4 p -97.7 -26.99 14.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.926 0.393 . . . . 0.0 110.776 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.62 18.25 21.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.988 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.455 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.1 p -84.73 155.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.062 0.458 . . . . 0.0 110.925 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.67 128.92 56.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.018 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.682 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -131.89 151.07 51.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 122.0 0.905 . . . . 0.0 111.517 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.2 p -72.98 -25.74 61.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.352 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.6 p -176.1 -170.31 0.37 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.964 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 35.1 mt -62.9 -21.88 66.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.312 176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.49 -33.18 71.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.234 0.54 . . . . 0.0 110.615 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.498 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.8 m -106.5 -20.49 13.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.748 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -61.62 -58.04 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.18 0.514 . . . . 0.0 109.895 177.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -87.39 49.78 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.858 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -111.65 145.93 38.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.483 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.26 24.67 6.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.172 0.511 . . . . 0.0 111.146 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 121.32 0.581 . . . . 0.0 110.58 -179.465 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 N--CA 1.432 -1.329 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 46.2 mmtm -100.12 152.41 20.28 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 48.2 t -55.75 117.42 3.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.604 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.12 -1.77 75.55 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.927 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 32' ' ' CYS . 8.1 mt -99.87 -37.33 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.761 0.315 . . . . 0.0 110.988 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.7 p -121.03 -18.3 7.55 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.44 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 29.1 mmm180 60.55 33.61 20.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.276 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.91 -78.31 1.3 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.23 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 m -112.91 -173.33 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.53 0.205 . . . . 0.0 110.72 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 32.6 m-20 -64.15 139.14 58.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.156 0.503 . . . . 0.0 110.925 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.54 81.45 1.65 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.714 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -66.4 -25.52 66.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.964 0.411 . . . . 0.0 111.505 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -105.54 153.45 21.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.139 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.5 tmtp? -134.75 146.46 49.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.349 -0.387 . . . . 0.0 109.994 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 19.9 t -101.29 103.54 27.18 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.29 -12.48 35.79 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.796 2.331 . . . . 0.0 112.693 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -76.52 -59.55 2.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.67 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.4 p -100.69 -31.85 11.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.227 0.537 . . . . 0.0 110.644 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.06 22.96 7.97 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.275 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.2 p -91.82 158.81 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.913 0.387 . . . . 0.0 110.953 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -114.93 126.89 55.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.368 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.609 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -126.87 154.1 44.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.684 0.754 . . . . 0.0 111.128 177.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.0 p -71.55 -23.11 61.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.253 -1.339 . . . . 0.0 111.616 -175.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.8 p 178.25 -167.92 0.07 Allowed 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.493 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 19.9 mt -63.09 -21.57 66.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.442 175.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -51.35 -46.62 62.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.251 0.548 . . . . 0.0 111.104 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.474 ' HB3' HD12 ' A' ' 10' ' ' ILE . 73.8 m -100.67 -14.99 17.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.933 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -62.44 -60.84 2.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 110.312 178.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -85.18 45.89 1.23 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.381 0.61 . . . . 0.0 111.101 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -104.92 148.61 26.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.942 178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.11 13.6 6.72 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.131 0.491 . . . . 0.0 110.983 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.577 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.766 179.34 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.437 -1.1 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 33.0 mmtp -95.22 159.21 15.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.0 t -62.79 118.63 7.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.278 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.52 2.86 76.41 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.682 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 32' ' ' CYS . 15.7 mt -102.33 -41.71 8.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 122.683 -0.304 . . . . 0.0 111.025 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.9 p -117.66 -16.36 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.242 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 62.34 21.96 12.89 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.515 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.97 -74.82 1.16 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.402 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.32 -169.35 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.9 p-10 -57.64 142.77 43.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.483 0.659 . . . . 0.0 111.556 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.402 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -96.5 70.87 0.84 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -63.28 -31.4 72.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -95.45 149.77 21.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.535 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.5 tmtp? -132.74 148.05 52.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 38.6 t -99.71 108.14 49.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.208 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 2.33 3.44 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.893 2.395 . . . . 0.0 113.188 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -97.47 -58.57 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.698 0.285 . . . . 0.0 111.095 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.27 -30.95 13.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.138 0.494 . . . . 0.0 110.498 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.33 17.51 19.69 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.845 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.409 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.3 p -84.7 159.31 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.0 110.777 -176.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 18.4 mmt180 -115.84 127.46 55.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.914 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.643 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.19 148.55 51.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.898 0.856 . . . . 0.0 111.538 178.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.6 p -69.94 -23.48 63.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.439 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.2 p -173.5 -167.62 0.4 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 111.633 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.4 tp -70.41 -20.14 62.95 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.257 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.6 -40.27 96.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.982 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.526 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.7 m -92.27 -22.47 19.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.645 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.412 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -58.85 -58.2 9.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.222 177.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -87.7 47.21 1.47 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.213 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -107.77 141.82 38.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.46 24.53 6.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.142 0.496 . . . . 0.0 110.792 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.61 0 CA-C-O 121.414 0.626 . . . . 0.0 109.719 178.861 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.434 -1.265 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 35.5 mmtp -99.81 157.12 16.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.655 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.3 t -62.18 113.69 3.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.073 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.51 5.01 47.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.771 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 32' ' ' CYS . 12.2 mt -108.41 -33.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.7 -0.294 . . . . 0.0 111.433 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.65 -14.75 6.72 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.313 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.22 30.31 18.17 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.238 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.84 -73.82 1.27 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.247 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -112.35 -169.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 122.941 -0.153 . . . . 0.0 110.596 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 9.6 p-10 -64.39 144.63 57.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.361 0.6 . . . . 0.0 111.088 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.24 73.73 1.68 Allowed Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.309 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -60.1 -33.38 72.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -100.05 157.65 16.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.85 0.357 . . . . 0.0 110.275 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 13.8 tmtt? -142.23 145.05 33.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.505 -174.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 50.6 t -95.6 114.87 64.87 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.556 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.92 -6.15 16.3 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.753 2.302 . . . . 0.0 113.34 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.23 -56.77 2.61 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.709 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 19.9 p -97.75 -23.04 16.09 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.016 -177.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.89 22.63 30.05 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.407 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 p -89.62 157.55 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.216 0.531 . . . . 0.0 110.552 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -114.27 127.97 56.13 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.821 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.655 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.29 153.82 48.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.873 0.844 . . . . 0.0 111.535 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.3 p -77.28 -22.07 52.62 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.055 -176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.4 p -176.05 -167.44 0.22 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.893 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 35.1 mt -65.93 -23.4 66.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.402 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -59.66 -35.7 74.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.141 0.495 . . . . 0.0 110.743 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HB3' HD12 ' A' ' 10' ' ' ILE . 78.5 m -100.66 -23.72 14.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.539 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.527 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -59.47 -57.41 13.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.157 0.503 . . . . 0.0 109.685 176.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -88.61 41.89 1.04 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.359 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -108.79 141.92 40.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.11 29.98 5.3 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.235 0.54 . . . . 0.0 110.515 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.657 0 CA-C-O 121.54 0.685 . . . . 0.0 109.443 177.402 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.498 -1.032 0 CA-C-O 121.233 0.54 . . . . 0.0 110.924 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.41 136.94 55.0 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.377 167.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.563 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 40.2 t -47.42 113.03 0.62 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.416 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.55 12.12 22.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.883 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 32' ' ' CYS . 16.2 mt -109.98 -41.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 O-C-N 122.727 -0.278 . . . . 0.0 110.669 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.9 p -117.1 -18.78 9.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.267 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 25.6 mmm180 59.09 33.94 23.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.609 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.44 -69.8 1.18 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.975 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.9 m -122.84 -170.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.554 0.216 . . . . 0.0 110.526 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 12.7 m-20 -63.7 140.75 58.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.125 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.97 77.11 2.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.945 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -71.48 -16.86 62.37 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -109.64 157.15 19.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.427 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.8 tmtm? -140.1 146.47 38.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.838 0.351 . . . . 0.0 111.058 -173.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.5 t -103.45 111.51 65.14 Favored Pre-proline 0 CA--C 1.515 -0.402 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.039 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.76 -0.16 7.32 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 122.584 2.189 . . . . 0.0 112.838 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -98.19 -56.06 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.557 0.218 . . . . 0.0 111.515 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.4 p -100.72 -15.81 17.57 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.059 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.36 9.73 62.93 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.628 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.54 157.35 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 121.089 0.471 . . . . 0.0 110.919 -173.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -116.47 118.86 33.84 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.964 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.563 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -117.32 155.14 30.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.811 0.815 . . . . 0.0 111.248 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.5 p -70.33 -31.6 68.96 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.176 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.2 m -171.12 -169.41 0.74 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.3 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.2 -24.42 66.62 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.726 0.298 . . . . 0.0 111.03 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -51.94 -43.38 63.43 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.478 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB3' HD12 ' A' ' 10' ' ' ILE . 73.2 m -96.87 -20.59 18.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.775 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -59.51 -62.49 1.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.674 176.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -87.91 52.91 2.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.772 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -117.97 145.01 45.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.61 10.9 7.26 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.109 0.48 . . . . 0.0 110.655 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.603 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.897 -179.721 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.439 -1.025 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -101.24 158.11 16.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.574 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 42.7 t -62.28 116.53 5.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.599 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.92 17.25 22.9 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.566 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 32' ' ' CYS . 10.2 mt -117.19 -37.5 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.617 -0.343 . . . . 0.0 110.864 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.3 p -120.6 -15.21 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.258 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 59.09 29.57 19.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.22 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.74 -76.08 1.31 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.9 m -112.88 -171.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 122.864 -0.198 . . . . 0.0 110.487 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -61.27 144.29 54.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.469 0.652 . . . . 0.0 111.339 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -88.23 68.17 3.0 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 175.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -29.9 68.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -104.07 153.77 20.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -133.03 146.71 51.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.305 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.53 ' CB ' HG12 ' A' ' 25' ' ' VAL . 38.4 t -94.43 106.29 22.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.99 -9.02 21.69 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.963 2.442 . . . . 0.0 112.563 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -81.8 -64.77 1.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.489 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.6 p -94.32 -38.38 11.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.195 0.521 . . . . 0.0 110.888 -174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.29 12.86 11.36 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.387 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.53 HG12 ' CB ' ' A' ' 20' ' ' CYS . 3.7 p -77.28 160.32 4.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.904 0.383 . . . . 0.0 110.727 -176.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 24.4 mmt180 -117.15 125.84 51.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.574 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -128.13 156.2 43.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.904 0.859 . . . . 0.0 111.426 178.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.3 p -75.97 -21.2 57.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.677 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 t 179.08 -171.39 0.13 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 79.2 mt -65.94 -20.67 66.29 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.773 0.32 . . . . 0.0 110.357 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -55.62 -32.22 62.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.82 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' HB3' HD12 ' A' ' 10' ' ' ILE . 99.9 m -110.56 -20.49 12.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.094 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.79 -57.92 10.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.305 0.574 . . . . 0.0 109.548 176.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.75 50.82 2.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.631 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -114.33 147.71 38.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.118 177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.07 14.0 7.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.042 0.449 . . . . 0.0 110.973 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.682 0 CA-C-O 121.339 0.59 . . . . 0.0 110.137 -179.354 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.6 mmtt -103.74 157.09 17.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.968 0.413 . . . . 0.0 110.807 -177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.615 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.6 t -62.35 115.77 4.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.553 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.89 12.85 40.31 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.644 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.439 HD12 ' HB3' ' A' ' 32' ' ' CYS . 7.7 mt -112.83 -38.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.737 0.303 . . . . 0.0 111.053 -177.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.1 p -119.9 -16.64 8.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.266 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 63.35 32.21 14.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.152 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.0 -81.73 1.41 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.304 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.27 -169.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.971 -0.135 . . . . 0.0 110.895 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 53.2 m-20 -63.28 141.27 58.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.313 0.577 . . . . 0.0 111.03 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.58 75.52 2.35 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -60.6 -30.17 69.67 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.94 151.86 24.72 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -134.66 145.64 48.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.419 ' HB3' HG12 ' A' ' 25' ' ' VAL . 22.0 t -97.11 107.42 37.82 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.97 0.42 5.08 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.086 2.524 . . . . 0.0 113.454 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -94.14 -63.81 1.15 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.018 0.437 . . . . 0.0 110.927 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.5 p -92.85 -26.64 17.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.181 0.515 . . . . 0.0 110.492 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.2 21.33 18.01 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.672 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.419 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.7 p -89.24 155.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.158 0.504 . . . . 0.0 110.601 -176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -112.86 129.74 56.35 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.791 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.615 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.91 148.82 52.72 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.803 0.811 . . . . 0.0 111.516 177.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -71.77 -19.92 61.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.691 -175.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 8.2 t 176.93 -168.02 0.05 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.233 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 45.8 mt -64.24 -23.22 67.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.385 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -60.12 -31.7 70.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.044 0.45 . . . . 0.0 110.985 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HB3' HD12 ' A' ' 10' ' ' ILE . 99.4 m -106.14 -21.5 13.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.729 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -59.5 -56.57 20.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.582 0.706 . . . . 0.0 109.489 176.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -91.47 39.81 1.01 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.111 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -103.15 140.57 37.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.68 19.66 13.77 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.231 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 121.226 0.536 . . . . 0.0 110.02 178.844 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.435 -1.223 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -101.2 154.43 18.76 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.2 t -58.28 116.1 3.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.525 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.414 ' HA2' HH11 ' A' ' 12' ' ' ARG . . . -77.74 6.08 49.09 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.791 -177.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 32' ' ' CYS . 8.6 mt -107.85 -38.73 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 120.654 0.264 . . . . 0.0 111.11 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.6 p -119.75 -15.42 8.9 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.605 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 29.3 mmm180 59.19 24.93 13.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.332 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.59 -73.53 1.27 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.268 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.8 m -114.84 -169.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.34 145.35 51.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.439 0.637 . . . . 0.0 111.421 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -93.65 72.99 1.23 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -65.93 -32.0 73.24 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -95.72 149.83 21.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.534 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.2 tmtp? -134.1 147.85 50.92 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.534 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.7 t -100.23 109.34 56.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.466 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 40.9 Cg_endo -67.72 -5.39 14.19 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.988 2.458 . . . . 0.0 112.788 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -88.94 -60.71 1.88 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.907 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.4 p -96.51 -29.82 13.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.941 0.401 . . . . 0.0 111.067 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.2 21.5 11.67 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.896 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.5 p -89.31 158.83 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.075 0.464 . . . . 0.0 110.655 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 23.1 mmt180 -114.69 128.13 56.14 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.171 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.61 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -127.65 153.25 46.68 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.84 0.829 . . . . 0.0 110.817 176.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.0 p -70.49 -34.39 72.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.044 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.3 m -168.8 -172.43 1.6 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.018 -173.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 22.5 mt -62.19 -23.42 66.61 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.634 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -55.98 -51.63 67.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.703 0.763 . . . . 0.0 110.273 -179.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.492 ' HB3' HD12 ' A' ' 10' ' ' ILE . 72.5 m -85.39 -24.3 27.6 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.315 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.534 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.41 -60.64 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.052 178.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -87.48 44.23 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.064 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -110.77 139.69 45.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.661 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.02 23.77 9.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.115 0.483 . . . . 0.0 110.843 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.651 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 178.913 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.441 -0.884 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 13.7 mmmm -103.96 157.67 16.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.865 0.364 . . . . 0.0 110.592 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.575 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.1 t -63.2 117.21 6.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.245 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 12' ' ' ARG . . . -80.67 5.38 65.08 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.666 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 32' ' ' CYS . 10.4 mt -105.25 -40.63 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 120.725 0.298 . . . . 0.0 110.975 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.3 p -117.99 -14.07 10.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.197 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.42 ' CZ ' ' HA2' ' A' ' 9' ' ' GLY . 38.6 mmt180 57.7 29.01 16.65 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.552 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.71 -77.91 1.27 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.359 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.0 m -113.42 -169.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 6.7 p-10 -64.35 143.32 57.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.469 0.652 . . . . 0.0 111.422 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -88.69 76.9 1.84 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 175.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -64.08 -28.09 69.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -104.93 159.32 15.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.583 0.23 . . . . 0.0 110.547 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.2 tmtp? -135.7 145.76 47.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.732 0.301 . . . . 0.0 110.779 -174.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.559 ' HB3' HG12 ' A' ' 25' ' ' VAL . 33.8 t -100.63 102.92 20.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.3 -7.93 18.97 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 122.782 2.321 . . . . 0.0 113.269 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -79.31 -61.9 1.86 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.067 0.461 . . . . 0.0 110.967 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.2 p -97.58 -31.94 12.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.664 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.37 14.29 18.64 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.982 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.5 p -82.12 156.27 4.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.148 0.499 . . . . 0.0 110.913 -175.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 24.3 mmt180 -113.34 121.5 44.56 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.014 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.575 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -119.47 148.33 43.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.859 0.838 . . . . 0.0 111.079 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.5 p -65.99 -26.14 67.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.518 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 p -176.11 -171.2 0.42 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.366 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.36 -20.88 66.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.671 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.54 -39.9 81.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.089 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.49 ' HB3' HD12 ' A' ' 10' ' ' ILE . 98.9 m -98.39 -17.82 18.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -65.02 0.73 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.912 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -85.06 48.16 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.217 0.532 . . . . 0.0 111.646 -174.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -106.73 150.0 26.73 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.511 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.09 29.03 4.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.166 0.508 . . . . 0.0 110.716 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.612 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.041 177.532 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.438 -1.051 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 69.9 mmtt -98.35 159.87 14.66 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 44.0 t -63.43 114.24 3.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.057 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.01 7.85 41.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.578 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.401 HD12 ' HB3' ' A' ' 32' ' ' CYS . 7.7 mt -110.17 -38.69 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 122.672 -0.311 . . . . 0.0 111.078 -177.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 p -121.78 -15.09 7.99 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.445 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 61.89 22.89 13.37 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.91 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.25 -72.59 1.2 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.307 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.1 -169.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.9 p-10 -59.66 145.52 44.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.505 0.669 . . . . 0.0 111.806 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.88 69.39 2.43 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -63.11 -27.37 69.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.335 -0.433 . . . . 0.0 111.835 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -99.75 148.03 24.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.785 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER -137.13 145.52 43.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.805 0.335 . . . . 0.0 110.292 -174.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.553 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 43.3 t -98.2 108.29 46.24 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.183 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.11 0.03 5.01 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 122.811 2.34 . . . . 0.0 112.967 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -96.16 -60.32 1.65 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.62 0.248 . . . . 0.0 111.419 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.8 p -95.38 -27.15 15.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.038 0.447 . . . . 0.0 110.676 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.23 20.95 21.62 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.548 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 p -86.14 158.0 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.05 0.452 . . . . 0.0 110.187 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -115.65 128.15 55.71 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.912 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.629 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.74 147.53 52.41 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.985 0.898 . . . . 0.0 110.909 177.099 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.2 p -66.98 -31.71 72.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.347 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.0 m -167.9 -176.25 2.99 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.647 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 47.8 mt -61.19 -26.3 67.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -56.26 -38.1 70.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.02 0.438 . . . . 0.0 111.127 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.401 ' HB3' HD12 ' A' ' 10' ' ' ILE . 81.2 m -95.11 -23.91 17.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.581 177.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -61.17 -57.8 10.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.807 176.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -85.27 43.56 1.02 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.331 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -111.35 149.17 31.53 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.82 3.23 6.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.014 0.435 . . . . 0.0 111.01 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 121.362 0.601 . . . . 0.0 110.103 179.395 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -104.15 154.74 19.38 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 44.9 t -59.46 112.21 1.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.322 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.85 0.62 43.8 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.776 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 32' ' ' CYS . 11.3 mt -103.14 -40.51 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 122.755 -0.262 . . . . 0.0 111.206 -174.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.2 p -119.0 -18.44 8.78 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.323 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.32 36.51 27.62 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.026 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.54 -62.91 0.98 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.126 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -125.75 -176.2 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.722 0.296 . . . . 0.0 111.254 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.74 135.29 55.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.551 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -86.95 74.82 2.27 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -68.34 -31.13 70.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -95.47 152.32 18.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.677 0.275 . . . . 0.0 110.331 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -134.31 145.82 49.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.864 0.364 . . . . 0.0 111.045 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.436 ' CB ' HG12 ' A' ' 25' ' ' VAL . 35.5 t -100.48 108.49 53.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.789 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 39.4 Cg_endo -66.94 -13.33 39.55 Favored 'Trans proline' 0 N--CA 1.471 0.174 0 C-N-CA 122.832 2.354 . . . . 0.0 112.744 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -82.82 -56.64 3.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.538 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.5 p -101.04 -29.47 12.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.969 0.414 . . . . 0.0 110.523 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.11 7.1 31.33 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.321 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.436 HG12 ' CB ' ' A' ' 20' ' ' CYS . 3.2 p -77.28 157.78 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.046 0.45 . . . . 0.0 111.447 -173.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.482 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.1 mmt180 -115.0 124.33 51.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.22 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.576 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -123.89 153.93 40.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.616 0.722 . . . . 0.0 110.825 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -70.08 -33.07 71.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.981 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.1 m -168.08 -173.53 2.08 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.589 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.65 -25.0 67.76 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.69 -41.07 73.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.923 0.392 . . . . 0.0 111.162 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.51 ' HB3' HD12 ' A' ' 10' ' ' ILE . 99.5 m -91.18 -23.0 20.37 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.803 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -60.91 2.93 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -86.95 52.79 2.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.226 0.536 . . . . 0.0 111.314 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -119.0 141.63 48.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 173.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.57 10.42 13.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.957 0.408 . . . . 0.0 111.16 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.326 -179.632 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.437 -1.121 0 CA-C-O 120.702 0.287 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -108.27 161.6 14.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 49.4 t -65.47 116.36 6.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.572 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.85 -4.87 78.09 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.785 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 32' ' ' CYS . 9.6 mt -98.0 -40.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.795 0.331 . . . . 0.0 110.963 -174.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.5 p -117.65 -15.71 10.14 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.417 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 61.38 32.55 19.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.456 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.0 -82.88 1.47 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.292 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.03 -168.96 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.649 0.262 . . . . 0.0 110.814 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.22 139.16 58.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.28 0.562 . . . . 0.0 111.964 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.72 70.45 3.17 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -62.36 -27.46 69.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.503 -0.349 . . . . 0.0 111.753 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.7 153.88 20.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -138.17 143.79 40.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.729 0.299 . . . . 0.0 110.333 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.439 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 18.8 t -98.72 107.48 43.24 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.818 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.22 -9.97 27.01 Favored 'Trans proline' 0 C--N 1.335 -0.156 0 C-N-CA 122.776 2.317 . . . . 0.0 112.824 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -83.92 -62.5 1.55 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.209 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -93.66 -28.69 15.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.106 0.479 . . . . 0.0 110.496 -176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.3 10.73 35.55 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.802 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.6 p -79.11 157.99 4.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.153 0.501 . . . . 0.0 111.368 -174.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -113.0 126.54 55.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.199 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.595 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -127.47 148.28 50.31 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.861 0.838 . . . . 0.0 110.716 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -65.57 -32.28 73.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.294 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.5 m -168.62 -169.92 1.12 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.859 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.69 -27.62 68.48 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.426 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.538 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -55.47 -45.0 76.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.51 0.671 . . . . 0.0 111.22 -177.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.442 ' HB3' HD12 ' A' ' 10' ' ' ILE . 73.7 m -87.69 -23.15 24.28 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.71 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -61.28 -63.03 1.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.782 176.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -84.98 52.53 2.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.201 0.524 . . . . 0.0 110.842 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -112.42 148.99 33.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.68 15.84 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.077 0.465 . . . . 0.0 110.799 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.614 0 CA-C-O 121.441 0.639 . . . . 0.0 109.759 179.644 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.443 -0.8 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.2 mmtt -110.08 158.11 18.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 0.0 110.734 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 33.9 t -66.16 113.95 4.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.123 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.23 3.06 59.57 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.861 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.494 HD12 ' HB3' ' A' ' 32' ' ' CYS . 16.5 mt -103.0 -40.55 6.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 122.715 -0.286 . . . . 0.0 110.955 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.7 p -118.09 -16.2 9.81 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.291 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 59.54 24.5 13.24 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.334 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.61 -69.76 1.36 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.408 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 m -120.79 -168.87 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.5 m-20 -66.77 142.8 57.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.133 0.492 . . . . 0.0 111.243 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.47 78.22 1.64 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -66.89 -33.44 75.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.883 0.373 . . . . 0.0 111.351 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.31 153.8 18.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 12.1 tmtt? -142.81 145.18 32.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.639 0.257 . . . . 0.0 110.694 -175.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.413 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.0 t -96.58 113.46 62.69 Favored Pre-proline 0 CA--C 1.516 -0.34 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.04 -13.77 41.38 Favored 'Trans proline' 0 C--N 1.334 -0.233 0 C-N-CA 122.575 2.184 . . . . 0.0 112.385 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -88.29 -56.02 3.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.819 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.0 p -98.35 -21.44 16.61 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.162 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.0 16.74 46.54 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.637 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.81 158.91 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 120.961 0.41 . . . . 0.0 110.4 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -116.62 129.07 55.94 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.014 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.651 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.96 152.94 48.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.795 0.807 . . . . 0.0 111.133 177.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.8 p -72.78 -20.5 61.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.442 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.4 p -178.28 -169.39 0.19 Allowed 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.291 0.369 . . . . 0.0 110.422 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 33.9 mt -65.34 -20.24 66.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.424 175.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -59.15 -39.47 82.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.162 0.506 . . . . 0.0 110.724 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.494 ' HB3' HD12 ' A' ' 10' ' ' ILE . 90.6 m -97.87 -22.31 16.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.453 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -57.96 -58.85 6.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.83 177.466 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -90.72 35.52 0.89 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.095 0.474 . . . . 0.0 111.07 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -101.13 122.32 43.39 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.36 17.11 24.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.904 0.383 . . . . 0.0 111.076 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.102 178.667 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.551 HG11 ' HG3' ' A' ' 26' ' ' ARG . 4.2 p . . . . . 0 N--CA 1.436 -1.157 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.5 mmtt -99.54 156.82 16.85 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.5 t -62.59 111.93 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.424 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.7 24.7 3.13 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.664 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 32' ' ' CYS . 10.1 mt -125.08 -39.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 122.666 -0.314 . . . . 0.0 110.857 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.4 p -119.78 -16.25 8.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.13 0.491 . . . . 0.0 110.745 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 56.75 27.69 13.14 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.518 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.19 -68.87 1.41 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.006 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.46 -168.91 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.514 0.197 . . . . 0.0 110.547 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.9 p-10 -61.31 146.52 47.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.418 0.628 . . . . 0.0 111.629 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.03 70.31 2.29 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.429 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -25.15 66.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.884 0.373 . . . . 0.0 111.805 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -98.68 149.49 22.77 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.545 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -131.73 145.66 51.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.822 0.344 . . . . 0.0 111.053 -174.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.569 ' HB3' HG12 ' A' ' 25' ' ' VAL . 43.4 t -102.51 107.28 53.24 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.109 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.33 -9.93 27.41 Favored 'Trans proline' 0 N--CA 1.472 0.236 0 C-N-CA 122.883 2.389 . . . . 0.0 112.97 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -82.7 -49.16 10.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.5 p -111.12 -33.18 6.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.844 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.45 16.2 13.74 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.152 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.569 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.3 p -81.19 158.9 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 110.675 -176.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HG3' HG11 ' A' ' 6' ' ' VAL . 61.3 mmt-85 -114.58 121.35 43.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.296 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.527 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -122.24 155.88 34.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.548 0.689 . . . . 0.0 110.909 176.211 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.1 p -71.21 -34.08 70.5 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.807 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -167.58 -172.93 2.04 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.328 -174.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 tp -62.77 -31.59 72.58 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 122.65 0.38 . . . . 0.0 111.508 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -53.6 -43.34 68.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.544 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.416 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.6 m -87.99 -23.1 23.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.66 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.494 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -56.67 -58.73 6.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.141 177.092 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -87.04 50.8 2.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.409 0.623 . . . . 0.0 111.526 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -109.87 150.76 27.95 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.12 -0.6 5.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.246 0.546 . . . . 0.0 111.002 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.75 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.057 -179.869 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.432 -1.372 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.45 158.68 16.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.3 t -63.66 115.73 5.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.15 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 12' ' ' ARG . . . -81.3 17.86 12.07 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.494 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 32' ' ' CYS . 10.1 mt -119.13 -46.03 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 120.853 0.359 . . . . 0.0 110.742 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.0 p -110.6 -13.87 14.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.485 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.457 ' CZ ' ' HA2' ' A' ' 9' ' ' GLY . 35.4 mmt180 55.45 30.63 15.41 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.833 178.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.24 -69.13 1.01 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.348 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.13 -170.18 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 121.276 -0.17 . . . . 0.0 110.765 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 5.7 p-10 -63.27 145.79 54.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.326 0.584 . . . . 0.0 111.619 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -92.1 65.74 2.21 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.365 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 6.7 ptpp? -56.89 -36.3 69.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.438 ' CD1' ' HG3' ' A' ' 17' ' ' LYS . 3.7 m-30 -94.65 149.63 21.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 13.1 tmtt? -134.43 144.29 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.789 0.328 . . . . 0.0 110.771 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.492 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 25.1 t -97.98 107.35 40.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.806 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 39.8 Cg_endo -66.64 -10.07 26.69 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.04 2.493 . . . . 0.0 113.565 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -84.55 -63.11 1.39 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.908 0.385 . . . . 0.0 111.232 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.6 p -94.05 -32.34 13.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.201 0.524 . . . . 0.0 110.601 -173.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.41 21.47 9.3 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.168 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.471 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.0 p -88.04 158.74 3.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.969 0.414 . . . . 0.0 110.618 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 21.5 mmt180 -116.02 129.53 56.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.011 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.581 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -131.32 151.05 51.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.702 0.763 . . . . 0.0 110.949 177.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.0 p -71.24 -19.61 62.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.751 -174.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.3 t -175.94 -171.35 0.44 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.76 0.315 . . . . 0.0 110.547 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.418 ' HG ' ' HE2' ' A' ' 34' ' ' LYS . 37.2 tp -69.89 -19.82 63.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.529 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.56 -49.34 77.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.051 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.4 m -81.53 -20.88 39.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.67 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -59.32 -59.57 5.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.869 176.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HE2' ' HG ' ' A' ' 30' ' ' LEU . 55.0 mtmt -84.86 54.31 3.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.632 0.73 . . . . 0.0 110.999 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -111.64 149.79 31.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.564 174.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.57 13.05 7.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.731 0.3 . . . . 0.0 111.628 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.583 0 CA-C-O 121.382 0.61 . . . . 0.0 110.092 -179.736 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 4.0 p . . . . . 0 N--CA 1.434 -1.254 0 CA-C-O 120.603 0.24 . . . . 0.0 110.501 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -106.18 154.01 21.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.7 t -59.41 110.02 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.538 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.26 18.14 3.63 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.732 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.5 mt -119.98 -36.1 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.565 0.221 . . . . 0.0 111.15 -177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.84 -14.7 6.64 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.439 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 5.7 mpt_? 58.77 28.9 17.98 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.835 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.4 -78.06 1.14 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.699 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.07 -171.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 6.2 p-10 -58.12 144.21 41.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.51 0.672 . . . . 0.0 111.425 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.602 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -86.92 68.54 3.22 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.175 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 17' ' ' LYS . 4.3 ptpp? -58.86 -34.29 71.43 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -94.94 146.7 24.06 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.65 145.98 51.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.822 0.344 . . . . 0.0 110.772 -174.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.431 ' CB ' HG12 ' A' ' 25' ' ' VAL . 38.3 t -98.4 106.75 37.93 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.951 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.41 -6.41 16.36 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.615 2.21 . . . . 0.0 113.119 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.64 -63.48 1.31 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.866 0.365 . . . . 0.0 111.037 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.8 p -93.97 -30.29 14.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.049 0.452 . . . . 0.0 110.245 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.72 7.96 35.56 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.051 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.431 HG12 ' CB ' ' A' ' 20' ' ' CYS . 3.4 p -74.68 157.34 6.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.42 . . . . 0.0 111.002 -173.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.602 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 22.2 mmt180 -114.73 125.75 54.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.518 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.593 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -128.02 153.22 47.01 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.724 0.773 . . . . 0.0 110.986 177.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.8 p -74.5 -20.24 60.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.434 -175.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.7 t -175.08 -177.03 1.01 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.683 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.0 tp -62.8 -24.98 68.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.081 0.467 . . . . 0.0 110.22 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -52.36 -54.05 36.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.261 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -84.1 -20.01 33.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.406 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -57.48 -56.14 25.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -89.55 47.34 1.46 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.693 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -110.55 133.26 53.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.11 25.38 11.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.064 0.459 . . . . 0.0 111.207 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.679 0 CA-C-O 121.445 0.641 . . . . 0.0 109.805 178.147 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.723 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.67 87.62 1.45 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 123.126 2.551 . . . . 0.0 112.406 -177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -112.63 -23.03 10.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.422 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -72.5 147.57 45.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.921 0.391 . . . . 0.0 110.33 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -129.5 19.6 2.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.679 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.7 t 61.23 68.88 0.7 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.866 -175.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.3 m -79.8 51.61 1.34 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.919 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.97 166.71 29.82 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.774 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 26' ' ' ARG . 9.8 p -135.3 154.46 35.64 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.815 -172.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.8 mmtt -97.51 158.89 15.24 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.578 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 49.3 t -63.86 112.17 2.79 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.99 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.95 -0.29 55.23 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.812 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 32' ' ' CYS . 7.3 mt -100.96 -37.35 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 120.692 0.282 . . . . 0.0 111.205 -175.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.7 p -123.6 -14.74 7.24 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.311 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.21 30.83 19.05 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.518 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.63 -71.03 1.27 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.342 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 m -118.34 -169.69 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.7 p-10 -62.64 145.99 53.19 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.489 0.661 . . . . 0.0 111.612 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.54 75.18 2.02 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.431 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -66.64 -27.59 67.8 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.673 -178.41 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.431 ' CD1' ' HG3' ' A' ' 17' ' ' LYS . 2.8 m-30 -102.62 154.78 18.81 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 11.9 tmtt? -136.93 145.73 44.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.741 0.305 . . . . 0.0 110.882 -175.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.515 ' HB3' HG12 ' A' ' 25' ' ' VAL . 36.6 t -99.09 107.32 43.55 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.0 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.66 1.25 5.22 Favored 'Trans proline' 0 CA--C 1.529 0.228 0 C-N-CA 123.148 2.565 . . . . 0.0 112.878 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 13.9 mmmm -92.19 -52.54 4.64 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.798 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.5 p -105.8 -37.03 6.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.081 0.467 . . . . 0.0 111.068 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.62 19.39 8.31 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.929 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.519 HG11 ' CD2' ' A' ' 39' ' ' HIS . 4.1 p -85.59 158.97 3.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.963 0.411 . . . . 0.0 110.224 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HG3' HG11 ' A' ' 6' ' ' VAL . 24.8 mmt180 -118.21 119.45 34.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.073 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.578 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -118.79 156.12 29.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.697 0.76 . . . . 0.0 110.886 179.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -74.66 -20.9 59.69 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.556 -174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.8 t -177.19 -171.64 0.35 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.347 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.5 tp -66.36 -20.64 66.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.121 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -54.75 -52.96 60.91 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.704 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.402 ' HB3' HD12 ' A' ' 10' ' ' ILE . 89.3 m -86.26 -18.7 31.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.779 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -61.85 -63.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 176.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -83.81 54.54 2.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.721 0.772 . . . . 0.0 110.944 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 8.3 t70 -116.48 145.93 42.94 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.792 -1.095 . . . . 0.0 108.853 175.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.51 28.65 5.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.295 0.569 . . . . 0.0 110.572 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.82 -43.9 2.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.069 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -109.59 -32.82 6.98 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.561 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.583 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 10.0 t-160 -82.89 89.75 6.88 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 175.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -93.23 126.97 45.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.614 0.721 . . . . 0.0 112.187 -170.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 4.2 m170 -122.4 64.45 0.95 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.382 176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 44' ' ' SER . 62.7 tttp -89.8 -46.21 8.74 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.623 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 67.0 -82.12 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.225 -178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.465 ' O ' ' HG2' ' A' ' 42' ' ' LYS . 26.9 t -113.99 -175.94 2.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.903 -0.776 . . . . 0.0 108.903 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.83 -49.12 78.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 59.5 mm-40 . . . . . 0 C--O 1.247 0.923 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.634 174.459 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.979 -0.448 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -75.57 81.51 2.31 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.648 2.232 . . . . 0.0 112.494 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -111.68 8.37 20.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.969 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm -117.6 173.95 6.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.935 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.77 -43.44 98.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 111.857 0.318 . . . . 0.0 111.857 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.3 m -103.2 -46.49 4.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.801 -0.182 . . . . 0.0 110.643 -177.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.1 m 57.55 46.12 18.29 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.373 0.606 . . . . 0.0 110.092 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -146.49 147.08 30.82 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.564 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.2 p -113.12 152.37 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.938 -173.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 75.2 mmtt -104.48 160.46 14.91 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.633 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.8 t -66.2 111.83 3.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.928 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -73.39 -1.36 57.29 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.943 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.53 HD13 ' HB2' ' A' ' 39' ' ' HIS . 11.4 mt -99.53 -40.4 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 120.799 0.333 . . . . 0.0 111.175 -176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.7 p -120.74 -14.48 8.55 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.428 -0.509 . . . . 0.0 111.207 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.01 27.99 14.12 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.034 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.14 -69.66 1.31 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.246 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.22 -169.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 120.563 0.221 . . . . 0.0 110.7 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 7.5 p-10 -62.89 143.01 58.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.434 0.635 . . . . 0.0 111.587 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.428 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -92.23 70.34 1.74 Allowed Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.408 178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.3 ptpt -65.1 -23.67 67.22 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -101.93 150.46 23.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 12.8 tmtt? -135.78 144.66 45.9 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.641 0.257 . . . . 0.0 110.545 -174.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.517 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 15.0 t -98.99 107.68 45.18 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.912 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 34.9 Cg_endo -64.55 -13.0 36.25 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.102 2.535 . . . . 0.0 113.58 -176.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 68.7 mmtt -82.22 -63.26 1.42 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.022 0.439 . . . . 0.0 111.147 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.9 p -92.12 -33.08 14.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.917 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.82 18.96 13.99 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.671 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 39' ' ' HIS . 3.5 p -84.2 158.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.129 0.49 . . . . 0.0 110.595 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.9 mmt180 -114.49 128.88 56.56 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.924 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.633 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.72 151.19 50.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.769 0.795 . . . . 0.0 111.173 176.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.3 p -71.34 -22.51 61.91 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.359 -1.291 . . . . 0.0 111.531 -176.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.6 p -176.94 -169.44 0.26 Allowed 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.58 0.229 . . . . 0.0 111.288 -177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.503 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 28.9 mt -65.82 -20.38 66.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.406 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -59.3 -43.38 92.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.118 0.485 . . . . 0.0 110.073 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.445 ' HB3' HD12 ' A' ' 10' ' ' ILE . 91.6 m -93.59 -23.53 18.26 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.881 178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -59.49 -59.38 5.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.203 0.525 . . . . 0.0 109.922 177.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -89.65 45.82 1.31 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.529 0.681 . . . . 0.0 110.953 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.568 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.8 t70 -108.79 141.17 41.19 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 174.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.93 22.6 11.44 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.216 0.531 . . . . 0.0 110.936 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.33 -44.47 3.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.405 0.621 . . . . 0.0 110.045 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -105.46 -33.45 8.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.056 -0.974 . . . . 0.0 109.818 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.568 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 11.0 t-80 -95.7 99.96 11.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.666 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.0 t -126.13 145.7 33.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.335 0.588 . . . . 0.0 111.046 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.443 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 5.0 m170 -113.58 164.06 14.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.606 -176.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 55.5 tttm -130.76 15.26 5.34 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.76 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -71.79 115.09 10.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.979 179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.0 m -77.82 83.42 4.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.179 0.514 . . . . 0.0 111.433 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -72.6 -28.43 62.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.087 176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.633 -0.699 . . . . 0.0 109.844 177.731 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.005 -0.438 . . . . 0.0 112.005 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.75 20.24 0.9 Allowed 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 123.503 2.802 . . . . 0.0 113.039 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 42.4 m80 71.89 -71.97 0.12 Allowed 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.388 0.675 . . . . 0.0 111.917 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.4 ttp -131.6 145.58 51.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.721 0.296 . . . . 0.0 110.475 -174.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.02 70.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.729 0.776 . . . . 0.0 110.361 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.9 t -145.14 105.35 4.06 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 174.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.3 m 63.12 55.62 1.89 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.518 0.675 . . . . 0.0 109.295 -169.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.64 -176.96 5.16 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.225 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 p -126.56 144.82 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.717 -172.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 34.9 mmtp -101.23 157.92 16.42 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.948 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.645 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 45.8 t -60.4 114.32 2.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.38 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.39 3.74 52.45 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.822 -177.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.42 HD12 ' HB3' ' A' ' 32' ' ' CYS . 12.0 mt -104.44 -39.66 5.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 122.676 -0.308 . . . . 0.0 110.98 -177.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.6 p -118.85 -18.08 8.97 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.199 -0.6 . . . . 0.0 111.578 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 12' ' ' ARG . 34.7 mmt180 59.12 29.46 19.03 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.284 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.92 -70.14 1.31 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.03 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 m -120.83 -171.93 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.3 p30 -54.66 146.57 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.533 0.682 . . . . 0.0 112.031 177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.24 71.77 1.61 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 174.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -60.23 -25.07 65.36 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -114.29 157.82 22.25 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.967 0.413 . . . . 0.0 110.942 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.57 146.02 51.58 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.134 -175.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.422 ' HB3' HG12 ' A' ' 25' ' ' VAL . 48.6 t -97.61 108.53 45.93 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.761 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 36.7 Cg_endo -65.18 -14.27 44.25 Favored 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 122.715 2.276 . . . . 0.0 112.964 -177.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -81.97 -59.97 2.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.293 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 26.1 p -95.81 -34.58 11.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.954 0.407 . . . . 0.0 110.545 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.7 6.91 26.35 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.237 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.5 p -75.18 157.04 6.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.146 0.498 . . . . 0.0 111.434 -173.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -111.8 127.96 55.97 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.242 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.645 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.1 155.06 46.8 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.833 0.825 . . . . 0.0 111.639 178.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 29' ' ' SER . 26.5 p -77.8 -17.4 57.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.507 -174.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 8.5 t 176.54 -171.42 0.08 Allowed 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.275 0.36 . . . . 0.0 110.052 -179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.467 ' HA ' ' CB ' ' A' ' 33' ' ' TYR . 23.2 tp -64.31 -19.78 65.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.168 0.508 . . . . 0.0 110.366 178.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -54.92 -48.39 73.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.12 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HB3' HD12 ' A' ' 10' ' ' ILE . 93.1 m -93.59 -18.6 22.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.727 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.467 ' CB ' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -57.77 -62.36 1.86 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.125 177.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -85.45 53.78 2.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.289 0.566 . . . . 0.0 111.165 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 12.2 t70 -109.93 144.64 38.14 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.231 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.16 27.28 5.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.191 0.52 . . . . 0.0 110.478 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.97 -41.61 3.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.951 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -112.42 -35.59 5.52 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.262 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.505 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 18.6 t-160 -80.73 105.18 11.77 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.4 t -107.78 138.87 32.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.414 -174.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -131.17 114.44 15.11 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.895 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -124.48 142.27 51.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.17 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 61.09 -168.19 0.18 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.682 0.614 . . . . 0.0 110.064 -175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.4 m 64.54 -72.85 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.16 0.584 . . . . 0.0 111.874 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -93.66 -20.06 20.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.036 0.446 . . . . 0.0 110.622 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.02 179.229 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -63.37 -33.9 68.32 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.937 2.425 . . . . 0.0 112.367 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -115.31 50.09 1.02 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.981 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.1 mtp 67.27 168.54 0.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.213 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.407 ' C ' ' H ' ' A' ' 4' ' ' SER . 32.1 m -121.24 9.84 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 m 71.81 -31.21 0.22 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.606 0.763 . . . . 0.0 112.303 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 2' ' ' VAL . 19.9 m -67.92 -33.76 75.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.846 0.355 . . . . 0.0 111.763 -178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.77 157.41 16.3 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 120.961 0.41 . . . . 0.0 109.975 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.476 HG21 ' HG3' ' A' ' 26' ' ' ARG . 4.4 p -128.59 145.66 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.523 -173.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 28.4 mmmt -104.29 159.29 15.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.718 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 45.6 t -62.98 114.78 3.88 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.52 8.65 39.89 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.663 -176.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.5 HG23 ' HB2' ' A' ' 38' ' ' LYS . 17.0 mt -109.3 -50.55 6.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.857 0.361 . . . . 0.0 110.657 -176.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.8 p -108.61 -15.45 14.42 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.342 0.591 . . . . 0.0 110.327 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 8' ' ' CYS . 92.7 mtt-85 55.95 32.26 19.47 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 114.579 -1.191 . . . . 0.0 112.001 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.12 -72.01 1.29 Allowed Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.183 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.3 m -115.49 -171.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 122.763 -0.257 . . . . 0.0 110.41 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.5 p-10 -58.86 146.16 38.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.449 0.642 . . . . 0.0 111.739 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.586 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -89.13 67.17 2.93 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.297 175.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.405 ' HG2' ' H ' ' A' ' 17' ' ' LYS . 3.3 ptpp? -57.68 -32.06 66.96 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -99.04 149.06 23.39 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.22 144.41 50.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.686 0.279 . . . . 0.0 110.758 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.546 ' HB3' HG12 ' A' ' 25' ' ' VAL . 33.7 t -95.12 104.79 16.17 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.598 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -64.29 -16.13 53.35 Favored 'Trans proline' 0 N--CA 1.471 0.181 0 C-N-CA 122.695 2.263 . . . . 0.0 112.853 -175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -73.66 -60.36 2.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.721 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.0 p -97.51 -35.62 10.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.639 -176.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.55 15.59 13.4 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.943 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.546 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.6 p -80.34 157.71 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.132 0.491 . . . . 0.0 110.723 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.586 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.7 mmt180 -114.24 124.71 52.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.323 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.507 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -124.9 150.92 46.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.613 0.72 . . . . 0.0 110.738 176.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 29.2 p -67.15 -28.95 68.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.667 -1.152 . . . . 0.0 111.443 -177.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.9 m -167.86 -177.32 3.38 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.421 0.153 . . . . 0.0 111.019 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 33.4 tp -62.46 -27.38 69.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.166 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -56.94 -43.49 81.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.513 -179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 95.1 m -85.55 -23.69 27.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.754 0.311 . . . . 0.0 110.735 177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.462 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -56.56 -56.26 23.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.34 0.591 . . . . 0.0 109.479 175.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -85.5 47.67 1.47 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.528 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.587 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 10.1 t70 -107.42 143.14 36.18 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.453 176.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -124.52 28.0 6.75 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.979 0.419 . . . . 0.0 110.837 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.67 -43.74 2.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.559 0.695 . . . . 0.0 110.255 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.5 ' HB2' HG23 ' A' ' 10' ' ' ILE . 99.4 mttt -110.88 -35.18 6.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.078 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.587 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 9.3 t-80 -78.45 93.91 4.83 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 176.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 42' ' ' LYS . 60.8 t -104.13 132.91 49.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.419 0.628 . . . . 0.0 111.955 -170.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -130.04 28.38 5.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.702 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' H ' HG12 ' A' ' 40' ' ' VAL . 57.0 tptt 70.55 -60.97 0.48 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.083 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -142.05 143.74 33.26 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.9 m -154.29 82.79 1.12 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.959 -178.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -89.29 -37.03 15.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.059 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.531 -0.747 . . . . 0.0 110.146 177.879 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.787 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.54 77.42 2.57 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.65 2.233 . . . . 0.0 112.609 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -73.53 -33.54 64.79 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 tpp -119.82 120.89 37.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.658 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -121.74 20.05 5.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 122.011 0.91 . . . . 0.0 109.787 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.1 m 65.09 19.27 11.76 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.34 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -89.42 -14.11 36.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.268 0.556 . . . . 0.0 110.091 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.75 155.47 18.86 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.093 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -118.5 157.67 19.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.803 -172.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 32.9 mmtp -101.87 158.87 15.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.744 0.307 . . . . 0.0 110.863 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.682 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 34.8 t -64.54 124.65 22.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.305 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -84.38 1.4 88.85 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.617 -178.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 32' ' ' CYS . 8.6 mt -105.34 -35.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.773 0.321 . . . . 0.0 111.152 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 25.3 p -120.88 -17.08 7.99 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.534 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.4 mmt180 61.08 21.78 12.13 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.05 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.67 -70.2 1.33 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.429 -174.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.4 m -117.24 -170.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.8 p-10 -61.07 145.76 49.7 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.518 0.675 . . . . 0.0 111.726 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.81 69.62 1.41 Allowed Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.4 ptpp? -61.85 -31.04 71.26 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.355 -0.422 . . . . 0.0 111.961 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -100.6 150.47 22.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.102 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.42 146.63 46.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.742 0.306 . . . . 0.0 110.482 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' HB3' HG12 ' A' ' 25' ' ' VAL . 47.8 t -96.07 108.64 42.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.148 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -68.25 -3.76 11.43 Favored 'Trans proline' 0 CA--C 1.53 0.299 0 C-N-CA 122.707 2.271 . . . . 0.0 112.593 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -88.85 -61.75 1.64 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.957 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.4 p -97.7 -26.99 14.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.926 0.393 . . . . 0.0 110.776 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.62 18.25 21.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.988 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.481 HG11 ' CD2' ' A' ' 39' ' ' HIS . 4.1 p -84.73 155.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 121.062 0.458 . . . . 0.0 110.925 -177.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.67 128.92 56.21 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.018 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.682 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -131.89 151.07 51.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 122.0 0.905 . . . . 0.0 111.517 177.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.2 p -72.98 -25.74 61.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.352 -176.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.6 p -176.1 -170.31 0.37 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.964 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 35.1 mt -62.9 -21.88 66.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.312 176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.49 -33.18 71.02 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 121.234 0.54 . . . . 0.0 110.615 -178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.498 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.8 m -106.5 -20.49 13.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.748 178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -61.62 -58.04 9.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.18 0.514 . . . . 0.0 109.895 177.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -87.39 49.78 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.858 -176.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.564 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 8.3 t70 -111.65 145.93 38.35 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.483 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.26 24.67 6.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.172 0.511 . . . . 0.0 111.146 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.22 -42.72 2.89 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.32 0.581 . . . . 0.0 110.58 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -112.12 -28.57 7.92 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.004 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.564 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 18.2 t-160 -84.62 98.57 10.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 173.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.3 t -92.51 114.21 29.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.468 0.651 . . . . 0.0 112.191 -170.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -126.85 -56.07 1.37 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.844 174.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -96.34 86.73 4.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.177 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -154.0 143.98 21.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.995 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.6 t -149.06 80.42 1.42 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.47 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -61.17 105.05 0.44 Allowed 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.412 -178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 . . . . . 0 C--O 1.248 0.996 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.66 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.822 0 N-CA-C 111.891 -0.484 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -52.12 126.77 21.29 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.092 2.528 . . . . 0.0 112.441 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -102.51 62.04 0.84 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.161 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtm -110.1 -65.39 1.16 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.224 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 t 52.12 46.47 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.711 0.767 . . . . 0.0 110.38 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.7 m -94.98 -14.3 24.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.104 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.3 m -147.21 89.06 1.76 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.959 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.12 148.61 22.18 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 121.248 0.546 . . . . 0.0 109.578 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.5 p -131.39 143.16 41.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.073 -170.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 46.2 mmtm -100.12 152.41 20.28 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.609 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 48.2 t -55.75 117.42 3.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.604 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.12 -1.77 75.55 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.927 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 32' ' ' CYS . 8.1 mt -99.87 -37.33 5.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.761 0.315 . . . . 0.0 110.988 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.7 p -121.03 -18.3 7.55 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.44 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.51 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 29.1 mmm180 60.55 33.61 20.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.437 -0.802 . . . . 0.0 111.276 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.91 -78.31 1.3 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.23 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.4 m -112.91 -173.33 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.53 0.205 . . . . 0.0 110.72 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 32.6 m-20 -64.15 139.14 58.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.156 0.503 . . . . 0.0 110.925 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.54 81.45 1.65 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.714 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -66.4 -25.52 66.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.964 0.411 . . . . 0.0 111.505 -177.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -105.54 153.45 21.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.139 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.5 tmtp? -134.75 146.46 49.4 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.349 -0.387 . . . . 0.0 109.994 -176.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.549 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 19.9 t -101.29 103.54 27.18 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.29 -12.48 35.79 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.796 2.331 . . . . 0.0 112.693 -176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -76.52 -59.55 2.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.67 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.4 p -100.69 -31.85 11.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.227 0.537 . . . . 0.0 110.644 -175.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.06 22.96 7.97 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.275 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.507 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.2 p -91.82 158.81 2.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 120.913 0.387 . . . . 0.0 110.953 -177.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -114.93 126.89 55.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.368 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.609 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -126.87 154.1 44.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.684 0.754 . . . . 0.0 111.128 177.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.0 p -71.55 -23.11 61.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.253 -1.339 . . . . 0.0 111.616 -175.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.8 p 178.25 -167.92 0.07 Allowed 'General case' 0 C--O 1.237 0.447 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.493 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.432 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 19.9 mt -63.09 -21.57 66.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.442 175.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -51.35 -46.62 62.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.251 0.548 . . . . 0.0 111.104 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.474 ' HB3' HD12 ' A' ' 10' ' ' ILE . 73.8 m -100.67 -14.99 17.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.933 -178.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 1.0 OUTLIER -62.44 -60.84 2.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 110.312 178.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -85.18 45.89 1.23 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.381 0.61 . . . . 0.0 111.101 -176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.58 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 14.7 t70 -104.92 148.61 26.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.282 -0.872 . . . . 0.0 108.942 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.11 13.6 6.72 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.131 0.491 . . . . 0.0 110.983 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.28 -48.05 5.21 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.766 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -110.66 -34.24 6.34 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.047 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.58 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 7.6 t-160 -79.62 92.87 5.4 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.6 t -94.59 122.34 45.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.283 -172.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -134.63 154.28 51.59 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.09 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -115.72 -71.6 0.73 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.294 -0.866 . . . . 0.0 108.843 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 63.44 141.07 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 124.009 0.818 . . . . 0.0 112.428 177.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.6 m 71.19 -60.29 0.52 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.172 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 57.77 62.88 1.96 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.474 0.654 . . . . 0.0 109.979 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.699 -179.338 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . 0.446 ' HA2' ' HD3' ' A' ' -1' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.78 0 N-CA-C 111.949 -0.46 . . . . 0.0 111.949 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . 0.446 ' HD3' ' HA2' ' A' ' -2' ' ' GLY . 2.8 Cg_exo -75.39 100.59 1.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.551 2.167 . . . . 0.0 112.006 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 60.58 56.34 3.1 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.7 mtp -119.57 -63.42 1.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.944 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.2 m 40.39 39.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.739 0.816 . . . . 0.0 112.092 -176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -142.22 140.74 32.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.219 -0.901 . . . . 0.0 108.741 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.0 m 61.85 20.86 11.81 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.193 0.521 . . . . 0.0 110.386 -174.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -164.97 162.37 20.5 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.874 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -147.84 154.64 10.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.326 -171.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 33.0 mmtp -95.22 159.21 15.12 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.0 t -62.79 118.63 7.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.278 178.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -80.52 2.86 76.41 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.682 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.717 HD13 ' HB2' ' A' ' 39' ' ' HIS . 15.7 mt -102.33 -41.71 8.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 122.683 -0.304 . . . . 0.0 111.025 -177.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.9 p -117.66 -16.36 10.08 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.242 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 62.34 21.96 12.89 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.515 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.97 -74.82 1.16 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.402 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.32 -169.35 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 4.9 p-10 -57.64 142.77 43.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.483 0.659 . . . . 0.0 111.556 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.402 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -96.5 70.87 0.84 Allowed Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -63.28 -31.4 72.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -95.45 149.77 21.03 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.535 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.5 tmtp? -132.74 148.05 52.32 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 -176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.535 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 38.6 t -99.71 108.14 49.61 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.208 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.42 2.33 3.44 Favored 'Trans proline' 0 CA--C 1.533 0.455 0 C-N-CA 122.893 2.395 . . . . 0.0 113.188 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 13.3 mmmm -97.47 -58.57 1.97 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.698 0.285 . . . . 0.0 111.095 -179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.27 -30.95 13.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.138 0.494 . . . . 0.0 110.498 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.33 17.51 19.69 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.845 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.409 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.3 p -84.7 159.31 3.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.095 0.474 . . . . 0.0 110.777 -176.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 18.4 mmt180 -115.84 127.46 55.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.914 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.643 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.19 148.55 51.14 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.898 0.856 . . . . 0.0 111.538 178.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.6 p -69.94 -23.48 63.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.439 -177.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.2 p -173.5 -167.62 0.4 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 111.633 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.4 tp -70.41 -20.14 62.95 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.257 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -62.6 -40.27 96.38 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.982 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.526 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.7 m -92.27 -22.47 19.74 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.645 177.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.412 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 0.9 OUTLIER -58.85 -58.2 9.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.222 177.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -87.7 47.21 1.47 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.213 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 12.5 t70 -107.77 141.82 38.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.46 24.53 6.69 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.142 0.496 . . . . 0.0 110.792 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.48 -44.45 3.52 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.414 0.626 . . . . 0.0 109.719 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -107.99 -36.7 6.27 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.537 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.717 ' HB2' HD13 ' A' ' 10' ' ' ILE . 13.8 t-160 -88.65 85.22 6.76 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 38.7 t -102.97 121.74 54.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.655 0.741 . . . . 0.0 112.148 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 4.5 m170 -100.25 167.91 10.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.339 -1.3 . . . . 0.0 110.975 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -94.31 15.3 17.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.451 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -94.25 7.22 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.919 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.1 m -74.3 89.54 2.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.825 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -75.24 77.21 2.36 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 C--O 1.249 1.049 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.759 -177.057 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 111.79 -0.524 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -70.72 140.97 40.23 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 122.574 2.183 . . . . 0.0 112.058 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 38.9 m170 -106.01 -18.72 13.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.651 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.0 mtp -126.49 134.24 50.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.626 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 p -92.07 -20.93 6.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.423 0.63 . . . . 0.0 109.567 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.7 t -89.86 169.01 11.61 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.765 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.9 t 58.94 44.24 16.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.363 0.601 . . . . 0.0 109.818 -176.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.72 176.6 6.47 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.723 -178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p -139.61 152.73 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.265 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.438 -169.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 35.5 mmtp -99.81 157.12 16.73 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.655 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.3 t -62.18 113.69 3.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.073 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.51 5.01 47.88 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.771 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.687 HD13 ' HB2' ' A' ' 39' ' ' HIS . 12.2 mt -108.41 -33.53 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.7 -0.294 . . . . 0.0 111.433 -177.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.65 -14.75 6.72 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.313 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 57.22 30.31 18.17 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.238 177.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.84 -73.82 1.27 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.247 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -112.35 -169.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 122.941 -0.153 . . . . 0.0 110.596 -178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 9.6 p-10 -64.39 144.63 57.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.361 0.6 . . . . 0.0 111.088 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.24 73.73 1.68 Allowed Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.309 177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -60.1 -33.38 72.03 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -100.05 157.65 16.4 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.85 0.357 . . . . 0.0 110.275 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 13.8 tmtt? -142.23 145.05 33.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.505 -174.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 50.6 t -95.6 114.87 64.87 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.556 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.92 -6.15 16.3 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.753 2.302 . . . . 0.0 113.34 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.23 -56.77 2.61 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.709 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.462 ' HB3' ' CD2' ' A' ' 41' ' ' HIS . 19.9 p -97.75 -23.04 16.09 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.016 -177.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.89 22.63 30.05 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.407 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 p -89.62 157.55 3.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.216 0.531 . . . . 0.0 110.552 -177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -114.27 127.97 56.13 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.821 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.655 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.29 153.82 48.25 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.873 0.844 . . . . 0.0 111.535 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.3 p -77.28 -22.07 52.62 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.055 -176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.4 p -176.05 -167.44 0.22 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.893 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 35.1 mt -65.93 -23.4 66.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.402 176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -59.66 -35.7 74.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.141 0.495 . . . . 0.0 110.743 -177.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HB3' HD12 ' A' ' 10' ' ' ILE . 78.5 m -100.66 -23.72 14.59 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.539 177.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.527 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -59.47 -57.41 13.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.157 0.503 . . . . 0.0 109.685 176.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -88.61 41.89 1.04 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.359 -175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 10.7 t70 -108.79 141.92 40.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -128.11 29.98 5.3 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.235 0.54 . . . . 0.0 110.515 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.07 -46.39 3.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.54 0.685 . . . . 0.0 109.443 177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -102.55 -37.35 8.01 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.086 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.687 ' HB2' HD13 ' A' ' 10' ' ' ILE . 23.9 t-160 -88.58 89.76 8.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.535 176.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.5 t -110.57 121.99 64.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.398 0.618 . . . . 0.0 111.491 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.462 ' CD2' ' HB3' ' A' ' 23' ' ' CYS . 3.2 m170 -79.15 84.4 5.12 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.895 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.0 ptmm? -135.64 114.87 12.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.99 175.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.35 5.17 42.13 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.451 0.643 . . . . 0.0 109.369 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.9 t -142.14 155.64 45.33 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.122 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -83.04 5.84 20.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.124 0.487 . . . . 0.0 110.213 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 . . . . . 0 C--O 1.25 1.117 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.767 175.796 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.662 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -80.71 50.16 3.47 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.849 2.366 . . . . 0.0 112.423 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -141.3 28.98 1.82 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.235 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 ttp -166.35 115.23 0.92 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.505 -179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p -88.73 -21.8 6.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.954 0.407 . . . . 0.0 110.576 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 p -81.25 61.03 4.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.071 0.462 . . . . 0.0 111.391 -177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.2 m -86.29 -17.98 33.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.131 0.491 . . . . 0.0 110.233 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.71 150.6 36.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.572 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -118.06 175.86 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 CA-C-O 121.233 0.54 . . . . 0.0 110.924 178.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -122.41 136.94 55.0 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.856 -1.066 . . . . 0.0 108.377 167.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.563 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 40.2 t -47.42 113.03 0.62 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.416 -177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.55 12.12 22.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.883 -177.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.605 HD13 ' HB2' ' A' ' 39' ' ' HIS . 16.2 mt -109.98 -41.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 O-C-N 122.727 -0.278 . . . . 0.0 110.669 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.9 p -117.1 -18.78 9.95 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.267 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 25.6 mmm180 59.09 33.94 23.13 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.609 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.44 -69.8 1.18 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.975 -177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.9 m -122.84 -170.06 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.554 0.216 . . . . 0.0 110.526 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 12.7 m-20 -63.7 140.75 58.9 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.125 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.97 77.11 2.15 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.945 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -71.48 -16.86 62.37 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -109.64 157.15 19.36 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.427 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.8 tmtm? -140.1 146.47 38.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.838 0.351 . . . . 0.0 111.058 -173.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.5 t -103.45 111.51 65.14 Favored Pre-proline 0 CA--C 1.515 -0.402 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.039 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -70.76 -0.16 7.32 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 122.584 2.189 . . . . 0.0 112.838 177.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -98.19 -56.06 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.557 0.218 . . . . 0.0 111.515 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.437 ' HB3' ' CD2' ' A' ' 41' ' ' HIS . 25.4 p -100.72 -15.81 17.57 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.938 0.399 . . . . 0.0 111.059 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.36 9.73 62.93 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.791 -0.718 . . . . 0.0 111.628 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.54 157.35 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-O 121.089 0.471 . . . . 0.0 110.919 -173.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -116.47 118.86 33.84 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.964 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.563 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -117.32 155.14 30.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.811 0.815 . . . . 0.0 111.248 179.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.5 p -70.33 -31.6 68.96 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.176 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.2 m -171.12 -169.41 0.74 Allowed 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.3 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.2 -24.42 66.62 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 120.726 0.298 . . . . 0.0 111.03 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -51.94 -43.38 63.43 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.478 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB3' HD12 ' A' ' 10' ' ' ILE . 73.2 m -96.87 -20.59 18.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.775 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -59.51 -62.49 1.84 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.674 176.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -87.91 52.91 2.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.772 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 19.5 t70 -117.97 145.01 45.03 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.61 10.9 7.26 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.109 0.48 . . . . 0.0 110.655 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.98 -41.95 8.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.897 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -109.63 -39.86 5.01 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.971 177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.605 ' HB2' HD13 ' A' ' 10' ' ' ILE . 23.4 t-160 -84.78 109.31 17.97 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.07 131.76 72.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.09 0.471 . . . . 0.0 111.193 -177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.437 ' CD2' ' HB3' ' A' ' 23' ' ' CYS . 2.3 m170 -98.1 111.85 24.02 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.562 177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -85.98 -152.7 0.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.025 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -63.99 96.15 0.13 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.763 0.316 . . . . 0.0 110.85 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.2 t -106.66 -26.94 11.12 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.858 0.361 . . . . 0.0 110.344 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -82.06 61.1 5.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.079 0.466 . . . . 0.0 110.584 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.594 -0.717 . . . . 0.0 109.977 179.179 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.29 -53.66 5.91 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.143 2.562 . . . . 0.0 112.924 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -121.81 11.98 10.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.926 0.393 . . . . 0.0 110.788 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.0 mtp -116.02 118.64 33.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.71 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.4 t -88.98 -26.71 5.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.483 0.659 . . . . 0.0 109.255 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.8 m -83.28 164.69 19.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.839 175.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 m 60.48 43.82 12.64 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 121.361 0.6 . . . . 0.0 110.162 -177.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -123.72 177.2 5.82 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.464 -177.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 8.7 p -135.13 149.38 28.93 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.753 -172.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -101.24 158.11 16.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 -178.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.574 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 42.7 t -62.28 116.53 5.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.599 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.92 17.25 22.9 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.566 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.554 HD13 ' HB2' ' A' ' 39' ' ' HIS . 10.2 mt -117.19 -37.5 2.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.617 -0.343 . . . . 0.0 110.864 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.3 p -120.6 -15.21 8.51 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.394 -0.522 . . . . 0.0 111.258 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 59.09 29.57 19.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.22 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -90.74 -76.08 1.31 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.9 m -112.88 -171.09 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 122.864 -0.198 . . . . 0.0 110.487 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -61.27 144.29 54.11 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.469 0.652 . . . . 0.0 111.339 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -88.23 68.17 3.0 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 175.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.66 -29.9 68.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -104.07 153.77 20.5 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -133.03 146.71 51.97 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.305 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.53 ' CB ' HG12 ' A' ' 25' ' ' VAL . 38.4 t -94.43 106.29 22.76 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.99 -9.02 21.69 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.963 2.442 . . . . 0.0 112.563 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -81.8 -64.77 1.11 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.489 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 45' ' ' GLU . 26.6 p -94.32 -38.38 11.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.195 0.521 . . . . 0.0 110.888 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 113.29 12.86 11.36 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.387 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' A' ' 39' ' ' HIS . 3.7 p -77.28 160.32 4.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.904 0.383 . . . . 0.0 110.727 -176.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.503 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 24.4 mmt180 -117.15 125.84 51.86 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.656 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.574 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -128.13 156.2 43.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.904 0.859 . . . . 0.0 111.426 178.621 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.3 p -75.97 -21.2 57.22 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.191 -1.368 . . . . 0.0 111.677 -174.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 t 179.08 -171.39 0.13 Allowed 'General case' 0 C--O 1.236 0.383 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.537 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 79.2 mt -65.94 -20.67 66.29 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 120.773 0.32 . . . . 0.0 110.357 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -55.62 -32.22 62.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.82 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' HB3' HD12 ' A' ' 10' ' ' ILE . 99.9 m -110.56 -20.49 12.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.094 177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.79 -57.92 10.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.305 0.574 . . . . 0.0 109.548 176.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -85.75 50.82 2.04 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.631 -177.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 13.0 t70 -114.33 147.71 38.69 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.118 177.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.07 14.0 7.29 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.042 0.449 . . . . 0.0 110.973 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.25 -44.64 5.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.339 0.59 . . . . 0.0 110.137 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.32 -30.14 6.01 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.309 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.586 ' CD2' HG11 ' A' ' 25' ' ' VAL . 10.4 t-80 -83.57 93.73 7.91 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 170.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.0 t -109.79 137.51 41.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.436 0.636 . . . . 0.0 111.413 -172.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -120.44 49.95 1.38 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.92 -1.037 . . . . 0.0 110.196 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.12 89.56 2.18 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.583 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 59.3 24.9 13.45 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.974 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.5 p -114.11 148.53 37.0 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.417 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 23' ' ' CYS . 8.8 tp10 60.76 36.83 19.2 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 122.022 0.915 . . . . 0.0 109.6 -176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 . . . . . 0 C--O 1.249 1.052 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.78 179.582 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -63.95 -33.29 63.86 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.908 2.405 . . . . 0.0 112.835 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 24.9 t-80 -71.9 -33.47 68.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.921 0.391 . . . . 0.0 110.539 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm -87.45 -72.04 0.54 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.678 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.4 p 37.8 47.78 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-O 122.367 1.079 . . . . 0.0 111.967 -178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.7 m -128.26 35.92 4.36 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.739 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.3 t -105.5 12.39 31.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.739 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 65.99 -172.07 0.19 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.692 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 p -157.11 151.85 8.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.179 -173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.6 mmtt -103.74 157.09 17.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.968 0.413 . . . . 0.0 110.807 -177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.615 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.6 t -62.35 115.77 4.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.553 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -81.89 12.85 40.31 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.644 -177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.494 HG23 ' HB2' ' A' ' 38' ' ' LYS . 7.7 mt -112.83 -38.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.737 0.303 . . . . 0.0 111.053 -177.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.1 p -119.9 -16.64 8.65 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.471 -0.491 . . . . 0.0 111.266 178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 63.35 32.21 14.75 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.152 178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.0 -81.73 1.41 Allowed Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.304 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.2 m -110.27 -169.1 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.971 -0.135 . . . . 0.0 110.895 -176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 53.2 m-20 -63.28 141.27 58.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.313 0.577 . . . . 0.0 111.03 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.58 75.52 2.35 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 176.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -60.6 -30.17 69.67 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -106.94 151.86 24.72 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -134.66 145.64 48.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.419 ' HB3' HG12 ' A' ' 25' ' ' VAL . 22.0 t -97.11 107.42 37.82 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.97 0.42 5.08 Favored 'Trans proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.086 2.524 . . . . 0.0 113.454 -177.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -94.14 -63.81 1.15 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.018 0.437 . . . . 0.0 110.927 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.5 p -92.85 -26.64 17.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.181 0.515 . . . . 0.0 110.492 -174.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.2 21.33 18.01 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.672 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.419 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.7 p -89.24 155.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.158 0.504 . . . . 0.0 110.601 -176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -112.86 129.74 56.35 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.791 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.615 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.91 148.82 52.72 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.803 0.811 . . . . 0.0 111.516 177.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -71.77 -19.92 61.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.691 -175.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 28' ' ' CYS . 8.2 t 176.93 -168.02 0.05 Allowed 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.233 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.484 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 45.8 mt -64.24 -23.22 67.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.385 178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -60.12 -31.7 70.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.044 0.45 . . . . 0.0 110.985 -177.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.439 ' HB3' HD12 ' A' ' 10' ' ' ILE . 99.4 m -106.14 -21.5 13.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.729 176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -59.5 -56.57 20.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.582 0.706 . . . . 0.0 109.489 176.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -91.47 39.81 1.01 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.111 -176.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 26.4 t70 -103.15 140.57 37.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 176.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.68 19.66 13.77 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.231 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -103.59 -45.07 4.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.226 0.536 . . . . 0.0 110.02 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.494 ' HB2' HG23 ' A' ' 10' ' ' ILE . 66.8 mmtt -103.12 -45.57 4.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.156 177.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.559 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 9.6 t-160 -80.7 105.29 11.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.792 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.9 t -118.86 135.31 59.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.09 0.471 . . . . 0.0 110.886 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -122.31 154.45 37.59 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.175 177.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -80.6 -1.6 42.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.512 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -81.81 -5.73 58.46 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.109 0.48 . . . . 0.0 109.782 174.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 20.2 m -109.55 25.24 12.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.607 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -80.42 59.46 3.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.205 0.526 . . . . 0.0 110.925 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.512 -0.756 . . . . 0.0 109.809 179.561 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.57 -56.01 2.84 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.076 2.517 . . . . 0.0 112.375 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 48.1 m-70 -87.43 137.07 32.65 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mmm 60.11 58.09 2.78 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 123.615 0.572 . . . . 0.0 110.226 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.53 -21.28 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.201 0.524 . . . . 0.0 110.637 -178.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 m -79.99 83.32 5.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.165 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.3 m -62.93 -34.12 76.78 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.229 0.538 . . . . 0.0 110.59 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -108.15 149.6 28.31 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.501 0.667 . . . . 0.0 109.942 174.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 p -129.85 157.97 42.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.92 -1.036 . . . . 0.0 109.244 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -101.2 154.43 18.76 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.61 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.2 t -58.28 116.1 3.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.525 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.414 ' HA2' HH11 ' A' ' 12' ' ' ARG . . . -77.74 6.08 49.09 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.791 -177.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' ' 39' ' ' HIS . 8.6 mt -107.85 -38.73 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 120.654 0.264 . . . . 0.0 111.11 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 23.6 p -119.75 -15.42 8.9 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.605 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 8' ' ' CYS . 29.3 mmm180 59.19 24.93 13.38 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.332 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -85.59 -73.53 1.27 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.268 -177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.8 m -114.84 -169.63 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.34 145.35 51.78 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.439 0.637 . . . . 0.0 111.421 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -93.65 72.99 1.23 Allowed Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 175.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 ptpp? -65.93 -32.0 73.24 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -95.72 149.83 21.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.534 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.2 tmtp? -134.1 147.85 50.92 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -176.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.534 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.7 t -100.23 109.34 56.32 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.466 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 40.9 Cg_endo -67.72 -5.39 14.19 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.988 2.458 . . . . 0.0 112.788 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -88.94 -60.71 1.88 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.907 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.4 p -96.51 -29.82 13.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.941 0.401 . . . . 0.0 111.067 -176.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.2 21.5 11.67 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.896 179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.5 p -89.31 158.83 2.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.075 0.464 . . . . 0.0 110.655 -177.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.417 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 23.1 mmt180 -114.69 128.13 56.14 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.171 176.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.61 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -127.65 153.25 46.68 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.84 0.829 . . . . 0.0 110.817 176.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.0 p -70.49 -34.39 72.31 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.044 -178.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.3 m -168.8 -172.43 1.6 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.018 -173.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.534 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 22.5 mt -62.19 -23.42 66.61 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.634 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -55.98 -51.63 67.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.703 0.763 . . . . 0.0 110.273 -179.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.492 ' HB3' HD12 ' A' ' 10' ' ' ILE . 72.5 m -85.39 -24.3 27.6 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.315 178.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.534 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -60.41 -60.64 3.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.963 0.411 . . . . 0.0 110.052 178.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -87.48 44.23 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.064 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.608 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 10.8 t70 -110.77 139.69 45.84 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.661 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.02 23.77 9.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.115 0.483 . . . . 0.0 110.843 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.65 -45.66 3.64 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.773 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -102.34 -43.43 5.68 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.214 177.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.608 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 20.2 t-160 -80.19 110.96 16.1 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.053 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.6 t -115.98 137.42 49.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.08 0.467 . . . . 0.0 111.455 -175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -117.63 -169.38 1.66 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.719 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -66.01 137.58 57.2 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.733 -172.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -153.74 -41.41 0.09 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.394 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.4 m -130.73 72.77 1.51 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.352 0.596 . . . . 0.0 111.61 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.22 17.94 18.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.994 174.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.915 179.077 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -70.56 109.93 2.59 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.504 2.136 . . . . 0.0 112.294 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -72.79 -32.99 65.96 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 mtm -123.5 144.29 49.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.118 174.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.46 -11.31 11.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.522 0.677 . . . . 0.0 109.669 178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.3 m -103.61 155.27 18.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.602 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.0 m -97.8 38.66 1.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.052 0.453 . . . . 0.0 110.319 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.78 160.68 25.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.516 -178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.93 152.66 36.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.729 -172.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 13.7 mmmm -103.96 157.67 16.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.865 0.364 . . . . 0.0 110.592 -177.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.575 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.1 t -63.2 117.21 6.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.245 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.42 ' HA2' ' CZ ' ' A' ' 12' ' ' ARG . . . -80.67 5.38 65.08 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.666 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 32' ' ' CYS . 10.4 mt -105.25 -40.63 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 120.725 0.298 . . . . 0.0 110.975 -177.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.3 p -117.99 -14.07 10.01 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.475 -0.49 . . . . 0.0 111.197 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.42 ' CZ ' ' HA2' ' A' ' 9' ' ' GLY . 38.6 mmt180 57.7 29.01 16.65 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.552 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -87.71 -77.91 1.27 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.359 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.0 m -113.42 -169.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 -176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 6.7 p-10 -64.35 143.32 57.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.469 0.652 . . . . 0.0 111.422 -179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.461 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -88.69 76.9 1.84 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 175.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -64.08 -28.09 69.55 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -104.93 159.32 15.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.583 0.23 . . . . 0.0 110.547 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 1.2 tmtp? -135.7 145.76 47.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.732 0.301 . . . . 0.0 110.779 -174.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.559 ' HB3' HG12 ' A' ' 25' ' ' VAL . 33.8 t -100.63 102.92 20.96 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.3 -7.93 18.97 Favored 'Trans proline' 0 N--CA 1.472 0.253 0 C-N-CA 122.782 2.321 . . . . 0.0 113.269 -176.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp -79.31 -61.9 1.86 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.067 0.461 . . . . 0.0 110.967 178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 29.2 p -97.58 -31.94 12.05 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.664 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.37 14.29 18.64 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.873 -0.68 . . . . 0.0 111.982 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 20' ' ' CYS . 4.5 p -82.12 156.27 4.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.148 0.499 . . . . 0.0 110.913 -175.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 24.3 mmt180 -113.34 121.5 44.56 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.014 176.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.575 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -119.47 148.33 43.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.859 0.838 . . . . 0.0 111.079 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.5 p -65.99 -26.14 67.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.518 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 p -176.11 -171.2 0.42 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.366 -177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.36 -20.88 66.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.671 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -58.54 -39.9 81.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.089 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.49 ' HB3' HD12 ' A' ' 10' ' ' ILE . 98.9 m -98.39 -17.82 18.62 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.947 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -59.08 -65.02 0.73 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.912 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -85.06 48.16 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.217 0.532 . . . . 0.0 111.646 -174.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.583 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 17.4 t70 -106.73 150.0 26.73 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.511 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -132.09 29.03 4.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.166 0.508 . . . . 0.0 110.716 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -118.19 -44.87 2.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.041 177.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -107.9 -33.51 7.2 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.447 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.583 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 8.8 t-160 -82.78 93.23 7.38 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.3 t -90.09 127.65 42.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.512 -170.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 4.6 m170 -141.92 137.22 31.15 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.438 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -136.27 17.53 3.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.818 170.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 51.83 50.11 19.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.433 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 45.3 m 56.5 68.62 0.84 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.834 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.35 71.22 3.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.387 0.613 . . . . 0.0 109.551 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 C--O 1.247 0.954 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.877 -178.524 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.698 0 N-CA-C 111.863 -0.495 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.14 -24.63 72.94 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.845 2.363 . . . . 0.0 112.774 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -87.56 69.4 9.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 110.842 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mtp -135.54 137.56 42.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.706 177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.5 m -95.26 -17.54 7.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.903 0.382 . . . . 0.0 111.117 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 m 61.67 32.74 18.35 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.797 176.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.4 m -86.52 9.43 18.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.65 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.94 170.86 9.24 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.078 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.13 152.45 13.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.178 -172.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 69.9 mmtt -98.35 159.87 14.66 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.629 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 44.0 t -63.43 114.24 3.75 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.057 177.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.01 7.85 41.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.578 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 39' ' ' HIS . 7.7 mt -110.17 -38.69 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 O-C-N 122.672 -0.311 . . . . 0.0 111.078 -177.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 18.1 p -121.78 -15.09 7.99 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.445 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 61.89 22.89 13.37 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.91 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.25 -72.59 1.2 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.307 -177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.1 -169.54 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.9 p-10 -59.66 145.52 44.47 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.505 0.669 . . . . 0.0 111.806 179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.88 69.39 2.43 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -63.11 -27.37 69.34 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.335 -0.433 . . . . 0.0 111.835 -177.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -99.75 148.03 24.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.785 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.553 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 0.7 OUTLIER -137.13 145.52 43.92 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.805 0.335 . . . . 0.0 110.292 -174.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.553 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 43.3 t -98.2 108.29 46.24 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.183 178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.11 0.03 5.01 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 122.811 2.34 . . . . 0.0 112.967 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -96.16 -60.32 1.65 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.62 0.248 . . . . 0.0 111.419 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.8 p -95.38 -27.15 15.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.038 0.447 . . . . 0.0 110.676 -177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.23 20.95 21.62 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.806 -0.712 . . . . 0.0 111.548 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.3 p -86.14 158.0 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.05 0.452 . . . . 0.0 110.187 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -115.65 128.15 55.71 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.912 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.629 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -130.74 147.53 52.41 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.985 0.898 . . . . 0.0 110.909 177.099 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 27.2 p -66.98 -31.71 72.46 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.019 -1.446 . . . . 0.0 111.347 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.0 m -167.9 -176.25 2.99 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.647 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.483 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 47.8 mt -61.19 -26.3 67.62 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -56.26 -38.1 70.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.02 0.438 . . . . 0.0 111.127 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.401 ' HB3' HD12 ' A' ' 10' ' ' ILE . 81.2 m -95.11 -23.91 17.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.581 177.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -61.17 -57.8 10.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.807 176.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -85.27 43.56 1.02 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.331 -175.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.538 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 20.0 t70 -111.35 149.17 31.53 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.82 3.23 6.03 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.014 0.435 . . . . 0.0 111.01 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -88.33 -45.54 9.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.362 0.601 . . . . 0.0 110.103 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -103.16 -42.01 5.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.435 177.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.539 ' HB2' HD13 ' A' ' 10' ' ' ILE . 14.5 t-160 -83.35 86.15 7.11 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.621 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -97.93 123.26 50.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.396 0.617 . . . . 0.0 111.83 -175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -100.76 117.22 34.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.829 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -137.76 22.93 2.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.807 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -60.75 -47.67 85.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.895 -172.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 37.8 t -87.41 132.1 34.09 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -72.93 93.26 1.71 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.34 0.59 . . . . 0.0 109.919 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 . . . . . 0 C--O 1.247 0.935 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.449 -179.007 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.87 -23.51 62.08 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.678 2.252 . . . . 0.0 112.807 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -108.15 105.03 14.59 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.902 0.382 . . . . 0.0 110.16 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 ttp -70.69 129.24 38.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.72 178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.4 t -66.32 -42.65 91.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.731 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -88.01 61.33 6.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.046 0.451 . . . . 0.0 110.115 177.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.1 p -64.06 113.72 3.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.536 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -144.52 163.55 33.52 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.409 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 p -126.9 150.65 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.68 -174.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -104.15 154.74 19.38 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.576 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 44.9 t -59.46 112.21 1.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.322 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -72.85 0.62 43.8 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.776 -176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.542 HD13 ' HB2' ' A' ' 39' ' ' HIS . 11.3 mt -103.14 -40.51 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 O-C-N 122.755 -0.262 . . . . 0.0 111.206 -174.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.2 p -119.0 -18.44 8.78 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.323 -178.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.32 36.51 27.62 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.026 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -95.54 -62.91 0.98 Allowed Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.126 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.1 m -125.75 -176.2 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.722 0.296 . . . . 0.0 111.254 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -56.74 135.29 55.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.551 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -86.95 74.82 2.27 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -68.34 -31.13 70.31 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -95.47 152.32 18.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.677 0.275 . . . . 0.0 110.331 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -134.31 145.82 49.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.864 0.364 . . . . 0.0 111.045 -174.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.436 ' CB ' HG12 ' A' ' 25' ' ' VAL . 35.5 t -100.48 108.49 53.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.789 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 39.4 Cg_endo -66.94 -13.33 39.55 Favored 'Trans proline' 0 N--CA 1.471 0.174 0 C-N-CA 122.832 2.354 . . . . 0.0 112.744 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -82.82 -56.64 3.71 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.538 -175.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 28.5 p -101.04 -29.47 12.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.969 0.414 . . . . 0.0 110.523 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.11 7.1 31.33 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.321 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.436 HG12 ' CB ' ' A' ' 20' ' ' CYS . 3.2 p -77.28 157.78 5.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.046 0.45 . . . . 0.0 111.447 -173.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.482 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 20.1 mmt180 -115.0 124.33 51.38 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.22 177.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.576 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -123.89 153.93 40.43 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.616 0.722 . . . . 0.0 110.825 178.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -70.08 -33.07 71.43 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.981 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.1 m -168.08 -173.53 2.08 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.589 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.9 mt -64.65 -25.0 67.76 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.69 -41.07 73.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.923 0.392 . . . . 0.0 111.162 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.51 ' HB3' HD12 ' A' ' 10' ' ' ILE . 99.5 m -91.18 -23.0 20.37 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.803 177.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -60.91 2.93 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -86.95 52.79 2.62 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.226 0.536 . . . . 0.0 111.314 -179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.669 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 18.2 t70 -119.0 141.63 48.51 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 173.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -117.57 10.42 13.47 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.957 0.408 . . . . 0.0 111.16 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.67 -45.27 6.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.326 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -109.52 -27.92 9.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.669 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 18.4 t-160 -89.17 97.95 11.49 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.7 t -92.79 118.87 39.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.674 0.749 . . . . 0.0 112.259 -170.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -123.72 -74.75 0.61 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.984 173.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -162.69 21.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.976 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -127.23 129.39 47.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.138 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.2 t 60.4 33.29 20.72 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.584 0.553 . . . . 0.0 110.633 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.28 34.41 0.95 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.279 0.562 . . . . 0.0 111.273 -177.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.505 -0.76 . . . . 0.0 109.757 176.61 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.63 122.33 11.11 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.797 2.331 . . . . 0.0 112.021 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -91.37 131.29 36.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.304 -178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 1.3 mmt -86.79 158.53 19.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.569 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.1 t 60.04 60.68 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.92 0.867 . . . . 0.0 109.463 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -125.33 135.51 52.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.102 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.7 m -118.3 13.52 13.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.108 0.48 . . . . 0.0 110.72 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -114.25 144.57 43.0 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-O 121.375 0.607 . . . . 0.0 110.697 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.3 p -109.17 148.86 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.389 -173.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -108.27 161.6 14.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 49.4 t -65.47 116.36 6.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.572 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -75.85 -4.87 78.09 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.785 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.501 HD13 ' HB2' ' A' ' 39' ' ' HIS . 9.6 mt -98.0 -40.88 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.795 0.331 . . . . 0.0 110.963 -174.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 19.5 p -117.65 -15.71 10.14 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.417 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 61.38 32.55 19.05 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.456 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -92.0 -82.88 1.47 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.292 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -109.03 -168.96 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.649 0.262 . . . . 0.0 110.814 -175.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.22 139.16 58.19 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.28 0.562 . . . . 0.0 111.964 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.72 70.45 3.17 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 175.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -62.36 -27.46 69.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.503 -0.349 . . . . 0.0 111.753 -177.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -103.7 153.88 20.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -138.17 143.79 40.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.729 0.299 . . . . 0.0 110.333 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.439 ' HB2' ' CE2' ' A' ' 27' ' ' TYR . 18.8 t -98.72 107.48 43.24 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.818 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.22 -9.97 27.01 Favored 'Trans proline' 0 C--N 1.335 -0.156 0 C-N-CA 122.776 2.317 . . . . 0.0 112.824 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.41 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 31.1 mmmt -83.92 -62.5 1.55 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.209 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.8 p -93.66 -28.69 15.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.106 0.479 . . . . 0.0 110.496 -176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.3 10.73 35.55 Favored Glycine 0 N--CA 1.442 -0.926 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.802 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 20' ' ' CYS . 3.6 p -79.11 157.99 4.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.153 0.501 . . . . 0.0 111.368 -174.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -113.0 126.54 55.62 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.199 176.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.595 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -127.47 148.28 50.31 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.861 0.838 . . . . 0.0 110.716 176.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 26.7 p -65.57 -32.28 73.77 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.294 -178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.5 m -168.62 -169.92 1.12 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.859 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.4 tp -65.69 -27.62 68.48 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.426 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.538 ' H ' ' HD2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -55.47 -45.0 76.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.51 0.671 . . . . 0.0 111.22 -177.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.442 ' HB3' HD12 ' A' ' 10' ' ' ILE . 73.7 m -87.69 -23.15 24.28 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.71 178.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.405 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -61.28 -63.03 1.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.782 176.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -84.98 52.53 2.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.201 0.524 . . . . 0.0 110.842 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -112.42 148.99 33.18 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.68 15.84 5.35 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.077 0.465 . . . . 0.0 110.799 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -104.31 -43.41 5.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.441 0.639 . . . . 0.0 109.759 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -108.56 -34.8 6.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.688 177.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.501 ' HB2' HD13 ' A' ' 10' ' ' ILE . 13.3 t-160 -91.67 94.0 9.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.935 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.6 t -115.92 126.61 73.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.61 0.719 . . . . 0.0 111.501 -176.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.41 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 3.5 m170 -95.85 -47.38 6.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.072 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -99.85 76.84 1.99 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.326 0.584 . . . . 0.0 110.331 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -105.47 -59.15 1.8 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.934 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.3 t -151.42 115.61 5.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.255 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.02 8.64 18.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.881 177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.977 -177.927 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -60.94 116.52 3.41 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.524 2.15 . . . . 0.0 111.522 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -79.55 51.09 1.2 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.175 0.512 . . . . 0.0 111.139 -176.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.9 mmm -114.48 -20.76 10.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.691 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.7 t 71.47 -54.77 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 123.151 0.58 . . . . 0.0 111.021 -175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.6 t -88.57 55.19 3.3 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.372 0.606 . . . . 0.0 109.678 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -77.8 -28.45 50.38 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.38 178.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.37 159.71 14.87 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.977 176.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 p -132.33 161.42 41.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.767 -173.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.2 mmtt -110.08 158.11 18.63 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 0.0 110.734 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.651 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 33.9 t -66.16 113.95 4.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.123 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -77.23 3.06 59.57 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.861 -177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.794 HD13 ' HB2' ' A' ' 39' ' ' HIS . 16.5 mt -103.0 -40.55 6.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 122.715 -0.286 . . . . 0.0 110.955 -177.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.7 p -118.09 -16.2 9.81 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.291 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 59.54 24.5 13.24 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.334 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.61 -69.76 1.36 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.408 -176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 m -120.79 -168.87 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 110.323 -0.251 . . . . 0.0 110.323 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.5 m-20 -66.77 142.8 57.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.133 0.492 . . . . 0.0 111.243 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.47 78.22 1.64 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.3 pttt -66.89 -33.44 75.6 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.883 0.373 . . . . 0.0 111.351 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -93.31 153.8 18.35 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 12.1 tmtt? -142.81 145.18 32.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.639 0.257 . . . . 0.0 110.694 -175.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.413 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 42.0 t -96.58 113.46 62.69 Favored Pre-proline 0 CA--C 1.516 -0.34 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.04 -13.77 41.38 Favored 'Trans proline' 0 C--N 1.334 -0.233 0 C-N-CA 122.575 2.184 . . . . 0.0 112.385 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.436 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 30.8 mmmt -88.29 -56.02 3.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.819 -175.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 20.0 p -98.35 -21.44 16.61 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.162 -178.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.0 16.74 46.54 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.637 176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -85.81 158.91 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 120.961 0.41 . . . . 0.0 110.4 -175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -116.62 129.07 55.94 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.014 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.651 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -129.96 152.94 48.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.795 0.807 . . . . 0.0 111.133 177.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.8 p -72.78 -20.5 61.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.442 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 79.4 p -178.28 -169.39 0.19 Allowed 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.291 0.369 . . . . 0.0 110.422 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.453 ' HA ' ' HB3' ' A' ' 33' ' ' TYR . 33.9 mt -65.34 -20.24 66.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.424 175.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -59.15 -39.47 82.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.162 0.506 . . . . 0.0 110.724 -177.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.494 ' HB3' HD12 ' A' ' 10' ' ' ILE . 90.6 m -97.87 -22.31 16.42 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.453 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 30' ' ' LEU . 0.9 OUTLIER -57.96 -58.85 6.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.83 177.466 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mtmm -90.72 35.52 0.89 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.095 0.474 . . . . 0.0 111.07 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 10.5 t70 -101.13 122.32 43.39 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 175.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.36 17.11 24.75 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.904 0.383 . . . . 0.0 111.076 -177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -99.63 -47.15 5.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.102 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -103.66 -32.42 9.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.531 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.794 ' HB2' HD13 ' A' ' 10' ' ' ILE . 12.9 t-160 -100.54 88.92 3.76 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.583 0.706 . . . . 0.0 109.511 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.3 p -120.96 122.51 67.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-O 121.718 0.77 . . . . 0.0 111.838 -174.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.436 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 5.4 m170 -75.62 79.34 2.61 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.317 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.1 tptt -87.08 115.66 24.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.599 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 59.24 48.33 10.43 Favored 'General case' 0 C--O 1.233 0.225 0 O-C-N 123.599 0.562 . . . . 0.0 110.636 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.5 p -81.66 58.51 3.79 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.262 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -93.52 88.63 5.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 . . . . . 0 C--O 1.245 0.852 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.067 -177.737 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.584 0 N-CA-C 111.993 -0.443 . . . . 0.0 111.993 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.36 161.63 34.53 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.948 2.432 . . . . 0.0 111.608 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -86.56 46.33 1.34 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.166 0.507 . . . . 0.0 110.309 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.1 mmm 61.45 59.62 1.85 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.791 -176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -82.89 -9.81 11.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.935 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.1 m -63.55 127.74 32.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.346 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m -86.01 86.26 7.36 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.029 0.442 . . . . 0.0 110.683 -177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.94 154.03 25.25 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-O 121.538 0.685 . . . . 0.0 110.699 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.551 HG11 ' HG3' ' A' ' 26' ' ' ARG . 4.2 p -99.55 155.94 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.59 -176.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 15' ' ' ASP . 74.5 mmtt -99.54 156.82 16.85 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 47.5 t -62.59 111.93 2.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.424 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -79.7 24.7 3.13 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.664 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.446 HD13 ' HB2' ' A' ' 39' ' ' HIS . 10.1 mt -125.08 -39.01 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 O-C-N 122.666 -0.314 . . . . 0.0 110.857 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 21.4 p -119.78 -16.25 8.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.13 0.491 . . . . 0.0 110.745 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? 56.75 27.69 13.14 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.518 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -83.19 -68.87 1.41 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.006 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -120.46 -168.91 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 120.514 0.197 . . . . 0.0 110.547 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 5.9 p-10 -61.31 146.52 47.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.418 0.628 . . . . 0.0 111.629 178.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -90.03 70.31 2.29 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.429 176.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.38 -25.15 66.65 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.884 0.373 . . . . 0.0 111.805 -178.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -98.68 149.49 22.77 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.545 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 0.6 OUTLIER -131.73 145.66 51.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.822 0.344 . . . . 0.0 111.053 -174.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.569 ' HB3' HG12 ' A' ' 25' ' ' VAL . 43.4 t -102.51 107.28 53.24 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.109 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.33 -9.93 27.41 Favored 'Trans proline' 0 N--CA 1.472 0.236 0 C-N-CA 122.883 2.389 . . . . 0.0 112.97 -177.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 30.3 mmmt -82.7 -49.16 10.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.007 -176.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.5 p -111.12 -33.18 6.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.844 -176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.45 16.2 13.74 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.152 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.616 HG11 ' CD2' ' A' ' 39' ' ' HIS . 4.3 p -81.19 158.9 4.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.977 0.418 . . . . 0.0 110.675 -176.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.551 ' HG3' HG11 ' A' ' 6' ' ' VAL . 61.3 mmt-85 -114.58 121.35 43.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.296 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.527 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -122.24 155.88 34.95 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.548 0.689 . . . . 0.0 110.909 176.211 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.1 p -71.21 -34.08 70.5 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.807 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.1 m -167.58 -172.93 2.04 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.328 -174.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 tp -62.77 -31.59 72.58 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 122.65 0.38 . . . . 0.0 111.508 -177.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -53.6 -43.34 68.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.544 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.416 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.6 m -87.99 -23.1 23.92 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.66 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.494 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -56.67 -58.73 6.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.141 177.092 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -87.04 50.8 2.09 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.409 0.623 . . . . 0.0 111.526 -176.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.66 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 9.4 t70 -109.87 150.76 27.95 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.12 -0.6 5.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.246 0.546 . . . . 0.0 111.002 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.88 -48.07 9.08 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.057 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -108.03 -33.9 7.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.518 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.66 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 10.4 t-160 -81.28 91.09 6.16 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.07 120.31 35.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.118 -169.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.441 ' CE1' ' HB2' ' A' ' 22' ' ' LYS . 5.4 m170 -138.54 172.43 12.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.228 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 22.3 pttp -143.9 -179.08 6.26 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 42' ' ' LYS . 17.3 mm-40 72.59 -65.6 0.35 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.479 0.487 . . . . 0.0 111.018 -179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.6 m -80.77 54.59 2.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.238 0.542 . . . . 0.0 110.381 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.14 -32.46 24.65 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.353 -177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.598 -0.715 . . . . 0.0 110.029 179.101 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -60.91 136.0 63.08 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.673 2.249 . . . . 0.0 112.306 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.57 37.07 4.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.552 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.4 mtp 68.28 111.29 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.529 -175.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 98.9 t -55.45 -38.21 48.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.336 0.589 . . . . 0.0 109.723 176.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.3 m -91.28 70.35 6.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.704 173.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.9 m -69.6 -29.68 67.26 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.94 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.2 149.76 49.84 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.273 0.559 . . . . 0.0 110.225 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.54 148.98 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.253 -174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.45 158.68 16.18 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 36.3 t -63.66 115.73 5.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.15 178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 12' ' ' ARG . . . -81.3 17.86 12.07 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.494 -177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.537 HG23 ' HB2' ' A' ' 38' ' ' LYS . 10.1 mt -119.13 -46.03 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 120.853 0.359 . . . . 0.0 110.742 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 24.0 p -110.6 -13.87 14.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.485 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.457 ' CZ ' ' HA2' ' A' ' 9' ' ' GLY . 35.4 mmt180 55.45 30.63 15.41 Favored 'General case' 0 N--CA 1.461 0.093 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.833 178.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.24 -69.13 1.01 Allowed Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.348 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.7 m -114.13 -170.18 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 C-N-CA 121.276 -0.17 . . . . 0.0 110.765 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 28' ' ' CYS . 5.7 p-10 -63.27 145.79 54.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.326 0.584 . . . . 0.0 111.619 -178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.513 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -92.1 65.74 2.21 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.365 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 6.7 ptpp? -56.89 -36.3 69.97 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.438 ' CD1' ' HG3' ' A' ' 17' ' ' LYS . 3.7 m-30 -94.65 149.63 21.05 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 20' ' ' CYS . 13.1 tmtt? -134.43 144.29 48.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.789 0.328 . . . . 0.0 110.771 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.492 ' N ' ' HD3' ' A' ' 19' ' ' LYS . 25.1 t -97.98 107.35 40.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.806 -178.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 20' ' ' CYS . 39.8 Cg_endo -66.64 -10.07 26.69 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 123.04 2.493 . . . . 0.0 113.565 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -84.55 -63.11 1.39 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.908 0.385 . . . . 0.0 111.232 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 30.6 p -94.05 -32.34 13.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.201 0.524 . . . . 0.0 110.601 -173.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.41 21.47 9.3 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.168 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.621 HG11 ' CD2' ' A' ' 39' ' ' HIS . 4.0 p -88.04 158.74 3.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.969 0.414 . . . . 0.0 110.618 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 21.5 mmt180 -116.02 129.53 56.41 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.011 178.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.581 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -131.32 151.05 51.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.702 0.763 . . . . 0.0 110.949 177.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.0 p -71.24 -19.61 62.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.555 -1.202 . . . . 0.0 111.751 -174.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.3 t -175.94 -171.35 0.44 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.76 0.315 . . . . 0.0 110.547 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.418 ' HG ' ' HE2' ' A' ' 34' ' ' LYS . 37.2 tp -69.89 -19.82 63.4 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.529 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.56 -49.34 77.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.051 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' A' ' 10' ' ' ILE . 97.4 m -81.53 -20.88 39.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.67 177.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.408 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -59.32 -59.57 5.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.869 176.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HE2' ' HG ' ' A' ' 30' ' ' LEU . 55.0 mtmt -84.86 54.31 3.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.632 0.73 . . . . 0.0 110.999 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.576 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 13.7 t70 -111.64 149.79 31.03 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.564 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.57 13.05 7.51 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.731 0.3 . . . . 0.0 111.628 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -101.73 -38.2 7.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.382 0.61 . . . . 0.0 110.092 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.537 ' HB2' HG23 ' A' ' 10' ' ' ILE . 96.8 mttt -118.49 -32.97 4.45 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.296 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.621 ' CD2' HG11 ' A' ' 25' ' ' VAL . 7.8 t-160 -84.36 93.93 8.37 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.47 120.41 45.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.899 -172.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -134.36 57.99 1.79 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.541 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm 68.72 134.41 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.422 -176.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -88.17 -156.72 0.38 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.063 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 11.0 p -51.26 -43.88 61.63 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.106 0.479 . . . . 0.0 111.125 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -145.73 -51.4 0.25 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.422 173.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--O 1.251 1.133 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.592 -177.586 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.805 0 N-CA-C 111.793 -0.523 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.91 135.13 17.1 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.553 2.169 . . . . 0.0 111.91 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -80.46 128.54 33.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.919 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptm -145.96 136.42 24.04 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.646 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.6 m -89.21 72.22 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.452 0.644 . . . . 0.0 110.101 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 m -52.4 125.41 16.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.357 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.7 m 60.53 78.64 0.27 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.925 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.99 165.03 23.0 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.706 178.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 15' ' ' ASP . 4.0 p -141.35 148.3 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.501 -170.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -106.18 154.01 21.3 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' SG ' ' HA ' ' A' ' 27' ' ' TYR . 38.7 t -59.41 110.02 1.01 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.538 179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.26 18.14 3.63 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.732 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.652 HG23 ' HB2' ' A' ' 38' ' ' LYS . 7.5 mt -119.98 -36.1 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.565 0.221 . . . . 0.0 111.15 -177.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 20.4 p -124.84 -14.7 6.64 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.439 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 12' ' ' ARG . 5.7 mpt_? 58.77 28.9 17.98 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.835 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.4 -78.06 1.14 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.699 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.07 -171.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 6.2 p-10 -58.12 144.21 41.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.51 0.672 . . . . 0.0 111.425 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.602 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . -86.92 68.54 3.22 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.175 175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 17' ' ' LYS . 4.3 ptpp? -58.86 -34.29 71.43 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -94.94 146.7 24.06 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.65 145.98 51.47 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.822 0.344 . . . . 0.0 110.772 -174.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.431 ' CB ' HG12 ' A' ' 25' ' ' VAL . 38.3 t -98.4 106.75 37.93 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.951 178.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.41 -6.41 16.36 Favored 'Trans proline' 0 CA--C 1.528 0.206 0 C-N-CA 122.615 2.21 . . . . 0.0 113.119 -177.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -86.64 -63.48 1.31 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.866 0.365 . . . . 0.0 111.037 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 27.8 p -93.97 -30.29 14.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.049 0.452 . . . . 0.0 110.245 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.72 7.96 35.56 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.051 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.499 HG11 ' CD2' ' A' ' 39' ' ' HIS . 3.4 p -74.68 157.34 6.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.983 0.42 . . . . 0.0 111.002 -173.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.602 ' HD2' ' O ' ' A' ' 16' ' ' GLY . 22.2 mmt180 -114.73 125.75 54.08 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.518 178.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.593 ' HA ' ' SG ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -128.02 153.22 47.01 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.724 0.773 . . . . 0.0 110.986 177.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 8' ' ' CYS . 28.8 p -74.5 -20.24 60.06 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.434 -175.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.7 t -175.08 -177.03 1.01 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.683 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 37.0 tp -62.8 -24.98 68.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.081 0.467 . . . . 0.0 110.22 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -52.36 -54.05 36.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.261 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -84.1 -20.01 33.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' HA ' ' CD2' ' A' ' 27' ' ' TYR . 1.0 OUTLIER -57.48 -56.14 25.78 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -89.55 47.34 1.46 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.693 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.681 ' O ' ' HB3' ' A' ' 39' ' ' HIS . 9.3 t70 -110.55 133.26 53.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -114.11 25.38 11.18 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.064 0.459 . . . . 0.0 111.207 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.98 -45.09 3.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.445 0.641 . . . . 0.0 109.805 178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.652 ' HB2' HG23 ' A' ' 10' ' ' ILE . 48.9 mmtm -97.67 -47.57 5.56 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.679 177.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.681 ' HB3' ' O ' ' A' ' 35' ' ' ASP . 12.3 t-160 -79.93 99.1 7.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.531 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.3 t -104.06 129.76 55.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.48 0.657 . . . . 0.0 111.966 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -123.05 97.44 5.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.652 175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -87.1 145.12 26.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.676 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.78 144.49 51.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.02 0.438 . . . . 0.0 110.059 174.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 t -137.45 60.27 1.65 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.606 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.26 41.54 1.25 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.993 178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.503 -177.731 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_